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1. Introduction  
Proventricular dilatation disease (PDD) is a chronic and fatal disease affecting mainly 
psittacine birds such as macaws, amazon or African grey parrots, conures, cockatoos, and 
cockatiels. PDD was identified in the late of 1970s and was originally known as "macaw 
wasting syndrome" (Graham, 1991; Hughes, 1984; Clark, 1984). PDD is characterized by 
ganglioneuritis in the enteric nervous system and encephalomyelitis (Berhane et al., 2001). 
Clinically, birds with PDD are presenting gastrointestinal tract dysfunction (diarrhea, 
dysphagia, regurgitation, and passage of undigested food in the droppings), and/or 
neurological symptoms (ataxia, abnormal gait, incoordination), or both (Mannl et al., 1987; 
Vice, 1992; Gregory et al., 1994). Avian borna virus (ABV) is a newly discovered member of 
the family Bornaviridae that has been identified as the etiological agent of PDD (Honkavuori 
et al., 2008, Kistler et al., 2008). Subsequent studies confirmed an association between ABV 
and PDD (Lierz et al., 2009; Villanueva et al., 2009; Gancz et al., 2009; Gray et al., 2010; 
Kistler et al., 2010; Raghav et al., 2010; Piepenbring et al., 2012). Until now, fourteen ABV 
genotypes have been detected in psittacine and non psittacine birds (Kuhn et al., 2015). The 
most successful route of infection for a widespread ABV distribution within the central and 
peripheral nervous system and association of antiviral immune response is yet unknown and 
needs to be investigated. In addition, host factors such as immunocompetence, individual 
constitution and genetic factors as well as virulence of the respective ABV genotype and 
time course of the infection most likely play an important role for the outcome of the disease. 
Therefore, the study aimed to characterize the distribution pattern of different ABV genotypes 
and inflammatory lesions combined with analysis of the invading immune cell populations 
after ABV-2 and after ABV-4 infection in cockatiels. This can essentially contribute to 
enlarge the knowledge on neurotropic virus infections that are able to cause neurological and 
gastrointestinal dysfunctions. Experimental ABV infections allow to analyse defined 
conditions, e.g. route of infection, time course of infection or pathogenicity of ABV 
genotype. To address the route of infection, animals were infected intracerebrally and 
intravenously and potential ABV infection of cockatiel blood cells was performed 
additionally. For this purpose, isolation, culturing, and infection of cockatiel blood cells was 
established in the current study. Moreover, subpopulations of the immune cells of the 
cockatiel blood were further characterized. Infection of cockatiel blood cells with ABV-4 was 
tried without and after stimulation with phytohaemagglutinin (PHA-M) mitogen in vitro. To 
sum up, differences in pathogenicity between ABV-2 and ABV-4 were identified after 
experimental infection with ABV-2 or ABV-4 in cockatiels as seen by differences in the 
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organ tropism and histological lesions. ABV-2 has a more pronounced tropism for the GIT 
and peripheral organs while ABV-4 was mainly found in the CNS and peripheral organs. The 
study also indicates that CD3-positive cells were found in the inflammatory lesions after 
experimental infection with ABV-2 and ABV-4 in cockatiels. Moreover, this study provides 
evidence that at least in vitro under the applied conditions ABV-4 infection of cockatiel blood 
cells is not possible. Whether the haematological route might play a role for viral 
dissemination after ABV infection has to be addressed in the future. 
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2. Literature review 
2.1. Psittacine proventricular dilatation (PDD) 
2.1.1. Definition  
Psittacine proventricular dilatation (PDD) is a progressive, variably contagious and often fatal 
disease affecting predominantly psittacine birds worldwide. Typical clinical signs such as 
gastrointestinal dysfunction and associated wasting with or without neurological symptoms 
are caused by non purulent inflammation in the enteric, autonomic and central nervous 
system. PDD is characterized by encephalomyelitis and ganglioneuritis (Berhane et al., 2001; 
Gregory et al., 1994). Ganglia of the crop, proventriculus, gizzard and small intestine are most 
frequently affected resulting in motility disorders and dilatation of the proventriculus. PDD is 
affecting not only psittacine birds (parrots) but also non psittacine birds such as waterfowl 
(Daoust et al., 1991; Guo et al., 2014), canary (Serinus canaria),  greenfinch (Carduelis 
chloris), a long-wattled umbrella bird (Cephalopterus penduliger), and a bearded barbet 
(Lybius dubius) (Perpiñán et al., 2007). Raptors such as red-tailed hawk (Buteo jamancensis), 
peregrine falcon (Falco peregrinus) and bald eagle (Haliaeetus leucocephalus) could also be 
infected with PDD (Shivaprasad, 2005; Hoppes et al., 2013). 
 
2.1.2. History of psittacine proventricular dilatation 
PDD was firstly identified in macaws imported into the United States and Germany from 
Bolivia (Ridgway et al., 1983; Mannl et al., 1987; Gerlach, 1991; Gregory et al., 1994; 
Gregory et al., 1995) and in Canada (Berhane et al., 2004). At that time, PDD was also 
described as “macaw wasting or fading syndrome”, “macaw wasting syndrome”, and “gastric 
distension of macaws” in 1979 because initially, the disease seemed to occur only in macaws 
(Gregory et al., 1994). Since then, the causative agent of this disease remained unclear. When 
it became apparent that the disease occurred also in psittacines other than macaws, more 
general terms were used to describe the syndrome including proventricular dilatation, 
proventricular dilatation syndrome, psittacine proventricular dilatation syndrome (Graham et 
al., 1991). Additionally, other lesions than proventricular dilatation, such as myocarditis, and 
non purulent encephalitis have also been reported (Hughes, 1984; Gerlach, 1991). Recently, 
PDD has been identified in more than 80 species of psittaciformes including members of the 
Cacatuidae families (i.e., cockatoos and cockatiels) and Psittacidae (i.e., lovebirds, macaws, 
parakeets, parrots, Amazon parrots, and conures) (Gregory et al., 1994; Mannl et al., 1987; 
Weissenböck et al., 2009a; Shivaprasad et al., 2010).  
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2.1.3. Clinical signs of PDD 
Clinical signs of PDD consist of gastrointestinal and/or neurological clinical signs. Both sexes 
suffered from PDD and birds of any age can be affected with PDD (Graham et al., 1991; 
Gregory et al., 1994; Kistler et al., 2010). Two forms of PDD have been identified; the 
classical form (gastrointestinal form) and the nervous form. Affected birds mostly develop 
gastrointestinal clinical signs such as depression, weight loss (with or without decreased 
appetite), constant or intermittent regurgitation, and/or passage of undigested seeds in the 
faeces indicating a malabsorptive or maldigestive disorder. Passing of nutrients and 
undigested feed in the faeces occurs due to inflammation of the enteric nervous system 
(Gregory et al., 1994). The affected birds may also exhibit neurological clinical symptoms 
such as abnormal gait, ataxia and propioceptive defect, tremors and occasionally seizures 
(Gregory et al., 1994). Some birds are displaying both gastrointestinal and neurological signs 
(Mannl et al., 1987; Vice 1992). Clinical signs of PDD can appear suddenly or progress 
slowly.  
Horie and colleagues (2012) detected avian borna virus (ABV-5) RNA in parrots Eclectus 
roratus with feather picking disorder (FPD) in Japan. Birds had no clinical signs of PDD. It 
remains unknown whether ABV-5 is associated with FPD. Feather picking disorder (FPD) is 
a destructive behaviour pattern of birds commonly seen in captive birds and commercial 
poultry which chew or bite their own feathers with their beak, resulting in damage to the 
feathers and occasionally the skin of the neck, chest, flank, inner thigh and ventral wing.  
 
2.1.4. Occurrence and geographical distribution of PDD 
Acute outbreaks of PDD with high mortality have been reported in psittacine birds (Lublin et 
al., 2006; Kistler et al., 2010). PDD outbreaks most frequently occur in crowded indoor 
aviaries (Gancz et al., 2010). PDD occurs worldwide,e.g. in the United States (Woerpel et al., 
1984), in Australia (Sullivan et al., 1997; Doneley et al., 2007), Middle East (Lublin et al., 
2006; Kistler et al., 2008; Wyss et al., 2009), South America (Marietto-Goncalves et al., 
2009), South Africa (Gancz et al., 2010; Last et al.,2012) and Japan (Ogawa et al.,2011). 
Birds trading and smuggling could have contributed to the global dissemination of PDD 
among continents (Gregory et al., 1997; Doneley et al., 2007; Honkavuori et al. 2008; Staeheli 
et al., 2010).  
 
2.1.5. PDD in psittacine birds 
PDD is threatening the aviculture of psittacine birds. PDD has been observed in more than 80 
species of psittacine birds (Clark et al., 1984; Mannl et al., 1987; Weissenböck et al., 2009a; 
Shivaprasad et al., 2010). Certain species, such as African grey parrots (Psittacus erithacus), 
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blue and gold macaws (Ara ararauna), cockatoos, and Amazon parrots, seem to be most 
frequently affected (Schmidt et al., 2003) whereas other species, such as budgerigars 
(Melopsittacus undulatus), appear to be more resistant to the disease (Graham et al., 1991; 
Reavill et al., 2007). It is noteworthy that Spix’s macaw is an endangered species in the 
wild in Brazil and it is undoubtedly affected by PDD (Wyss et al., 2009; Enderlein et al., 
2011).  
 
2.1.6. PDD in non psittacine birds 
A PDD-like disease was identified in wild Canada geese (Branta canadensis) which showed 
emaciation, severe proventricular food impaction, nonsuppurative encephalomyelitis and 
ganglioneuritis typical to PDD in psittacine birds (Daoust et al., 1991). PDD-like disease has 
also been described in many raptors such as red-tailed hawk (Buteo jamancensis), peregrine 
falcon (Falco peregrinus) (Shivaprasad 2005). Perpiñán and colleagues (2007) identified 
PDD in canaries (Serinus canaria), a long-wattled umbrella bird (Cephalopterus penduliger), 
a bearded barbet (Lybius dubius), honey creeper, and weaver finch with clinical and 
pathologic findings compatible with PDD. 
 
2.1.7. Aetiology 
Since the description of PDD in the late 1970’s in Macaws which had been imported into the 
United States and Germany (Graham, 1984; Hughes, 1984; Gerlach, 1991), a viral agent was  
believed as a cause of the disease (Gregory1995; Gregory et al., 1998a). Several viruses have 
been supposed as cause, e.g. adeno-like virus, herpes virus (Pacheco’s disease virus), 
polyomavirus, avian encephalomyelitis virus, and paramyxo-like virus (Gregory et al., 1998b; 
Grund, et al., 2002) and the cause remained unknown for approximately 40 years. In 2008, 
independent researchers detected a novel avian borna virus (ABV) in birds suffering from 
PDD and claimed it is as the etiological agent for PDD (Honkavuori et al., 2008; Kistler et al., 
2008).  
 
2.2. Discovery of avian borna viruses (ABV) 
ABV was firstly identified from psittacines suffering from PDD (Kistler et al., 2008; 
Hounkavouri et al., 2008). In one of the first studies, RNA extracted from parrots with PDD in 
the United States was hybridized to a panviral microarray. This screening yielded a discovery 
of a Borna disease virus (BoDV-1-like virus) in birds with PDD, which was confirmed by 
high-throughput sequencing (Kistler et al., 2008). In a second independent study, RNA 
extracted from tissues of parrots with PDD in Israel was reversely transcribed and also 
directly subjected to high throughput sequencing followed by searches for sequence 
Chapter two - Literature review 
 
 6
similarities to known viruses. Again, genetic material with similarity to BoDV-1 was 
identified (Hounkavouri et al., 2008). 
 
2.3. Avian borna virus (ABV)            
2.3.1. Taxonomy 
Avian borna viruses (ABV) belong to the order Mononegavirales, family Bornaviridae, genus 
Borna virus and was discovered in psittaciform birds with proventricular dilatation disease 
(PDD) in 2008 (Kistler et al., 2008; Hounkavouri et al., 2008). At that time, it was designated 
to five distinct ABV genetic subgroups or genotypes (ABV-1, ABV-2, ABV-3, ABV-4, and 
ABV-5, Kistler et al., 2008). Until now, a total of 14 ABV genotypes have been identified in 
psittacine and non-psittacine birds (Weissenböck et al., 2009; Delnatte et al., 2011; Horie et 
al., 2010; Horie et al., 2013; Kuhn et al., 2015). Seven ABV genotypes (ABV-1, ABV-2, 
ABV-3, ABV-4, ABV-5, ABV-6, and ABV-7) have mainly been identified in psittacine birds 
(Honkavuori et al., 2008; Gancz et al., 2010; Kuhn et al., 2015). Moreover, seven additional 
ABV genotypes have also been detected in non psittacine birds (Kuhn et al., 2015), in 
canaries (Serinus canaria) from Germany named as ABV-C1, ABV-C2, and ABV-C3 
(Weissenböck et al., 2009b; Rinder et al., 2012), in Canada geese (Branta canadensis) 
designated as (ABV-CG) genotype (Delnatte et al., 2011), in mallards (Anas platyrhynchos) 
and in wood ducks (Aix sponsa) (Guo et al., 2014), in a Bengalese finch (Lonchura striata) 
(Rubbenstroth et al., 2013), in trumpeter swans (Cygnus buccinator) and feral mute swans 
(Cygnus olor) in North America (Guo et al., 2012; Delnatte et al., 2013). ABV-2 and ABV-4 
genotypes are the most common genotypes in psittacine birds in Europe and North America. 
The genetic variability of ABV is much greater than the variability observed among the 
mammalian borna viruses (Dürrwald et al., 2007; Weissenböck et al., 2009; Kuhn et al., 
2015). For ABV, there is conservation in genomic nucleotide sequence is around 91–100% 
within one ABV genotype, and 68-85% between ABV genotypes, and 60-69% when 
compared to BoDV isolates (Kistler et al., 2008; Payne et al., 2011). For mammalian borna 
viruses, a highly homology in genomic nucleotide sequence (95%) have been detected in all 
mammalian borna viruses isolates (Staeheli et al., 2000; Dürrwald et al., 2006; Dürrwald et 
al., 2014; Kuhn et al., 2015). Borna disease virus 2 (BoDV-2) (No/98 isolate) showed 
diversity in genomic nucleotide sequence (15%) when compared to BoDV-1 (Nowotny et al., 
2000; Kuhn et al., 2015). Recent study revealed that an additional genotype of borna virus 
were discovered in a Loveridge’s garter snake (Elapsoidea loveridgei) from Tanzania 
(Stenglein et al., 2014), and an unclassified bornavirus was detected in reptiles (Fujino et al., 
2012). Due to sequence comparisons of bornavirus genomes, alignments comparison of 
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genomic and protein sequences, phylogenetic analyses and known biological characteristics of 
bornaviruses, Kuhn and colleagues, (2015) reorganized species classification of the genus 
Bornavirus, family name Bornaviridae in an proposed updated taxonomy for ABV as given in 
table 1.  
 
Table 1: Proposed classification of bornaviruses (Kuhn et al., 2015) 
 
Order Family Genus Species Virus 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mononegavirals  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bornaviridae 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Borna virus  
 
Mammalian 1 
bornavirus 
 
Borna disease virus 1 
(BoDV-1) 
Borna disease virus 2 
(BoDV-2) 
 
 
 
 
Psittaciform 1 
bornavirus 
parrot bornavirus 1 
(PaBV-1) 
parrot bornavirus 2 
(PaBV-2) 
parrot bornavirus 3 
(PaBV-3)  
parrot bornavirus 4 
(PaBV-4) 
parrot bornavirus 7 
(PaBV-7) 
 
 
 
Passeriform 1 
bornavirus 
canary bornavirus 1 
(CnBV-1) 
canary bornavirus 2 
(CnBV-2) 
canary bornavirus 3 
(CnBV-3) 
munia bornavirus 1 
(MuBV-1) 
Waterbird 1 
bornavirus 
aquatic bird 
bornavirus 1  
(ABBV-1) 
Passeriform 2 
bornavirus 
estrildid finch 
bornavirus 1(EsBV1) 
unassigned 
bornaviruses 
Elapid 1 
bornavirus 
Loveridge’s garter 
snake virus1(LGSV1)
tentative, 
unclassified 
bornaviruses 
 avian bornavirus 
MALL (ABVMALL) 
Gaboon viper virus 1 
(GaVV-1)  
parrot bornavirus 5 
(PaBV-5)  
parrot bornavirus 6 
(PaBV-6) 
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2.3.2. Virion morphology and physical characteristics 
ABV shares similarities to the mammalian borna virus regarding the genome organization and 
morphology. ABV viral particles were 83 to 104 nanometer (nm) in diameter with lipid 
envelope (Hopes et al., 2010; reviewed in Herden et al., 2013).  
 
2.3.3. ABV genome 
Avian borna viruses are negative-sense, single-stranded, none segmented enveloped RNA 
viruses (Kistler et al., 2008). ABV has six open reading frames (ORF) with a typical 3’ to 5’ 
genome organization as known for Mononegavirales (reviewed in Herden et al., 2013). The 
first predicted transcription unit encodes for the viral nucleoprotein (N), the second predicted 
transcription unit for the regulatory protein (X) and the viral phosphoprotein (P), and the third 
transcription unit is predicted to code for the viral matrix protein (M), the viral glycoprotein 
(G)  and the RNA-dependent-RNA- polymerase (L) (Kistler et al., 2008). Similarly to BoDV-
1 genome organization, ABV X and P are encoded from overlapping reading frames and the 
primary transcript of the third transcription unit is likely formed by splicing (Kistler et al., 
2008). Three transcription units (I, II, III) have been determined in the genomic organization 
of BoDV-1 with three transcription initiation signals (S1–S3) and four transcription 
termination signals (T1-T4) which harbour at least six open reading frames (ORFs) (Carbone 
et al., 1994, Schneemann et al., 1995, de la Torre 2002, Tomonaga 2002, reviewed in Herden 
et al., 2013). BoDV replicates and transcribes in the nucleus of the host cells. A 21-22 
nucleotide (nt) deletion in the region between the N and X gene have been identified in parrot 
bornavirus 1 (PaBV-1), parrot bornavirus 2 (PaBV-2), parrot bornavirus 3 (PaBV-3), parrot 
bornavirus 4 (PaBV-4), parrot bornavirus 5 (PaBV-5), parrot bornavirus 7 (PaBV-7), ABV-
Canada geese (ABV-CG), and reptile bornavirus (Kistler et al., 2008; Rinder et al., 2009; 
Payne et al., 2011a; Fujino et al., 2012; Mirhosseini et al., 2012; Rubbenstroth et al., 2012; 
Horie et al., 2012). These fragments might have regulatory function for the control of 
expression of the viral proteins X and P (Rinder et al., 2009). The loss of these elements in 
ABV suggests that regulation of the X protein expression may be carried out by other means 
in ABV-infected cells (Kistler et al., 2008; Rinder et al., 2009; Staeheli et al., 2010). 
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2.3.4. ABV proteins  
2.3.4.1. ABV nucleoprotein (N) 
The BoDV-N gene is encoded by the first transcription unit (Cubitt et al., 1994; Schneemann 
et al., 1995; Kobayashi et al., 2001). BoDV-N interacts with the viral RNA and accumulates 
in the nucleus during the life cycle of the virus (Briesa et al., 1992). During the viral 
replication cycle, BoDV-1-N is synthesized like other proteins within the cytoplasm and then 
enters the nucleus, where it participates in the transcription and replication process 
(Schwemmie et al., 1999; reviewed in Herden et al., 2013). There are two different isoforms 
of BoDV-1-N (p38 (38 kDa) and p40 (40 kDa) (Briese et al., 1996; Kobayashi et al., 2001). 
Both isoforms (p38 and p40) are differed in presence or absence in the amino acids terminal 
basic sequence that mediates the nuclear localization. The p40 is primarily located within the 
nucleus while p38 is mainly expressed in the cytoplasm (Pyper and Gartner, 1997).  In 
comparison to ABV-N, until now, there is no evidence that ABV have different isoforms as it 
was found for classical BoDV-1 (Gray et al., 2010; Villanueva et al., 2010). So far, ABV-N 
was detected in vivo in the nucleus of neurons with or without weaker immunoreactivity in the 
cytoplasm. In vivo, Ouyang and colleagues (2009) searched for ABV-N in the CNS of 13 
psittacines with confirmed PDD. ABV-N was present intranuclearly in glial cells of the 
cerebrum, and Purkinje neurons of the cerebellum in all 13 PDD birds. These findings were 
confirmed by investigations by Weissenböck et al., 2009a. In a subsequent study, 
Wünschmann and colleagues, (2011) detected ABV-N in neurons, astroglial cells, Bergmann 
glial cells, ependymal cells, ganglia of the myenteric plexus in the gastrointestinal tract, 
cardiomyocytes, tubular epithelial cells of the kidney, epithelial cells of the GIT organs, 
photoreceptors, smooth muscle cells of the lamina muscularis of the GIT organs, arteries in 
the heart in tissues of 7 psittacines with PDD and 8 psittacines without PDD. In vitro, Gray 
and colleagues, (2010) injected forebrain from a yellow-collared macaw with confirmed 
proventricular dilatation disease (M24) into primary duck embryonic fibroblasts (DEFs). 
Three days later, nuclear and cytoplasmic signals for ABV-N were detected in DEFs by 
immunofluorescence assay.  
 
2.3.4.2. ABV phosphoprotein (P) 
BoDV-P is encoded by the second transcription unit (Cubitt et al., 1994; Schneemann et al., 
1995). The 5'-end of the P protein ORF overlaps with the 3'-end of the regulatory X protein. 
The function of BoDV-P is a cofactor for the RNA-dependent RNA polymerase. Moreover, 
BoDV-P may also be responsible for binding to other viral proteins and served as a regulatory 
cofactor in persistently infected cell. In vivo, ABV-P was present in the neurons and nerve 
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fibers of the brain, enteric ganglia of the upper digestive tract, nerve fibers and smooth muscle 
fibers of the upper digestive tract as well as in myocytes and fibers of the conductive system 
of the heart in tissues of 31 psittacine birds with PDD (Weissenböck et al., 2009a). 
Weissenböck and colleagues (2009a) also referred that staining pattern of ABV-P was 
variable; they found ABV-P in neuronal nuclei only or also in the cytoplasm and vice versa. 
ABV-P was also detected in the nuclei and cell bodies of enteric ganglia as well as nerve 
fibers in 31 psittacine birds with PDD (Weissenböck et al., 2009a). In another study, ABV-P 
was present in the cytoplasm and nuclei of infected cells of the lamina propria, epithelial cells 
in the gastrointestinal tract (GIT), myocytes and hepatocytes in 30 captive European parrots 
with clinical and/or histopathological signs of PDD (Rinder et al., 2009). Due to detection of 
ABV-P in both the cytoplasm and nucleus of infected cells, nuclear replication of ABV was 
suggested as known for BoDV-1 (Rinder et al., 2009). ABV-P was also detected in the central 
nervous system and gastrointestinal tract in 10 psittacine birds with PDD indicating that ABV 
has a broad distribution pattern and tissue tropism in psittacine birds with PDD (Kistler et al., 
2009). Recently, Payne et al., (2011a) showed that ABV-P was present in the nucleus and/or 
cytoplasm in the cells of various organs such as glial cells and neurons of the brain and spinal 
cord, enteric nervous tissues, cells in the lamina propria of the GIT, cells of the retina, tubular 
epithelial cells of the kidneys, seminiferous tubules, islet cells of the pancreas and smooth 
muscle cells of blood vessels in the heart of 14 apparently healthy cockatiels. Until now, there 
are no in vitro studies on expression patterns of ABV-P. 
 
2.3.4.3. ABV- X Protein (X) 
Mammalian borna virus-X is encoded by the second transcription unit (Wehner et al., 1997). 
In naturally and experimentally infected animals, BoDV-X is localized  
mainly in the cytoplasm (Wehner et al., 1997; Herden et al., 1999). The function of the small 
non-structural X protein in viral pathogenesis is not completely understood. Recently it was 
proved that ABV-X (1322 strain isolated from a psittacine bird with PDD) and BoDV-X 
(He/80 and No/98 strains isolated from horses) interfered with the type I IFN system and have 
type I IFN-inhibiting properties (Wensman et al., 2013). It has been proposed that the function 
of the 10 kDa BoDV-X is to be a regulatory component for the viral polymerase complex 
(Schneider et al., 2003; Poenisch et al., 2009). For ABV, ABV-X is the smallest non structural 
protein of ABV. ABV-X is not a part of the viral RNP in all ABV genotypes. The ABV-X 
protein is non structural protein and it was shown to be present in both nucleus and cytoplasm 
of the ABV-infected cells in vivo (Mirhosseini et al., 2011). Until now, there are no in vitro 
studies on the expression pattern of ABV-X.  
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2.3.4.4. ABV matrix protein (M)                 
A 16-kDa (M) non glycosylated BoDV-M is encoded by the third transcription unit (Cubitt et 
al., 1994; Schneemann et al., 1995). BoDV-M has been co-purified with N and colocalized 
with other nucleocapsid proteins, including P, suggesting the association of M with viral 
RNPs. The function of BoDV-M is binding to RNPs and other viral proteins without blocking 
the viral polymerase to release mature viral particles during the process of assembly and 
budding (Chase et al., 2007). Until now, there are no in vitro or in vivo studies on ABV-M 
expression patterns. 
 
2.3.4.5. ABV glycoprotein (G) 
For BoDV-1, a 56-kDa (G) glycoprotein is encoded by the third transcription unit (Cubitt et 
al., 1994; Schneemann et al., 1995). Posttranslationally, a modification by N-glycosylation 
with high-mannose oligosaccharides increase mass of the G precursor to a mass of 84 to 94 
kDa (gp94) Richt et al., 1998; Perez et al., 2001). Cleavage by the cellular protease furin 
yields GP-1 and GP-2 that correspond to the N- and C-terminal regions, respectively, of gp94 
(Richt et al., 1998). The GP-1 product is transported to the plasma membrane where it is 
anchored through its C-terminal transmembrane domain (Richt et al., 1998; Lipkin and 
Briese, 2007; Clemente and de la Torre, 2007). The function of GP–N is necessary for virus 
receptor recognition and cell entry (Perez et al., 2001) while function of GP–C transported to 
the cell surface has a central role in the fusion of the viral envelope with the cell membrane of 
the host (Kiermayer et al., 2002; Eickmann et al., 2005). BoDV-1-G accumulates in 
cytoplasim of infected cells (Eickmann et al., 2005). There were additional predicted potential 
N-linked glycosylation sites in ABV-G sequences, suggesting that in ABV-G may be even 
more highly glycosylated than BoDV-1-G (Mirhosseini, 2011). Presence of glycosylation 
sites might allow the virus to attach to many epitopes on the host cells, which could explain 
the multitropism of ABV. For ABV-G, in vivo and in vitro studies for analyses of its 
expression pattern are lacking so far. 
 
2.3.4.6. ABV RNA-dependent RNA polymerase (L) 
For BoDV-1-L, a 190 kDa protein is encoded by the third transcription unit (Cubitt et al., 
1994; Schneemann et al., 1995). BoDV-1-L is localized in the nucleus of the infected cells 
(Walker et al., 2000). For ABV-L, there are no in vivo and in vitro studies for analyses of its 
expression pattern so far. 
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2.4. Infection cycle of ABV 
As ABV was firstly identified in psittacines suffered from PDD in 2008, there are no 
published data on the molecular mechanism of ABV replication and transcription. As ABV is 
homologous (60-70%) to the classical BoDV, similarities to the replication cycle of classical 
BoDV-1 seem to be likely. BoDV-1 attached to cell surface receptors of the host cells via 
receptor-mediated endocytosis (Gonzalez-Dunia et al., 1998). Entry of an enveloped virus 
into host cells usually requires membrane-fusing activity of viral surface glycoproteins, thus 
BoDV-1 glycoprotein has an important role in receptor recognition and cell entry (Gonzalez-
Dunia et al., 1998; Richt et al., 1998; Clemente and de la Torre, 2007). BoDV-1-G binds to 
one or more (still unidentified) cell surface receptors of the host cells. BoDV-1-G is sufficient 
for virus receptor recognition and cell entry (Perez et al., 2001) as well as mediates the pH 
dependent fusion event (Gonzalez-Dunia et al., 1998). As the virus fuses to host membrane, 
its ribonucleoprotein RNP is released into the cytoplasm of infected cells (de la Torre, 2006; 
Clemente and de la Torre, 2009). Then, the viral ribonucleoprotein RNP is imported into the 
nucleus, where both RNA replication and transcription occur (Cubitt et al., 1994). BoDV has 
unique properties in replication and transcription of its genome (Pringle et al., 1996; reviewed 
in Herden 2013). BoDV replicates and transcribes in the nucleus of the host infected cells 
(Briese et al., 1992; De la Torre, 1994; Schneeman et al., 1995). Therefore, nuclear import 
and export of the viral genome are critical for the viral life cycle. It has been shown that the 
nucleolus could be the site for BoDV replication and/or transcription (Pyper et al., 1998). For 
transcription of BoDV, BoDV has also unusual transcriptional strategy. The genome is 
transcribed into six primary transcripts, two of which are modified posttranslationally by 
splicing to yield two additional mRNAs. The BoDV polymerase uses three transcriptional 
initiation sites and four transcriptional termination sites for the transcription of the viral 
genome (Briese et al., 1994; Cubitt et al., 1994). Among six different proteins of BoDV, only 
N is translated from a monocistronic mRNA, while transcripts of other viral proteins are 
polycistronic. The BoDV polymerase produces a 1.2-kb mRNA that codes for the N protein in 
the first transcription unit. Moreover, the BoDV polymerase produces a bicistronic 0.8-kb 
mRNA that codes for X and P in the second transcription unit. In the third transcription unit, 
the BoDV polymerase produces either short or long transcripts at the transcription termination 
sites T3 or T4. These transcripts contain introns which may or may not be removed by 
splicing. The resulting mature transcripts are synthesize the viral proteins M, G, and L (Briese 
et al., 1992; de la Torre., 2002; Schneemann et al., 1994; reviewed in Herden et al., 2013). 
BoDV employs the RNA splicing machinery for gene expression and the genome contains 
Chapter two - Literature review 
 
 13
three introns: intron I, intron II, and a proposed intron III (Cubitt et al., 1994; Cubitt et al., 
2001; Tomonaga et al., 2000). Transcripts that retain intron I serve as messages for expression 
of the M protein of BoDV, and those that retain intron II serve as messages for expression of 
the envelope glycoprotein. Transcripts that lack both introns serve as messages for expression 
of the polymerase protein of BoDV. Once the BoDV replication and transcription occur, the 
viral ribonucleoprotein RNP is subsequently transport to the cytoplasm. Recent studies have 
suggested that nuclear localization signal (NLS) and/or nuclear export signal (NES) are 
expressed by the major viral antigens such as N and P are imported to travel between the 
cytoplasm and nucleus through the nuclear pore complex (Kobayashi et al., 1998; Kobayashi 
et al., 2001). BoDV employs a switch mechanism that changes the direction of nuclear 
transport of the viral RNPs dependent on the viral life cycle in infected cells. BoDV-N and 
BoDV-P in the nucleus may play a key role for determining the direction of BoDV-RNP 
movement (Kobayashi et al., 2001). Increased levels of P could mediate retention of the viral 
RNPs in the nucleus by the masking of the NES of N during the nuclear replication stage 
(Cubitt et al., 1994; Malik et al., 1999; Kobayashi et al., 2001). On the other hand, a decreased 
level of P in the nucleus can increase free NES, mediating nuclear export of N-containing 
RNP complexes (Kobayashi et al., 2001). It is possible that the nuclear export activity of 
BoDV-N is blocked by direct binding of P to the NES of N (Kobayashi et al., 2001). 
Assembly and release of BoDV are poorly understood (Compans et al., 1994). Budding of 
BoDV particles is only observed at the cell surface of BoDV-infected MDCK cells after 
treatment with n-butyrate. Whether this reflects the natural pathway for the exit of BoDV 
remains to be determined (Kohno et al., 1999). 
 
2.5. Cultivation of ABV 
In vitro, ABV is well adapted to avian cells tissue culture such as quail fibroblast cell line 
(CEC32), the quail skeletal muscle cell line (QM7) and duck embryonic fibroblast (DEF) 
(Rinder et al., 2009). Results of a recent study (Rinder et al., 2009) showed that ABV-2 and 
ABV-4 genotypes caused persistent, noncytolytic infections in quail and chicken cell lines but 
they did not replicate in cultured mammalian cells used for classical BoDV infection. This 
was also proved in a subsequent study (Staeheli et al., 2010). In contrast, mammalian borna 
viruses grow efficiently in both mammalian and avian cell lines (Rinder  et al., 2009; Staeheli  
et al., 2010; Rubbenstroth et al., 2012; Rubbenstroth et al., 2013; Rubbenstroth et al., 2014). 
Data of other studies revealed that ABV has low affinity to adapt and cultivate in mammalian 
cell lines such as Vero cells or Madin-Darby canine kidney (MDCK) cell line (Gray et al., 
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2010; Herzog et al., 2010). Piepenbring and colleagues (2012) isolated ABV from the brain of 
a scarlet macaw (Ara macao) that died from PDD successfully in the quail cell line CEC-32.  
 
2.6. Natural ABV infection in psittacines  
Many ABV infected birds do not develop obvious clinical symptoms after ABV infection and 
remain healthy as carriers for long time in captivity (Payne et al., 2011a, Heffels-Redmann et 
al., 2011; Heffels-Redmann et al., 2102). Heffels-Redmann and colleagues (2011) analyzed 
presence of ABV infection in 1515 birds of 54 different genera of the order Psittaciformes 
and 5 genera of non-psittacine birds. Findings of the study showed variability in the course of 
ABV infection in Europe. Thirty seven out of 73 birds had histotpathological lesion typical 
for PDD, ABV antigen and ABV RNA was found in 26 out of 37 birds, and the ABV 
isolation from brain and retina was successful in 37 out of 73 birds. Moreover, 36 out of 73 
birds had no histopathological lesion, had no ABV antigen and ABV RNA in 29 out of 73 
birds and the ABV isolation from brain and retina was not successful in 15/ 36 birds. These 
birds were seropositive probably indicating an inapparent infection with a low pathogenic 
ABV strain or an early stage of infection. 
Heffels-Redmann and colleagues (2102) detected different courses of natural ABV infection 
in 63 psittacines in an investigation period of one year. The course of ABV infection showed 
variability in ABV shedding, serum antibody production, occurrence of clinical signs typical 
for PDD, and histopathological findings in psittacines as follows: Group 1 (acute ABV 
infection) consist of six out of the 63 psittacines had various courses of acute ABV infection 
and forms of clinical PDD. Group 2 (inapparent ABV infection) consist of thirteen out of the 
63 psittacines that were consistently or inconsistently ABV positive by PCR and serology. 
Group 3 (subclinical ABV infections) consist of thirteen out of the 63 psittacines exhibiting 
only anti-ABV antibodies. Group 4 (Intermittent ABV infection) consist of eight out of the 63 
psittacines that had positive ABV-RNA detection in crop and cloaca, but did not develop anti-
ABV specific antibodies. Group 5 (Abortive ABV infection) consist of twenty-three out of the 
63 psittacines that had negative ABV-RNA detection or anti-ABV antibodies over the whole 
observation period. 
Lierz and colleagues (2009) tested 61 psittacine birds for the presence of ABV infection. One 
out of 61 birds had classical symptoms, gross lesions and histological alterations of PDD. One 
out of 61 birds had gross lesions, but no histological alterations or clinical signs consistent 
with PDD. The remaining 59 birds did not develop PDD signs. Finding of this study revealed 
that nineteen out of 59 parrots had ABV RNA in their cloacal swabs by quantitative real-time 
reverse transcription-PCR, indicating that ABV infection may occur without clinical evidence 
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of PDD. Moreover, ABV was also detected in clinically healthy parrots, cockatiels, and 
macaw (Lierz et al., 2009; Kloet Dorrestein, 2009; Payne et al., 2011). 
Until now, seven genotypes (ABV-1, ABV-2, ABV-3, ABV-4, ABV-5, ABV-6, and ABV-7) 
of avian borna viruses (ABV) have been identified in psittacine birds (Honkavuori et al., 
2008; Gancz et al., 2010). So far, avian borna viruses were detected in over 80 species of 
psittacine and non psittacine birds (Kuhn et al., 2015). In more recent study, avian Borna virus 
was identified in 40 out 86 wild parrots in Brazil (Encinas-Nagel et al., 2014). For instance, 
ABV infection with clinical PDD was detected in Australia in sulphur-crested cockatoo 
(Cacatua galareta), palm cockatoo (Probosciger atterimus), red-tailed black cockatoo 
(Calyptorhynchus magnificus), galah (Eolophus roseicapillus), gang gang (Callocephalon 
fimbriatum), cockatiel (Nymphicus hollandicus), red-capped parrot (Purpureicephalus 
spurius), eclectus parrot (Eclectus roratus) and spix macaw (Cyanopsitta spixii) (Wyss et al., 
2009; Enderlein et al., 2011; Heffels-Redmann et al., 2011).  
Encinas-Nagel and colleagues (2014) detected mononuclear infiltrates in the ganglia of the 
proventriculus or crop, which were diagnosed as suspected PDD and also in the brain of 50 
out of 86 free-ranging wild psittacine birds. By real-time reverse transcription PCR (rRT-
PCR), ABV-4 RNA was detected in brain, eye, crop, proventriculus, gizzard, adrenal gland, 
and heart in 86 out of 86 free-ranging psittacine birds (Encinas-Nagel et al., 2014). 
 
2.7. Natural ABV infection in non psittacines 
Up to now, seven ABV genotypes have been detected in non psittacine birds (Weissenböck et 
al., 2009b ; Delnatte et al., 2011; Rinder et al., 2012 ; Guo et al., 2012; Delnatte et al., 2013 ; 
Rubbenstroth et al., 2013; Guo et al., 2014). ABV-4 was present at a high prevalence in North 
American geese, swans, and ducks (Hoppes et al., 2013).  
In canaries, three genotypes of ABV were discovered and designated as ABV-C1, ABV-C2, 
and ABV-C3 (Kuhn et al., 2015). Weissenböck and colleagues (2009) detected ABV-C1 in a 
canary (Serinus canaria) from Germany. The animal showed nonsuppurative ganglioneuritis 
of the proventriculus and gizzard and encephalitis, lesions comparable to proventricular 
dilatation disease (PDD) of psittacine birds. A wide distribution of ABV was also detected in 
captive canary birds in Germany (Rubbenstroth et al. 2013). Rubbenstroth and colleagues, 
(2014a) inoculated domestic canaries (Serinus canaria forma domestica) and cockatiels 
(Nymphicus hollandicus) with ABV. Findings of this study showed that ABV-infected 
canaries did not exhibit PDD-like symptoms. Moreover, ABV RNA in cloacal swabs and 
organ samples or ABV-specific antibodies were not detected after ABV infection in 
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cockatiels and canaries which could indicate that horizontal transmission of ABV is 
inefficient in immunocompetent fully fledged domestic canaries and cockatiels. 
In finches, a new genotype of ABV was discovered in captive estrildid finches (Estrildidae) in 
Saxony in Germany called ABV-EF for estrildid finch (Rubbenstroth et al., 2014b). ABV-EF 
genotype is differ markedly from the genotypes present in psittacine birds. ABV infection was 
also detected in a Bengalese finch (Lonchura striata) (Rubbenstroth et al. 2013). 
In geese, it has also been shown that healthy Canada geese (Branta canadensis) could harbour 
ABV-CG without clinical signs of PDD (Payne et al., 2011; Payne et al., 2013). Avian borna 
virus of Canada geese (ABV-CG) was also found in the brain of bald eagles (Haliaeetus 
leucocephalus) that died with characteristic pathological findings (encephalitis) of PDD 
(Hoppes et al., 2013). ABV-CG was also found in the Mississippi kite (Ictinia 
mississippiensis), trumpeter swans (Cygnus buccinator), feral mute swans (Cygnus olor) 
(Smith et al., 2010; Payne et al., 2012b ;  Guo et al. 2012 ; Delnatte et al. 2013). Delnatte and 
colleagues, (2011) detected ABV-N and ABV-RNA in wild Canada geese and trumpeter 
swans (Cygnus buccinators). Findings of the study (Delnatte et al., 2011) showed that the 
ABV antigen and ABV-RNA were detected in 11/12 wild goose brains and 2/2 swans brains. 
By analyzing the sequences of the amplified gene, a unique new genotype designated as 
(ABV-CG) genotype was discovered. Recent studies revealed that ABV-CG was also 
detected in snow geese (Chen caerulescens) and Ross’s geese (Chen rossii) (Payne et al. 
2012a, Payne et al. 2012b). ABV-CG and viral RNA were also isolated from Pekin duck eggs 
from commercial sources (Payne et al. 2012b). ABV-CG RNA was also detected in three 
species of gulls in North American, herring gull (Larus argentatu  ) ring-billed gull (Larus 
delawarensi  ) and laughing gull (Larus atricilla) (Payne et al. 2012b). ABV-CG infection was 
also found in toucan (Rhamphastos sp.), in mallards (Anas platyrhynchos) and in wood ducks 
(Aix sponsa) (Guo et al. 2014). 
 
2.8. Experimental ABV infection in psittacines  
Initial studies of experimental infections in birds fulfilled Henle-Koch postulates by using 
small numbers of animals. Gancz and colleagues (2009) inoculated 3 cockatiels (Nymphicus 
hollandicus) by multiple routes (intramuscular, intraocular, intranasal, and oral) with brain 
homogenate containing ABV-4. Sixty-six days post infection, PDD-associated signs, 
characteristic histopathologic lesions in the CNS and myenteric ganglia occurred in 2 out of 
the 3 birds, and test results were positive for ABV-4. ABV-N and ABV-4 RNA were detected 
in the CNS, GIT, and peripheral organs in cockatiels (Nymphicus hollandicus) after 
experimental infection with brain homogenate containing ABV-4 via multiple routes (Gancz 
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et al., 2009). However, brain homogenate also contained sequences with partial analogy to 
viruses of the family Astroviridae and family Retroviridae. Gray and colleagues (2010) 
inoculated 2 adult Patagonian conures (Cyanoliseus patagonis) with ABV-4, strain M24 
originally isolated from a yellow-collared macaw. The conures were known to be chronic 
carriers of psittacine herpesvirus, but they appeared to be healthy. Antibodies against ABV 
were detected 33 dpi, and shedding of viral RNA was detected 62 dpi. Clinical PDD 
developed in both birds, after which 1 bird died and the other was euthanized. Histopathologic 
analysis showed typical PDD lesions in the gastrointestinal tract organs, adrenal gland, and 
heart. It was not determined whether the herpesvirus infection was a potentiating factor for 
ABV infection (Gancz et al., 2009; Gray et al., 2010). Piepenbring and colleagues (2015) 
inoculated 19 cockatiels (Nymphicus hollandicus) with ABV-4 and 18 cockatiels ABV-2 via 
intracerebral and intravenous route of infection. Twelve birds exhibited clinical signs typical 
for PDD from day 22 onward after ABV-2 infection while five birds exhibited clinical signs 
typical for PDD from day 33 onward after ABV-4 infection. These findings could indicate 
effect of the ABV genotype on the outcome of disease after ABV infection. 
 
2.9. Epidemiology of ABV 
ABV infection does not spread quickly among birds except in crowded aviaries and nurseries 
(Lierz et al., 2009; Rubbenstroth et al., 2014). Mode of ABV transmission is still unknown. 
Recent epidemiological data indicate that ABV infection occurs in psittacine and non-
psittacine birds worldwide e.g. in Israel, USA, Australia, Canada and Brazil (Kistler et al., 
2008; Honkavuori et al., 2008; Weissenböck et al., 2009; Raghav et al., 2010; Encinas-Nagel 
et al., 2014), Spain, Italy, United Kingdom, Denmark, Germany (Enderlein et al., 2009; Lierz 
et al., 2009; Rinder et al., 2009), Austria, Switzerland and Hungary (Weissenböck et al., 
2009a). There are many factors that complicate analysis of the epidemiology of ABV 
infection in parrots such as apparently healthy carriers, presence of many ABV genotypes, 
and extent of incubation period (Payne et al. 2011).  
 
2.10. Pathogenesis  
The incubation period of ABV after natural infection is unknown. The incubation period of 
ABV in experimental infections ranged between 11 days (Gregory et al., 1997), or 2 to 4 
weeks (Kistler et al., 2010), 20 to 60 days, up to 200 days (reviewed in Herden et al., 2013), 
months to years (Gregory et al., 1995, Gancz et al., 2009, Gray et al., 2010). ABV-specific 
serum antibodies have been detected already at 6 days post infection in experimentally ABV-
2 and ABV-4 infected cockatiels (Piepenbring et al., 2015, Lierz et al., 2012). ABV-specific 
serum antibodies could be present between 7 and 60 days after ABV infection (reviewed in 
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Herden et al., 2013). Many recent studies have elucidated that these ABV antibodies are non-
neutralizing antibodies and raised against the phosphoprotein, nucleoprotein, matrix protein 
and X protein (de Kloet et al., 2009; Villanueva et al., 2010; de Kloet et al., 2011; Heffels-
Redmann et al., 2011). Neutralizing antibodies against mammalian BoDV also do not occur, 
if ever only late after infection and are potentially directed against viral glycoprotein (Stitz et 
al., 1998). Heffels-Redmann and colleagues (2012) reported that the anti-ABV serum 
antibodies did not protect birds from development of disease and onset of lesions, similarly as 
/or BoDV-infected immune competent mammals (Narayan et al., 1983, Herden et al., 1999). 
Payne and colleagues (2011a) observed a massive lymphocytic infiltration and lymphoid 
nodule formation within and around the ganglia throughout the gastrointestinal tract in 
apparently healthy cockatiels shedding ABV-4 and seropositive, suggesting that presence of 
ABV antibodies in sera of asymptomatic cockatiels do not induce efficient humoral immune 
response. It has been shown that birds displaying high serum antibody titers are rather prone 
to develop clinical PDD (Heffels-Redmann et al., 2012). In swabs, ABV-RNA was detected 
between 20 and 72 days post infection (dpi) depending on the inoculation route of ABV 
(intracerebral, intravenous, intramuscular). Piepenbring and colleagues (2012) detected the 
presence of ABV-RNA earlier after intracerebral infection in cockatiels than after intravenous 
infection. Recent study (Heffels-Redmann et al., 2012) referred that birds with high viral 
RNA load more likely develop PDD symptoms. ABV-infected birds could also shed the virus 
without showing clinical signs which may contribute to ABV transmission (reviewed in 
Herden et al., 2013). The characteristic gross finding of ABV infection and PDD is dilatation 
of the proventriculus. Lymphoplasmacytic infiltrates within autonomic nerves and ganglia in 
the digestive tract is the characteristic histopathologic lesion of PDD (Gregory, 1995). 
Moreover, nonpurulent encephalitis, myelitis and/or ganglioradiculitis of spinal nerves have 
also been detected (Greogry et al., 1994; Ouyang et al., 2009; Hopes et al., 2010; Kistler et al., 
2010; Raghav et al., 2010; Wünschmann et al., 2011; Piepenbring et al., 2012). Peripheral 
neuritis, inflammation of the myocardium, cardiac muscle cells and conducting fibers, adrenal 
glands and eye may also occur (reviewed in Herden et al., 2013). It has been shown that ABV 
has high tropism not only to the central nervous tissues but also to peripheral organs. ABV 
antigen or ABV RNA was detected most frequently in the brain, spinal cord, gastrointestinal 
tract (reviewed in Herden et al., 2013). ABV antigen or ABV-RNA could also be present in 
many other organs such as heart, liver, kidney, spleen, pancreas, lung, gonads, thyroid, and 
skin (reviewed in Herden et al., 2013). Weissenböck and colleagues (2010) detected 
hybridization signals in the brain, in the vegetative nerve system, glandular epithelia and 
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smooth muscle cells of the intestinal tract and in cardiomyocytes in naturally PDD affected 
birds. Whether a comparable immunopathogenesis as known for mammalian Bornavirus 
infections occur requires further investigations. 
 
2.11. Comparison of ABV and BoDV-tropism 
BoDV exhibit a high preference for the CNS in naturally or experimentally infected animals 
whereas ABV can have a broad distribution patterns in PDD positive birds but also in 
psittacines without clinical signs (Rinder et al., 2009; Ouyang et al., 2009; Heffels-Redmann 
et al., 2011; Weissenböck et al., 2009a, Gray et al., 2010, Wünschmann et al., 2011, 
Piepenbring et al., 2012). Distribution patterns of ABV in naturally PDD affected birds has 
been characterized in many studies but a detailed kinetic analyses of organ distribution as it is 
possible in experimental trials was lacking. Distribution patterns of ABV in organs of 
naturally PDD affected birds has been described by demonstrating either viral antigen by  
immunohistochemistry (IHC) or Western blotting (WB), or detection of viral RNA by reverse 
transcription polymerase chain reaction (RT-PCR) or in situ hybridization (Honkavuori et al., 
2008; Gancz et al., 2009; Kistler et al.,2010; Lierz et al., 2009; Ouyang et al.,2009; 
Weissenböck et al.,2009a; Weissenböck et al., 2009b; Lierz et al.,2010; Raghav et al.,2010; 
Reßmeyer et al., 2010; Wünschmann et al.,2011; Rubbenstroth et al.,2013). Results of 
Piepenbring et al., (2012) showed that ABV-RNA was detected in numerous tissues after 
experimental infection ABV-4 in cockatiels. Rinder and colleagues (2009) detected ABV-N 
in the brain, crop, liver, kidney, heart, and lung. Ouyang and colleagues (2009) detected 
ABV-N mainly in the cerebrum, cerebellum and spinal cord of PDD infected birds. Raghav 
and colleagues (2010) detected ABV-N in the brain, spinal cord, adrenal gland, pancreas, and 
kidney in psittacine birds with histopathologic evidence of PDD. Ouyang and colleagues 
(2009) detected ABV-N in neurons of the cerebral cortex, Purkinje cells and Bergmann glial 
cells in the cerebellum and ependymal cells of the central nervous system. Rinder and 
colleagues (2009) detected ABV-N and ABV-P in the intestinal mucosa, epithelial cells, 
lamina propria cells, liver cells and myocytes supporting the conclusion that ABV can 
productively infect non-neuronal cells. Weissenböck and colleagues (2010) detected ABV-2 
and ABV-4 RNA in the vegetative nerve system, glandular epithelia and smooth muscle cells 
of the intestinal tract and cardiomyocytes in naturally PDD affected birds by in situ 
hybridization. 
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2.12. Routes of ABV transmission 
2.12.1. Horizontal route of transmission 
Many studies described the intermittent ABV shedding in urine and faeces of ABV-infected 
birds (Raghav et al., 2010; Villanueva et al., 2010; Payne et al., 2011a, Heffels Redmann et 
al., 2011). Based on these findings, the oral-faecal route of infection was assumed as the most 
common mode of transmission of ABV. Other authors proposed that ABV shedding via urine 
is the main way of viral release and more important than via faeces of ABV infected birds 
suffering from PDD (Heffels-Redmann et al., 2011; Piepenbring et al., 2012; Heatley and 
Villalobos, 2012). Piepenbring and colleagues (2012) demonstrated sucessul experimental 
infection with ABV-4 via intravenous and intracerebral routes of infection in cockatiels. 
Findings of Piepenbring and colleagues showed that ABV-RNA was not only found in the 
central nervous system but also in gastrointestinal organs and skin. ABV was found in fecal 
particles passing from one host and introduced into the oral cavity of another host. This 
indicates that the orofecal route might be the main way of horizontal ABV transmission 
(Piepenbring et al., 2012). In another study experimental infection of cockatiels via the oral-
nasal route only was not successful. Orofecal transmission after hatch could also be a mode of 
transmission as described in a recent study (Kerski et al. 2012). Heffel-Redmann and 
colleagues (2011) detected the ABV RNA in 86 of 347 crop swabs and 99 of 381 cloacal 
swabs in captive psittacines with PDD by real time RT–PCR which supports possible 
orofeacal transmission. Findings of the study (Rubbenstroth et al., 2014) suggested that direct 
contact transmission of ABV was not successful in domestic canaries (Serinus canaria forma 
domestica) and cockatiels (Nymphicus hollandicus).  
 
2.12.2. Vertical route of transmission 
A previous study already showed that ABV antigen was detected in testes and ovaries of 
infected parrots (Raghav et al., 2010). Lierz and colleagues, (2011)  detected ABV-RNA in 2 
out of 30 dead-in-shell embryos of various psittacines that originated from ABV-infected 
flocks with a history of PDD. These findings indicated that ABV might be transmitted 
vertically from ABV-infected parents to offspring. Findings of subsequent studies showed 
that ABV RNA was detected in eggs, embryos, and hatchlings of different psittacine species 
and canaries (Kerski et al., 2012; Monaco et al., 2012; Rubbenstroth et al., 2013). These data 
might argue for a vertical transmission, however, productive viral replication has so far not 
been shown. It was assumed that ABV reach eggs either from penetration of the shell after 
egg contamination, or contamination of oviduct secretions or ABV infection of ova or sperm 
(Monaco et al., 2012).  Findings of the study by Payne et al., 2012 showed that ABV grow in 
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the fibroblasts derived from commercial duck eggs suggesting that the vertical transmission 
may be possible. Kerski and colleagues (2012) detected anti-ABV antibodies and ABV-2 
RNA in egg yolks of embryos obtained from infected sun conures (Aratinga solstitialis), 
supporting that vertical transmission might occur. 
 
 
2.13. Diagnosis  
2.13.1. Intra vitam diagnosis  
Visualization of dilatation of the proventriculus can be carried out by diagnostic imaging 
techniques/radiography. Detection of anti-ABV antibodies and ABV-RNA are the best 
diagnostic approach for intra vitam diagnosis of ABV. Serological tests can be used to 
diagnose anti-ABV antibodies such as western blot assay (De Kloet & Dorrestein, 2009; Lierz 
et al., 2009; Villanueva et al., 2009), enzyme linked immunosorbent assay (ELISA) technique 
(de Kloet et al., 2011) and indirect immunofluorescence (IIF) assay (Gray et al., 2010; Herzog 
et al., 2010). IIF assay is an appropriate serological technique with high sensitivity and 
specifity for detection of ABV-specific serum antibodies (Herzog et al., 2010). Another 
suitable method is to test the presence of ABV-RNA in faeces, swabs of crop and cloaca by 
using RT-PCR, (Rinder et al., 2009; Lierz et al., 2009; Enderlein et al., 2009; Gray et al., 
2010; Kistler et al., 2010; Piepenbring et al., 2012).  
In some birds only the detection of anti-ABV serum antibodies succeeded, in others ABV-
RNA was undetectable, while still others in both tests reacted positively (Herzog et al., 2010; 
Enderlein et al., 2010, Heffels-Redmann et al., 2011, 2012). Thus, diagnosis of ABV infection 
requires a combination of serological investigation and genome detection (Gough et al., 1996; 
Herzog et al., 2010; Enderlein et al., 2010, Lierz et al., 2010; Heffels-Redmann et al., 2011, 
2012).  
 
2.13.2. Post mortem diagnosis  
Histopathology, ABV isolation, ABV antigen and ABV-RNA detection are the best methods 
for the post mortem diagnosis of ABV. Identification of the lymphoplasmacytic infiltrates in 
the GIT and CNS in biopsy sample is typical and comprise the characteristic histopathological 
lesion. Detection of ABV-RNA by in situ hybridization (ISH) and RT-PCR in tissues was 
also used. Detection of viral genomic and mRNA of ABV-2 and ABV-4 by in situ 
hybridization (ISH) procedure using digoxigenin-labeled RNA probes in tissues of birds with 
PDD has been described by Weissenböck et al. (2010). Many studies used RT-PCR to 
demonstrated the presence of ABV RNA in biopsies of psittacine birds with PDD, in feather 
calami, in eggs, embryos, and hatchlings obtained from infected sun conures (Aratinga 
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solstitialis), and in the brain of apparently healthy macaws (de Kloet et al., 2009 ; de Kloet et 
al., 2011; Heffels-Redmann et al., 2012; Kerski et al., 2012). Immunohistochemistry (IHC) 
has been performed to study the tissue distribution and localization of ABV antigen in 
psittacines (Gancz et al., 2009; Weissenböck et al., 2009a; Rinder, et al., 2009; Ouyang et al., 
2009; Herzog et al., 2010; Raghav et al., 2010, Wünschmann et al., 2010) by applying either 
cross reactive anti-BoDV-1 antibodies against viral N, P, X protein or ABV specific 
antibodies against ABV N (reviewed in Herden et al., 2013). It has been shown that the 
monoclonal anti-BoDV-1 N antibody Bo18 is not good marker for detection of ABV antigen 
by IHC (reviewed in Herden et al., 2013). Isolation of ABV is also a good diagnostic 
procedure. ABV has been isolated successfully in the quail fibroblast cell lines CEC-32, the 
quail skeletal muscle cell line QM7 (Rinder et al., 2009, Herzog et al., 2010, Piepenbring et 
al., 2012), and duck embryo fibroblasts (Gray et al., 2010). 
 
2.14. Differential diagnoses 
Many diseases may have the same clinical symptoms as in PDD such as megabacteriosis 
(infection with Ornithogaster macrorhabdos). Other diseases which have to be differentiated 
from PDD are clostridial enteritis, fungal and yeast infections, heavy metal toxicosis, 
intestinal obstruction, neoplasia and parasitism, pyloric dysfunction and pancreatitis (Bond et 
al., 1993; Taylor et al., 1997; Antinoff et al., 2001; Hoppes et al., 2010).  
 
2.15. Prevention and control 
It is quite advisable to examine birds for presence of the ABV infection periodically and then 
separate the positively tested birds (Lierz et al., 2010). 
 
2.15.1. Vaccination  
A recent study (Heffels-Redmann et al., 2012) suggested that serum antibodies are not 
protective and that ABV might escape recognition by the innate immune system (Staeheli et 
al., 2010). This might indicate that induction of an immune response may actually increase the 
severity of the disease, so vaccination may be contraindicated. Serological examination 
should be performed continuously and suspected birds should be removed from flocks and 
incoming birds should be tested again and quarantined. Sanitation, disinfection, isolation of 
ABV-infected birds, control of the illegal trading are also useful for good management and 
control of the infection. Counseling the owner, as well as establishing a long-term 
management plan, are also important aspects of veterinary care. 
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2.15.2. Therapeutics   
There is no curative therapy for PDD infected birds or ABV infection (Staeheli et al., 2010, 
Lierz et al., 2010). Supportive care of the PDD affected birds such as providing easily 
digested food to diseased birds, prevention secondary infections, symptomatic therapy by the 
use of anti-inflammatory medication to diminish the amount of inflammatory nerve injury in 
PDD affected birds (Levine and Practice,2003; Gancz et al.,2010; Hoppes et al.,2010, Hoppes 
et al.,2012). The supportive therapy may maintain the survival of PDD affected birds for 
months up to years (Suedmeyer, 1992; Gerlach, 1994; Gregory et al., 1997). Many affected 
birds respond favourably to none steroidal anti-inflammatory drugs (NSAIDs). Birds under 
treatment should be housed separately from any susceptible birds. Another study suggested 
that PDD affected birds which displayed severe gastro-intestinal and neurological signs were 
successfully treated after taking amantadine hydrochloride (Clubb et al., 2009; Gancz et al., 
2010).  
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3. Materials and Methods 
The study was governmentally approved according to the guide for the care and use of animals 
(Registration number: GI 18/9 – NR.02/210). All clinical data, demonstration of ABV RNA 
data and ABV-specific antibodies data were part of the doctoral thesis of Anne Piepenbring. In 
the current Ph.D thesis, inflammatory lesions, distribution patterns of ABV antigen, ABV-2 
RNA and ABV-4 RNA were characterized in the central nervous system (CNS) as well as in 
the peripheral organs of the experimentally infected cockatiels over the investigation period of 
33 weeks. 
3.1. Animals 
Ten females and nine males of cockatiels Nymphicus hollandicus were infected with ABV-2.  
Eleven females and seven males of cockatiels Nymphicus hollandicus were also infected with 
ABV-4. All birds were investigated over a period of 231 days post infection (dpi) after ABV-2 
infection and 230 dpi after ABV-4 infection (table 2 and table 3). 
3.2. Experimental infection of cockatiels with ABV-2  
For the experimental infection of cockatiels with ABV-2, nineteen cockatiels were divided into 
2 groups (intracerebral (ic) and intravenous (iv) inoculation), each composed of 9 birds. One 
bird remained untreated and served as sentinel bird in group ic. Two birds were inoculated ic 
and two birds were inoculated iv with mock cell suspension without ABV-2 and served as 
control group (table 2). Birds of the mock group were separated from the ABV-2 infected 
birds.  
3.3. Experimental infection of cockatiels with ABV-4  
Eighteen cockatiels were randomly divided into 2 groups (group ic and group iv), each 
composed of 9 birds and were inoculated either intracerebrally or intravenously with ABV-4. 
One bird did not receive any treatment and served as sentinel bird in group ic. For details, see 
table 3). 
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3.4. Animals housing  
The cockatiels were obtained from the flock from Clinic for Birds, Reptiles, Amphibians and 
Fishes, Justus-Liebig-University-Giessen. The cockatiels were reared by their parents. The 
flock was kept in aviaries with nesting boxes and a seed diet without sunflower seeds (Versele-
Laga, Germany). 
 
3.5. Virus preparation and isolation 
ABV-2 and ABV-4 genotypes were isolated by Sibylle Herzog, Institute of Virology, Faculty 
of Veterinary Medicine, Justus-Liebig-University-Giessen. The ABV-2 genotype was isolated 
from the brain of a cockatiel suffering from PDD. The ABV-4 genotype was isolated from the 
brain of a scarlet macaw (Ara macao) that died from PDD. Tissue samples were homogenized, 
clarified, 10-fold diluted in culture medium, and used for infection. The persistently ABV-
infected CEC-32 cells were incubated for 6 days at 37°C (Herzog et al., 2010). By using 
polyclonal serum from rats experimentally infected with BoDV, indirect immunofluorescence 
was used (Herzog et al., 2010). 
 
 
 Table 2: list of experimentally ABV-2  
  infected cockatiels  
Table 3: list of experimentally ABV-4  
 infected cockatiels  
(iv) intravenous, (ic) intracereberal (iv) intravenous, (ic) intracereberal 
sentinel was reared in group ic 
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3.6. Inoculation of the virus 
For inoculations, the supernatant of the virus was used for infection. The infectivity titer of 
ABV-4 was 1×104 TCID50/mL. The infectivity titer of ABV-2 was 3×103 ID50/ml. For the 
experimental infection, 0.1 mL of the inoculum of each genotype was inoculated. 
 
3.7. Clinical examination 
All birds were examined daily until 231 days after ABV-2 infection, 230 days after ABV-4 
infection as part of the doctoral thesis of Anne Piepenbring to determine the health status of the 
infected cockatiels. Blood and swabs samples were collected weekly. 
 
3.8. Euthanization  
If the experimentally ABV-2 or ABV-4 infected birds exhibited clinical signs typical for PDD 
(table 4 and 5), they were euthanized immediately. After ABV-2 infection, 12/18 
experimentally ABV-2 infected birds exhibited clinical sign (six birds were died at 32, 46, 50, 
84, 86, and 137 dpi, and six birds were euthanized at 68, 76, 88, 120, 172 and 231 dpi (table 4). 
Six out of 18 experimentally ABV-2 infected birds did not display clinical signs and were 
euthanized at the end of the experiment at day 231 dpi (table 4). After ABV-4 infection, 5/18 
experimentally ABV-4 infected birds exhibited clinical sign and were euthanized at 60, 116, 
206, 229, and 229 dpi. Moreover, 11/18 experimentally ABV-2 infected birds did not display 
clinical signs and were euthanized at 115 dpi (3 birds), 116 dpi (2 birds), 229 dpi (3 birds) and 
230 dpi (3 birds) (table 5). Two out of 18 experimentally ABV-4 infected birds did not exhibit 
clinical sign and died suddenly at 66 and 120 dpi (table 5). 
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Table 4: List of cockatiels which showed clinical signs after ABV-2 infection 
 
 
 
Bird 
ID 
 
 
gender  
 
 
Route of  
infection 
 
    Birds with clinical signs 
 
gastrointestinal 
signs 
neurological 
signs 
death euthanasia 
days p.i days p.i dpi dpi 
N39 female ic 22  32  
N 32 female iv 45  46  
N 25 female iv 46  50  
N 24 female ic 40 32  68 
N 34 female iv 57   76 
N 47 male ic 83  84  
N 27 female ic 71 85 86  
N 45 male iv 78   88 
N 19 male iv 104   120 
N 48 female iv 121  137  
N 30 female ic 139   172 
N 46 female ic 86   231 
N 22 male ic    231 
N 40 female ic    231 
N 33 male iv    231 
N 42 male iv    231 
N 29 male iv    231 
N 49 male ic    231 
N28 male sentinel    231 
 
 
(iv) intravenous, (ic) intracereberal, (dpi) days post infection. ABV-2 infection, early time 
points (32-86) dpi, mid time points (87-172) dpi, and late time points (173-231) dpi. 
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Table 5: List of cockatiels which showed clinical signs after ABV-4 infection 
 
 
 
Bird 
ID 
 
 
gender  
 
 
Route of  
infection 
 
     Birds with clinical signs 
 
gastrointestinal  
signs 
neurological  
signs 
death euthanasia 
days p.i days p.i dpi dpi 
N15 female ic 37 41  60 
N 21 male ic   66   
N 19 female ic    115 
N 26 female ic    115 
N 16 female ic    115 
N 13 male iv 116   116 
N 18 male iv    116 
N 25 male iv    116 
N 12 female iv   120   
N 11 female ic  199  206 
N 10 female iv 126   229 
N 22 female iv  159  229 
N 23 female iv    229 
N 27 male iv    229 
N 29 female iv    229 
N 20 female ic    230 
N 24 male ic    230 
N 30 male ic    230 
N 14 male sentinel    230 
 
(iv) intravenous, (ic) intracereberal, (dpi) days post infection. ABV-4 infection, early time 
points (37-66) dpi, mid time points (67-126) dpi, and late time points (127-230) dpi. 
 
3.9. Organ sampling  
Swab samples from the crop and cloaca were collected weekly. Blood samples were also 
collected. Tissue samples from brain, spinal cord, sciatic nerve, eye, heart, liver, kidney, liver, 
spleen, pancreas, crop, proventriculus, gizzard, intestine, skin and skeletal muscles were also 
collected.  
 
3.10. Re-isolation of ABV-2 and ABV-4 
Infectious virus was re-isolated by using samples from brain and retina as described (Herzog et 
al., 2010).  
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3.11. Histological examination of tissue sections 
3.11.1. Fixation of tissue sections of ABV infected cockatiels 
Organ samples were fixed in 10% formalin, then embedded into embedding plastic cassettes. 
 
3.11.2. Preparation of formalin-fixed tissue sections 
Organs samples were processed in an automatic Tissue Tek VIP® machine (Sakura, Germany). 
Tissues were dehydrated through using different concentrations of alcohols at 37 ͦ C (50% 
ethanol for 30 minutes, 70% ethanol for 60 minutes, 80% ethanol for 60 minutes, 96% ethanol 
for 30 minutes, 100% isopropanol two times for 60 minutes each), and cleared by xylene at 40 ͦ 
C three times for 90 minutes each and then infiltrated with Roti-plast paraffin (Roth, Germany) 
at 60 ͦ C three times for one hour each to enable sectioning. After embedding the biopsies into 
paraffin by Tissue-Tek® TEC TM (Sakura, Germany), biopsies were sectioned at 5µm using 
Leica RM2255 rotary microtome (Leica, Germany) and then placed on Superfrost plus® slides 
(R.Langenbrinck, Germany). Slides were routinely stained by an automatic HMS740 Microm 
robot-stainer (Microm GmbH, Germany) with heamatoxylin and eosin (H&E). The HE 
staining protocol was performed according to the protocol provided by the manufacturer of the 
machine (Microm GmbH, Germany). Slides were mounted with Tissue-Tek® coverslipping 
films (Sakura, Germany) in an automated coverslipper machine (Vogel, Germany). 
 
3.12. Evaluation of inflammatory lesions 
For evaluation of inflammatory lesions after ABV-2 and ABV-4 infection, respective 
semiquantitative scores were established for assessing the severity of lesions as mild, moderate 
and severe by 200 magnification power as given in table 6. 
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Table 6: Scores of inflammatory lesions 
 
  Organs Scores 
Mild  Moderate  Severe  
 
 
 
CNS 
A- Perivascular infiltration 
of mononuclear cells as a 
monolayer. 
B- Infiltration of 1-15 
mononuclear cells 
perivascularly per field. 
A- Perivascular 
infiltration of 
mononuclear cells as 
bilayer. 
B- Infiltration of 15-
30 cells 
perivascularly per 
field. 
A- Perivascular 
infiltration of 
mononuclear cells as 
three layers or more. 
B- Infiltration of more 
than 30 cells 
perivascularly per field. 
 
 
GIT 
A- Infiltration of mononuclear cells in the intestinal mucosa, lamina muscularis, 
submucosa, connective tissue in the GIT and/or perineural/ periganglionic 
infiltration. 
B- Infiltration of 10-30 cells
per field. 
B- Infiltration of 30-50 
cells per field. 
B- Infiltration of more 
than 50 cells per field. 
 
 
 
 
 
 
Peripheral 
organs 
A- Infiltration of 
mononuclear cells either as 
perivascular/ perineural/ 
periganglionic or follicular-
shape like aggregations. 
B- Perivascular/ 
periganglionic or perineural
infiltration of mononuclear 
cells as a monolayer. 
C- Infiltration of 1-15 
mononuclear cells per field.
 
A- Infiltration of 
mononuclear cells 
either as perivascular/ 
perineural/ 
periganglionic or 
follicular-shape like. 
B- Perivascular/ 
periganglionic or 
perineural infiltration 
of mononuclear cells 
as abilayer or triple 
layer. 
C- Infiltration of 15-
30 cells per field. 
A- Infiltration of 
mononuclear cells either 
as perivascular/ 
perineural/ periganglionic 
or follicular-shape like. 
B- Perivascular/ 
periganglionic or 
perineural infiltration of 
mononuclear cells more 
than three layers. 
C- Infiltration of more 
than 30 mononuclear cells 
per field. 
 
 
(CNS) central nervous system, (GIT) gastrointestinal tract, 200 magnification power 
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3.13. Immunohistochemistry (IHC) 
For demonstration of the presence of ABV antigen in all ABV-2 and ABV-4 infected animals, 
a polyclonal rabbit anti Borna disease virus antibody was used. The anti BoDV antibody had 
been proven to be cross reactive antibody with ABV by (Herzog et al., 2010).  
 
3.13.1. BoDV-antibody 
The antibody directed against BoDV phosphoprotein (BoDV-P) was provided by Professor 
Dr. Juergen Richt, Kansas State University. The anti-BoDV antibody (p24) was diluted 
1:2000 with 20% pig serum/tris buffered saline (TBS) and 100μl of the diluted primary 
antibody was applied on each slide. 
 
3.13.2. Secondary antibody  
A biotinylated pig anti-rabbit IgG (Vector laboratories Inc, USA) served as secondary 
antibody. The secondary antibody was diluted with 20% pig serum/TBS and 100μl of the 
diluted secondary antibody was applied on each slide. 
 
3.13.3. Block serum   
20% pig serum (PAA Laboratories GmbH, Germany) in TBS was applied and 100μl of the 
diluted serum was applied on each slide. Slides were incubated with the blocking solution for 
15 minutes at room temperature.         
 
3.13.4. Control  
A brain and GIT tissue sections from ABV-2 experimentally infected cockatiel were used as a 
positive control. In parallel, a serum (Sigma-Aldrich, Germany) of healthy rabbit served as a 
negative control for the polyclonal anti-BDV antibody without adding the primary antibody. 
 
3.13.5. Evaluation the positive signals  
Presence of intranuclear or intracytoplasmic immunostaining was considered as positive 
immunohistchemical reaction for staining of the ABV antigen.  
 
3.13.6. IHC protocol  
1. Deparaffinization of the slides was performed by immersing slides with xylene (3x5 
minutes), isopropanol (2x3 minutes), 96% ethanol (3 minutes), and 80% ethanol (3 minutes). 
3. Inhibition of the endogenous peroxidase (H2O2) was performed by adding 197ml of 
methanol and 3ml 30% hydrogen peroxidase (H2O2) for 30 minutes at room temperature. 
4. Washing three times with TBS, five minutes each. 
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5. Citrate pretreatment pH= 6.5 as antigen retrieval method was used. Slides were placed in 
heated water bath and incubated with citrate buffer solution at 95 °C for 25 minutes. Slides 
were left to cool for 10 minutes at room temperature. 
6. For blocking, 100µl 20% pig serum in TBS was applied for 15 minutes at room temperature.         
7. A 100µl of the primary antibody and the rabbit serum diluted 1:2000 in 20% pig serum/TBS 
were applied and subsequently incubated in the refrigerator at 4 °C overnight. 
8.  Tissue sections were washed in TBS/buffer three times, 5 minutes each. 
9.  A 100µl of the secondary antibody diluted 1:100 in 1% bovine serum albumin (BSA) /TBS 
was applied on each slide and were incubated with the secondary antibody for 30 minutes at 
room temperature. 
10. Tissue sections were washed in TBS/buffer three times, 5 minutes each. 
11. Tissue sections were incubated with 100μl avidin biotin complex (ABC) Vectastain kit® 
(Vector laboratories Inc, USA). The ABC kit was diluted 1:100 in 1% BSA/TBS before 
applying to each slide. 
12. Tissue sections were washed in TBS/buffer three times, 5 minutes each. 
13.Tissue sections were incubated with 3, 3 diaminobenzdine-teterahydrochloride (DAB) 
solution for 10 minutes at room temperature. 
14. Tissue sections were washed in TBS/buffer three times, 5 minutes each, followed by 
washing in distilled water once for 5 minutes at room temperature. 
15. Tissue sections were immersed in Kardasewitsch stain for 5 minutes at room temperature. 
16. Tissue sections were washed in TBS/buffer twice, 5 minutes each. 
17. Tissue sections were stained with Papanicolaou for 30 seconds at room temperature. 
18. Tissue sections were washed in tap water twice, 5 minutes each followed by washing in 
distilled water once for 5 minutes at room temperature. 
19.Dehydration of tissue sections was carried out by immersing them in different 
concentrations of alcohols (50% ethanol, 70% ethanol, 80% ethanol, 96% ethanol, and in 2 
changes of 100% isoproponal), 3 minutes each. 
20. Tissue sections were immersed in 2 changes of xylene, 3 minutes each. 
21. Slides were mounted with Tissue-Tek® coverslipping films (Sakura, Germany) in an 
automated coverslipper machine (Vogel, Germany). 
 
3.14. Evaluation of ABV distribution pattern 
For evaluating the distribution of the ABV antigen, semi quantitative scores were established 
(score 1, score 2 and score 3) by 200 magnification power as shown in table 7. 
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Table 7: Scores of ABV antigen detection 
 
Organs Scores 
Score 1 Score 2 Score 3 
 
CNS 
presence of 1-15 positive 
cells in the field. 
presence of 15-30 
positive cells in the field 
presence of more 
than 30 positive cells 
in the field 
 
GIT 
presence of 1-10 positive 
cells in the field 
presence of 10-30 
positive cells in the field 
presence of more 
than 30 positive cells 
in the field 
Peripheral 
organs 
presence of 1-15 positive 
cells in the field 
presence of 15-40 
positive cells in the field 
presence of more 
than 40 positive cells 
in the field 
 
(CNS) central nervous system, (GIT) gastrointestinal tract, 200 magnification power 
 
3.15. Characterization of the immune cells  
Characterization of the immune cells was done by IHC to characterize B lymphocytes, T 
lymphocytes and macrophages in all organs after ABV-2 and ABV-4 infection. Due to the lack 
of the specific antibodies that recognise T cells (table 8), macrophages (table 9) and B cells 
(table 10) of cockatiels, cross reactivity of different cell surface markers from other species of 
mammals was tested in advance.  
 
3.15.1. Preparation of tissue sections  
The same formalin-fixed and paraffin-embedded tissues that were used for demonstration of 
ABV antigen were applied. 
 
3.15.2. Controls 
Formalin-fixed and paraffin-embedded tissue sections of feline B-cell lymphoma and feline T-
cell lymphoma were used as positive control. Moreover, formalin-fixed and paraffin-embedded 
normal chicken spleen, normal chicken bursa, feline lymph node were also used. For 
monoclonal antibodies, mouse anti-chicken T cells (T1) (Hirschberger et al., 1987) was 
applied. Serum of healthy rabbit was centrifuged at 1500 g for 10 minutes and served as 
negative control for polyclonal antibodies. 
 
3.15.3. Primary antibodies, secondary antibodies, and blocking procedures 
They are listed in table 8, 9 and 10. 
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3.15.4. Antigen retrieval 
Citrate buffer, proteinase, and target retrieval methods were applied as in table (8, 9, and 10). 
Table 8:  List of tested T cell markers 
 
Primary antibodies  Secondary antibodies  Substrate  Antigen 
retrieval  
Blocking  
Description Dilution  Description Dilution  Antibody  
Rabbit-anti- 
human CD3 
Dako, 
Germany 
1:100 in 
 20 % pig  
serum/TBS 
Pig anti- 
Rabbit IgG, 
Dako,  
Germany 
1:100 in 
 20 % pig  
serum/TBS 
Rabbit 
peroxidase 
anti-
peroxidase 
(PAP) 
Dianova, 
Germany 
target  
retrieval  
pH 9 
Dako, 
Germany 
20 % pig  
serum in 
TBS, Sigma 
Aldrich, 
Germany 
Rat anti- 
human CD3 
Biorad,  
Germany 
1:100 in 
 20% pig  
serum/TBS 
 
Pig anti-  
Rabbit IgG, 
Dako,  
Germany 
 
1:100 in 
 20 % pig  
serum/TBS 
 
Avidin biotin 
complex 
(ABC)  Kit 
Vector,USA 
citrate  
 buffer 
  pH 6.5 
20 % pig  
serum in 
TBS, Sigma 
Aldrich, 
Germany 
 
(ABC) avidin biotin complex, (PAP) peroxidase anti peroxidase. Target retrieval at 97 °C for 
25 minutes, citrate buffer at 95 °C for 25 minutes. 
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Table 9: List of tested macrophage markers  
 
Primary antibodies Secondary antibodies Substrate  Antigen  
retrieval 
Blocking  
Description Dilution Description Dilution Antibody 
Myeloid 
histiocyte 
antigen, 
clone MAC 
378, Dako, 
Germany  
1:1000 
in 1%  
BSA/TBS 
Sigma 
Aldrich , 
Germany 
Rat anti-
mouse 
IgG, Dianova, 
USA 
 
1:100 
in 1%  
BSA/TBS 
 
Mouse PAP 
Dianova, USA 
 
proteinase 
pH 7.4 
Sigma 
Aldrich , 
Germany 
10 % rat  
serum in 
TBS, 
Sigma 
Aldrich , 
Germany 
Rabbit anti 
human 
lysosome,  
Dako, 
Germany 
1:600 in 
 20 % pig  
serum 
/ TBS 
Pig anti-rabbit 
IgG, Dako, 
Germany 
 
1:100 in 
 20 % pig  
serum/TBS 
Rabbit PAP 
Dianova, USA 
 
proteinase 
pH 7.4 
Sigma 
Aldrich , 
Germany 
20 % pig  
serum in 
TBS, Sigma 
Aldrich, 
Germany 
Mouse anti-
chicken 
monocytes, 
KUL01, 
Biorad , 
Germany 
1:200 
in 1%  
BSA/TBS 
 
Pig anti-rabbit
IgG, Dako, 
Germany 
 
1:100 in 
 20 % pig  
serum/TBS 
Elite ABC 
complex, 
Vector, USA  
citrate  
  buffer 
  pH 6.5 
20 % pig  
serum in 
TBS, Sigma 
Aldrich, 
Germany 
 
(ABC) avidin biotin complex, (PAP) peroxidase anti peroxidase. Proteinase (type XXIV) at 
37 °C for 5 minutes, citrate buffer at 95 °C for 25 minutes 
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Table 10: List of tested B cell markers 
 
Primary antibodies Secondary antibodies  
Substrate 
Antigen 
retrieval 
Blocking 
Description Dilution Description Dilution 
Mouse  
anti-duck 
 IgY , Biorad, 
Germany 
1:100 
in TBS 
Biotinlynated 
goat anti- 
mouse IgG,  
Vector, USA 
1:100 
 in 1%  
BSA/TBS 
Mouse 
peroxidise anti- 
peroxidise (PAP)
Dianova, USA  
  citrate  
  buffer 
   pH 6.5 
20 % goat 
serum 
in TBS 
Mouse  
anti-human 
CD20, DCS 
ImmunoLine, 
Germany 
1:100 
in 1%  
BSA/TBS
 
Biotinlynated 
horse anti- 
mouse IgG  
Vector, USA 
1:100 
 in 1%  
BSA/TBS 
Mouse PAP 
Dianova, USA 
 
citrate  
  buffer 
   pH 6.5 
10 % rat  
serum in  
 TBS 
 Rat anti- 
feline CD45, 
clone B220  
Cedarlane,USA
1:1000 
in 1%  
BSA/TBS
 
Biotinlynated 
rabbit anti- 
rat IgG (H+L) 
Vector, USA 
1:100 
in 1%  
BSA/TBS 
ABC Kit, 
Vector, USA.  
  citrate  
  buffer 
pH 6.5 
horse 
serum 
Dako, 
Germany 
Mouse anti- 
 dog  IgG, 
Dianova, USA 
1:600 in  
20% pig  
Serum in 
 TBS 
Pig anti rabbit 
IgG1 
Dako, Germany
 
1:100 in  
20% pig  
serum in 
    TBS 
Rabbit PAP 
Dianova, USA 
 
proteinase 
pH 7.4 
Sigma, 
Germany 
20 % pig  
serum in 
 TBS,  
 
Mouse anti-
human MUM1  
protein,  
Dako, 
Germany 
1:100 
in 1%  
BSA/TBS
Pig anti rabbit- 
IgG1, 
Dako, Germany
 
 
1:100 in  
20% pig  
serum in 
    TBS 
Mouse PAP 
Dianova, USA  
 
citrate  
buffer 
pH 6.5 
20 % pig  
serum in 
TBS, 
Dako, 
Germany 
Mouse anti- 
CD79α ,  
clone JBC117 
Dako, 
Germany 
1:50 
in 1%  
BSA/TBS
Biotinlynated 
horse anti-
mouse IgG, 
Vector, USA 
1:100 in  
1% 
BSA/TBS 
ABC complex 
Vector, USA 
target  
retrieval  
Dako, 
Germany 
undiluted 
horse 
serum 
Mouse anti 
CD79a cy, 
clone HM 57, 
Acris,Germany 
1:100 
in 1%  
BSA/TBS
Biotinlynated 
horse anti- 
mouse IgG, 
Vector, USA 
1:100 in  
1% 
BSA/TBS 
ABC complex 
 
citrate  
buffer 
pH 6.5 
undiluted 
horse 
serum 
 
 
 
 
(H+L) heavy and light chain antibody, (MUM-1 protein) multiple myeloma oncogene 1. (ABC) 
avidin biotin complex, (PAP) peroxidase anti peroxidase. Proteinase (type XXIV) at 37 °C for 
5 minutes, citrate buffer at 95 °C for 25 minutes, target retrieval at 97 °C for 25 minutes 
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2.15.5. IHC protocol for characterization of the immune cells in cockatiels after ABV-2 
and ABV-4 infection   
IHC protocol was applied as mentioned in paragraph (3.14.5) except of the following different 
steps. 
1.  Antigen retrieval was performed as given in table 8, 9, and 10 at 95 °C for 25 minutes 
followed by cooling for 10 minutes at room temperature. 
2. For blocking, 100µl diluted blocking solution was applied onto each slide (see table 8, 9, and 
10). 
3. A 100µl diluted primary antibodies were applied (table 8, 9, and 10). Tissue sections were 
subsequently incubated in the refrigerator at 4 °C overnight. 
4. A 100µl diluted secondary antibody was applied (table 8, 9, and 10). Tissue sections were 
subsequently incubated for 30 minutes at room temperature. 
5. Avidin biotin complex (ABC) and peroxidise anti peroxidise (PAP) methods were used as 
listed in table 8, 9, and 10 and 100μl of ABC Vectastain kit® (Vector laboratories Inc, USA), 
diluted 1:100 in 1% BSA/TBS was applied. 
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3.16. Generating the ABV-2 and ABV-4 RNA specific probes for the ISH 
3.16.1. Generating the ABV-2 specific oligonucleotide probes  
In order to design hybridization probes specific for ABV-2 N gene, ABV-2 N gene sequence 
(accession number at Genbank: GQ850506.1) was used. Using primer-BLAST, we designed 
primers suitable for amplification of a fragment 230 bases in length (table 11). The exact 
location of the primers in the sequence chosen are 706 to 726 (forward primer) and 915 to 935 
(reverse primer). The sequence from position 706 to position 935 was used for the design of 
two oligonucleotides (accession number: GQ850501.1) as shown in (Fig. 1). The sequence of 
oligonucleotides 1 is identical to 706-826 bases (table 12).  Oligonucleotides 2 are homologous 
to 800-935 bp of the ABV-2 N but oligonucleotides 2 have the reverse complementary 
sequence (table 12). Both oligos overlap by 20 bases. A PCR was performed (tables 13 and 
14). In the first cycle, oligo1 and oligo2 annealed at the overlapping region and the polymerase 
extended both oligos producing a double stranded template. This template was subsequently 
amplified using the forward and reverse primers. This amplicon was subsequently ligated into 
PCR 4.0 TOPO vector (Invitrogen, Germany). After ligation, amplification of the ligated DNA 
was performed by PCR. After amplification of the ligated DNA, the obtained PCR products 
were used as template for producing sense probe (Fig. 2) and antisense probe (Fig. 3) by in 
vitro transcription. Because of the location of the promoter for T7 polymerase between the 
annealing sites for primer M13-F and the annealing site for primer ABV-2 N-R, the sense RNA 
transcript was produced transcripts by T7 polymerase (Fig. 2). Because of the location of the 
promoter for T7 polymerase between the annealing sites for primer M13-F and the annealing 
site for primer ABV-2 N-F, the antisense RNA transcript was generated transcripts by T7 
polymerase (Fig. 3). 
 
Fig. 1: Oligonucleotides used for generation of the ABV-2 specific probes 
 
 
 
 
 
 
 
 
The amplification reaction of the ABV-2 N oligonucleotides is listed in table 17. PCR 
conditions are demonstrated in the table 18. PCR was applied in PTC-200 peltier thermal 
cycler (Biozyme, Germany).  
 
3' 
   3' ABV-2 N- oligo 2 (right side) 
ABV-2 N- oligo 1 (left side) 
   706  826  
800  935  
R Primer 
 F Primer 
5' 
   5' 
5' 
  5'    3' 
  3' 
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  Primary construct 
  DNA template 
   Sense probe 
Fig. 2: Schematic diagram of generating of the ABV-2 N sense probe. PCR products 
containing ABV-2 N segments (primary construct) were used. From the primary construct (see 
above), amplified DNA was generated (green row) and used as a DNA template for in vitro 
transcription. From the template, the ABV-2 N sense probe was generated starting from T7 
promoter till ABV-2 N reverse priming sites (violet row). 
    Primary construct 
  DNA template 
  Antisense probe 
Fig. 3: Schematic diagram of generating of the ABV-2 N antisense probe. PCR products 
containing ABV-2 N segments (primary construct) were used. From the primary construct (see 
above), amplified DNA was generated (green row) and used as a DNA template for in vitro 
transcription. From the template, the ABV-2 N antisense probe was generated starting from T7 
promoter till ABV-2 N forward priming sites (violet row). 
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Table 11: Sequences and orientation of the specific ABV-2 N gene primers 
 
 Primers  Sequence (5'->3') Length (bases) 
ABV-2-N-F 5´-ATGCCACACTGACAATCCCG-3´ 20 
ABV-2-N-R 5´-TAGCCGGCCATTGTTGGATT -3´ 20 
 
F= forward, R= reverse 
 
Table 12: Sequences of the ABV-2-N oligonucleotides 
 
Oligonucleotides of 
ABV-2 N Sequence (5'->3') 
 
Oligo 1 (left side) 
acattgacaatcccggccgtagcacttgaaattaaggagttcctagatgtaactacaaagctaaagg
cagagcatggggacatgtttaaatatcttggtgctattcgtcattccgacgcga 
 
Oligo 2 (right side) 
tgaaagccctggcaaagagtttatggatcagatcaaattagtggcagggtttgcacaaatgaccac
atacacaacaatcaaagagtatctcaacgagtgtatggatgccacattgacaatcccggccgta 
 
ABV-2-N oligonucleotides (designed using the accession number: GQ850501.1) 
 
Table 13: Composition of the PCR-reaction for amplification of the ABV-2 N 
oligonucleotides 
 
Reagent  Amount  µl Concentration  
Sterile H2O 13.4 µl  
Buffer containing MgCl2 (complete buffer) 2.4 µl 10X concentrated
ABV-2-N-R 0.8 µl 10µM 
ABV-2-N-F 0.8 µl 10µM 
dNTP 0.4 µl 0.2 mM 
BioThermTM DNA-Polymease (Thermo Scientific,
Germany) 0.2 µl 
           5U/µl 
Oligo 1- ABV-2 N- left side (DNA) (Biomers, Germany) 1µl 10µM 
Oligo 2-ABV-2 N-right side (DNA) (Biomers, Germany) 1 µl 10µM 
Total volume per reaction 20 µl  
 
F= forward, R= reverse, µM= micromolar, U/µl= unit per microliter, mM= millimolar 
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Table 14: Conditions of the PCR-reaction using ABV-2 N oligonucleotides 
 
Reaction Time Temperature in °C Cycles 
Initial denaturation 120 seconds 94 °C  
Denaturation  15 seconds 94 °C 
 
   35 cycles 
Annealing  30 seconds 50 °C 
Extension 60 seconds. 72 °C 
Final extension 10 minutes 72 °C  
Cooling  ∞ 4°C  
 
 
3.16.1.1. Visualization of PCR products by gel electrophoresis 
PCR products were analyzed by gel electrophoresis.  2% agarose (Biozyme, Germany) in 0.5x 
tris base, boric acid and ethylenediaminetetraacetic acid (TBE) buffer was used. Gel 
electrophoresis protocol was carried out as follows: 
1. Weigh 0.6 g agarose powder (Biozym, Germany) and add it to beaker. 
2. Add 30 ml (0.5x) TBE buffer to the flask.   
3. Melt the agarose on hot plate until the solution becomes clear. Heat the solution from 150°C 
up to 200°C until it boils.  
4. Add 1μl Midori-green dye (Nippon Genetics Europe GmbH, Germany), diluted 1:10 to the 
agarose solution. 
5. Pour the melted agarose solution into the casting tray and let cool until it becomes solid. 
6. Let the solution cool at room temperature for 30 minutes or in refrigerator for 15 minutes. 
7. Add enough 0.5x TBE buffer over the gel. 
8. Add 1l of 6X orange DNA loading dye (Thermo Scientific, Germany) to each 5l PCR-
reaction. 
9. In a separate well, add 3.5l pUC Mix Marker, 8 (MBI Fermentas, Germany). 
10. Carefully pipette mixture of each sample into separate wells in the gel. 
11. Turn on the power supply 6 volt/cm electrodes distance for one hour. 
12. Observe the PCR products through UV light with a transilluminator (Bachhofer 
Laboratories, Germany) with 254 nm wave length. 
 
3.16.1.2. Purification of DNA 
Amicon Ultra Centrifugal filters (Merck, Germany) were used to purify PCR products. The 
purification protocol was performed according to the manufacturer. Concentration of the DNA 
was measured by Nanodrop®2000 spectrophotometer (Thermo scientific GmbH, Germany). 
The purified DNA was stored in a centrifuge tube at -20°C. 
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3.16.1.3. Ligation of PCR products into PCR TOPO 4 TA® Vector    
The TOPO TA cloning kit (Life Technologies, Germany) was used to ligate two DNA 
fragments. The first DNA is the amplified DNA strand which has identity to the ABV-2 N 
gene sequences. The second DNA is the PCR 4.0 TOPO vector. PCR 4.0 TOPO vector 
contains the M13-F and M13-R priming sites. The components of the ligation reaction are 
listed in table 15.  
Table 15: Composition of the TOPO® ligation reaction 
 
Reagent amount in µl Concentration  
Fresh PCR product 3 µl        112 ng/μl 
5X T4 DNA ligase reaction buffer 1 µl  
Sterile H2O 2 µl  
PCR 4.0 TOPO® vector 1 µl          25 ng/μl 
Final volume  7 µl  
  
PCR products (amplified ABV-2-N segments), ng/μl= nanogram per microliter, µl= microliter 
 
The protocol of the TA ligation reaction was performed according to the instructions of the 
manufacturer. The TA TOPO® reaction was placed on ice for 2 minutes and then stored at -20 
°C.    
 
3.16.1.4. Polymerase chain Reaction (PCR)     
We used QIAGEN Multiplex PCR Kit (Qiagen, Germany) to generate the template for the 
ABV-2 N probes. Insert-specific primers (ABV-2-N primers) were commercially produced by 
(Biomers, Germany). The PCR was carried out in PTC-200 Peltier thermal cycler (MJ 
Research, Canada). The composition of the PCR reaction is stated in table 16 and the 
conditions of the PCR are listed in table 17. 
 
Table 16: Composition of the PCR-reaction 
Reagent  Amount  µl Concentration 
Sterile H2O 13.2 µl  
Multiplex-master mix (MM) (Qiagen®, Germany) 15 µl 2 X concentrated 
M13-F + ABV-2-N-R      OR 
M13-F+ ABV-2-N-F 
0.8 µl 10µM 
0.8 µl 10µM 
Ligated DNA containing ABV-2-N gene fragments 1 µl 10µM 
Total volume per reaction 30 µl  
 
F= forward, R= reverse, µM= micromolar, µl= microliter 
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Table 17: Conditions of the PCR-reaction 
 
Reaction Time Temperature in °C Cycles 
Initial denaturation 120 seconds 94 °C  
Denaturation  15 seconds 94 °C 
 
   35 cycles 
Annealing  30 seconds 55 °C 
Extension 60 seconds. 72 °C 
Final extension 10 minutes 72 °C 
 Cooling  ∞ 4°C 
 
3.16.1.5. Purification of PCR products 
PCR products were cleaned by Amicon Ultra Centrifugal filters (Merck, Germany) and 
protocol of the purification was performed according to the instructions of the manufacturer. 
 
3.16.1.6. In vitro transcription 
DIG-RNA labeling kit (Roche, Germany) was used for this purpose. For initiation of in vitro 
transcription, T7 RNA polymerase was added to generate the sense and anti sense orientated 
ABV-2 RNA probes (table 18). For generating the sense probe, the T7 RNA polymerase was 
added to PCR products (DNA template) and the transcription started from T7 promoter until 
ABV-2 N-R priming sites (Fig. 2). For synthesis of the antisense RNA probe, the T7 RNA 
polymerase was added to PCR products (DNA template) and the transcription started from T7 
promoter until ABV-2 N-F priming sites (Fig. 3). The sense orientated probe is detecting 
ABV-2 genome while antisense probe is targeting ABV-2 mRNA. After producing of the 
probes, probes were kept at -80 °C until use. In vitro transcription reaction was prepared as 
given in table 22. For generating of the ABV-2 probes, we employed the same protocol for the 
in vitro transcription as mentioned (3.16.1.5.1.). The components of the in vitro transcription 
reaction are listed in table 18.  
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Table 18: In vitro transcription reaction for generating the ABV-2 probes 
 
       Components  Amount in µl Concentration  
Sterile H2O                    12 µl  
10x transcription buffer        3 µl 10 times concentrated 
 
10x NTP Labelling Mix        
 
2 µl 
10 times concentrated and 
containing (10 mM ATP,10 
mM CTP,10mM GTP,6.5 
mM UTP,3.5 mM DIG-11-
UTP) 
Ribolock RNase inhibitor (Fermentas,
Germany) 
1 µl 40 U/µl 
 PCR product (ABV-2-N) 10 µl 85 ng/µl 
T7 RNA polymerase       2 µl 20 U/µl   
  Total   30 µl  
 
 
NTP= nucleotides triphosphate, µl= microliter, ng/µl= nanogram per microliter, U/µl= units 
per microliter, mM= millimolar 
 
3.16.1.7. In vitro transcription protocol  
1. Add the components of the in vitro transcription (table 14) in order to 500 µl microfuge tube 
on ice. 
2. Mix the reagents of the in vitro transcription gently and spin down. 
3. Incubate the mixture on Accu BlockTM Mini heat block (Labnet International, Germany) at 
37°C for 2 hours.  
4. Add 2µl DNAse І (10 units/µl). Vortex, centrifuge, and incubate for 15 minutes at 37°C on 
heat block. 
5. Add 2µl of (0.2M) ethylenediaminetetraacetate (EDTA), vortex and spin down. 
6. Add 2.5µl of 4M lithium chloride, vortex and spin down. 
7. Add 75µl of 98% ethanol, vortex and spin down. Then store it at -20 °C overnight.     
8. At the second day, centrifuge the mixture at 14,000 g for 15 minutes. 
9. Remove supernatant and wash the pellet with aliquots of 50µl of 70% ethanol, vortex and 
spin down. 
10. Centrifuge the mixture 14,000 g at 4 °C for 5 minutes. 
11. Remove supernatant and let the pellet to dry for 10 minutes. 
12. Add 100 µl of bi-distilled DEPC treated water, then mix, vortex and spin down. 
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13. Add 1 µl of RNase inhibitor to the mixture and mix it. 
14. Aliquot the 100 µl into eppendorfs (10µl pro eppendorf) and store it at -80°C freezer until 
use. 
 
3.16.2. Generation of ABV-4 specific riboprobes  
3.16.2.1. Sequencing of the DNA plasmid carrying the ABV-4 N segment 
Cloned DNA carrying the ABV-4 N gene sequences had been generated by a former doctoral 
study (Saskia Ressmeyer) using the PCR4® TOPO vector (Invitrogen, Germany). The cloned 
DNA was commercially sequenced by GATC (Biotech AG, Germany) and analyzed by Blast 
(Zhang et al., 2000; Morgulis et al., 2008). The inserted sequence was complimentary to the 
ABV-4 N segment (isolate 16) (accession number: GQ496360.1) with a homology of 100% for 
the respective ABV-4 N segments and therefore suitable for generating the ABV-4 riboprobes 
(Fig. 4 and 5). 
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Fig. 5: Schematic diagram of generating of the ABV-4 N antisense probe. From the primary 
construct (see above), amplified DNA was generated (green row) and used as a DNA template 
for in vitro transcription. From the template, the ABV-4 N antisense probe was generated 
starting from T3 promoter till ABV-4 N forward priming sites (blue row). 
Primary construct 
DNA template 
Antisense probe 
  Primary construct 
DNA template 
Sense probe 
Fig. 4: Schematic diagram of generating of the ABV-4 N sense probe. From the primary 
construct (see above), amplified DNA was generated (green row) and used as a DNA template 
for in vitro transcription. From the template, the ABV-4 N sense probe was generated starting 
from T7 promoter till ABV-4 N reverse priming sites (violet row). 
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3.16.2.2. Amplification of the plasmid DNA carrying the ABV-4 N segment by PCR 
The PCR 4.0 TOPO vector primers (M13 primers) were commercially synthesized by 
Invitrogen GmbH, Germany while insert-specific primers (ABV-4 N primers) were 
commercially produced by Metabion International GmbH AG, Germany. PCR was carried out 
in a PTC-200 peltier thermal cycler (MJ research, Canada). The primers sequences, orientation 
and sizes are given in table 19. Composition and conditions of the PCR reaction are stated in 
table 20 and 21. 
 
Table 19: Sequences and orientation of the insert-specific and vector primers  
Primer Base sequences      
 
Length  
(Bases) 
ABV-4-N-F 5'-CATGAGGCTATWGATTGGATTA- 3' 20 
ABV-4-N-R 5’-TAGCCNGCCMKTGTWGGRTTYT-3' 25 
M13-F 5' -TGTAAAACGACGGCCAGT-3' 20 
M13-R 5' -CAGGAAACAGCTATGACC-3' 20 
 
 F= forward, R= reverse 
 
Table 20: Composition of the PCR-reaction  
 
Reagent  Amount   
      µl 
Concentration 
Sterile H2O 18.7 µl  
Buffer containing MgCl2 (complete buffer) 2.5 µl 10X concentrated 
M13-F+ ABV-4-N-R   OR   
M13-R+ ABV-4-N-F 
     2 µl  
            10µM 
      2 µl 
dNTP 0.5 µl 10µM 
BioThermTM DNA-polymease (Thermo Scientific,
Germany)     0.3 µl 
5U/µl 
cloned DNA                        1 µl 140 ng/µl 
Total volume per reaction 25 µl  
 
F= forward, R=reverse, µl= microliter, µM= micromolar, U/µl= unit per microliter, ng/µl= 
nanogram per microliter 
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Table 21: Conditions of the PCR-reaction 
Reaction Time Temperature in °C Cycles 
Initial denaturation 120 seconds 94 °C  
Denaturation  15 seconds 94 °C 
 
   35 cycles 
Annealing  30 seconds 55 °C 
Extension 45 seconds 72 °C 
Final extension 10 minutes 72 °C  
Cooling  ∞ 4°C  
 
 
3.16.2.3. Visualization of PCR products by gel electrophoresis 
The same gel electrophoresis protocol for visualization was used as shown previously 
(3.16.1.1.) with pUC Mix, 8 (MBI Fermentas, Germany) as marker. 
 
3.16.2.4. Purification of DNA 
Amicon Ultra Centrifugal filters (Merck, Germany) were applied to clean PCR products. The 
purification protocol was performed according to the instructions of the manufacturer. 
 
3.16.2.5. In vitro transcription  
For in vitro transcription, PCR products generated by the standard plasmid-specific primers 
M13 forward and M13 reverse in conjunction with one insert specific primer each were used. 
The amplificates contain promoters for the binding sites for the T7 and T3 RNA polymerase. 
Digoxigenin (DIG) RNA labeling kit (Roche, Germany) was used to produce DIG–labeled 
ABV-4 riboprobes. For initiation of the in vitro transcription, T7 or T3 RNA polymerase were 
added (table 22). For generating the sense orientated RNA probe, the T7 RNA polymerase was 
added to PCR products (DNA template) and the transcription started from T7 promoter until 
ABV-4 N-R priming sites (Fig. 4). For synthesis of the antisense RNA probe, the T3 RNA 
polymerase was added to PCR products (DNA template) and the transcription started from T3 
promoter until ABV-4 N-F priming sites (Fig. 5). The sense orientated probe is detecting 
ABV-4 genome while antisense probe is targeting ABV-4 mRNA. After producing of the 
probes, probes were kept at -80 °C until use. The components of the in vitro transcription 
reaction are listed in table 22.  
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Table 22: The in vitro transcription reaction for generating the ABV-4 probes 
       Components  Amount 
 in µl 
Concentration  
Sterile H2O                    12 µl  
10x transcription buffer        3 µl 10 times concentrated 
 
10x NTP Labelling mix        
 
2 µl 
10 times concentrated and 
containing (10 mM ATP,10 
mM CTP,10 mM GTP, 6.5 
mM UTP,3.5 mM DIG-11-
UTP) 
Ribolock RNase inhibitor (Fermenta, USA) 1 µl 40 U/µl 
PCR product  10 µl 60 ng/µl 
T7 RNA polymerase OR       
T3 RNA polymerase       
2 µl 20 U/µl   
2 µl 20 U/µl  
  Total   30 µl  
 
µl= microliter, U/µl= unit per microliter, ng/µl= nanogram per microliter, mM= millimolar 
 
3.16.2.6. In vitro transcription protocol  
We used the same in vitro transcription protocol that applied to generate ABV-2 probes as 
mentioned in (3.16.1.7.). 
 
3.17. Determination of digoxigenin labeling of the probes  
Spot test was applied to quantify and estimate the efficiency of the labeling of the ISH 
riboprobe with digoxigenin (DIG). Serial dilutions of the respective riboprobes were applied on 
positive charged Zeta-Probe GT membrane (Biorad, Germany). Labeled control RNA 
(100ng/µl, 760 base pairs, it contains 10µg DIG) was used as a standard for comparison with 
sense and antisense riboprobes. Labeled control RNA was provided with the in vitro 
transcription kit (Roche, Germany). Quantification of the labeling of the respective probe was 
performed as follows: 
1. Apply 2μl of eight different dilutions in DEPC-H2O of the DIG-labeled probe and labeled 
control to Zeta-Probe GT membranes (Biorad, Germany). 
2. Dry the membrane at room temperature, fix nucleic acid to the membrane by cross linking 
with UV light at 125 millijoules for 1 minute. 
3. Incubate membrane 1 minute in 1xPBS at room temperature. 
Chapter three - Materials and Methods 
 
 50
4. Background blocking: per 1.2 ml sterile neutral sheep serum and 1.8 ml of 10 % triton-X 
100 (Sigma Aldrich, Germany), add 57 ml of buffer 1. Afterwards, incubate the membrane in 
the mixture for 30 minutes at room temperature. 
5. For the immunological detection, incubate the membrane with the alkaline phosphatase (AP) 
conjugated anti-digoxigenin (Fab fragments) antibody (Roche, Germany) for two hours in a 
dark chamber. The antibody was diluted 1:300 in DEPC-H2O. 
6. Membrane washing: for 2x5 minutes in sterile 1xPBS. 
7. For the colorimetric detection of the AP activity, dissolve 15 mg of levamisole in 50 ml 
buffer 3 and then add 250µl of Nitroblueteterazolium (NBT) (Sigma Aldrich, Germany), 200µl 
of 5-bromo-4-chloro-3-indolyl-phosphate X-Phosphate (BCIP) (Sigma Aldrich, Germany) to 
the solution respectively. Incubate the membrane in the staining solution for 30 minutes at 
room temperature. 
8. The working concentration of NBT was 75mg/ml while the working concentration of BCIP 
was 50mg/ml. NBT was diluted in 70% dimethylformamide while BCIP was diluted in 100% 
dimethylformamide. 
9.  Membrane washing was performed for 2 x 5 minutes in sterile 1xPBS. 
10. The intensity of the colour reaction of the labeled control RNA was compared with the 
DIG-labeled probe in different dilutions. 
 
3.18. In situ hybridization (ISH) 
ISH was used to detect the ABV-2 and ABV-4 RNA in paraffin embedded tissue sections of all 
experimentally ABV-2 and ABV-4 infected birds.  
 
3.18.1. Controls 
A brain and GIT tissue sections from ABV-2 experimentally infected cockatiel were used as a 
positive control. In parallel, we prepared a negative control for each slide where the ABV-2 or 
ABV-4 riboprobes were not added but only hybridization mix. 
 
3.18.2. Evaluation the positive signals for ISH probes  
Presence of intranuclear hybridization signals are considered as positive reaction for the 
genomic RNA while intranuclear and/or intracytoplasmic hybridization signals are considered 
as positive reaction for the mRNA of the virus. 
 
3.18.3. DIG-labeled riboprobes  
We used ABV-2 and ABV-4 probes for the ISH as presented in Fig 1, 3 and 4. Each 5µl of 
each DIT-labeled riboprobes was diluted in 100µl hybridization mix. Concentration of the 
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ABV-2 and ABV-4 riboprobes was measured by Nanodrop®2000 spectrophotometer (Thermo 
scientific GmbH, Germany). The 40µl diluted probe was added onto each slide. 
 
3.18.4. Preparation of paraffinized tissue sections 
Tissue sections were cut into 5µm by microtom, mounted on positively charged Super Frost 
Plus slides (Thermo Scientific, Germany) and adhered to the slide by baking at 60°C for 
approximately 30 minutes. Tissue sections were not employed for in situ hybridization 
technique before drying at room temperature for at least 24 hour to ensure that the tissue was 
well adhered to the slide and to avoid loss of tissue during the hybridization process. 
 
3.18.5 Evaluation of ABV-2 and ABV-4 RNA distribution pattern 
For evaluating the distribution of the ABV-2 RNA and ABV-4 RNA, we used the same semi 
quantitative scores which were shown in table 7. 
 
3.18.6. ISH protocol 
1. Deparaffinizing tissue sections was carried out by immersing them in xylene (3 times 
changes, 5 minutes each). 
2. Dehydration of tissue sections was carried out by immersing through series of alcohol 
concentrations: 98% isopropanol, 96% ethanol, 70% ethanol (once, 5 minutes each), followed 
by washing in bi-distilled DEPC treated water (2 times, for 5 minutes), and in sterile 1xPBS 
(once, for 5 minutes). 
3. To obtain better penetration of the probe in tissue sections, tissue sections were washed in 
2M HCl for 20 minutes at room temperature. 
4. Washing in 2 x standard saline citrate (SSC) +5 mM EDTA-Na2 (see annex) at 50 °C for 30 
minutes twice. 
5. For proteolysis, tissue sections were incubated with RNase free Proteinase K (Carl Roth 
GmbH, Germany) at 37 °C for one hour. Proteinase solution composed of (1ml 1M  tris, pH8; 
1ml 0.1M  CaCl2, and 60ml bi-distilled water treated with DEPC) for each glass cuvette. A 6µl 
of RNase free Proteinase K (5μg/ml) was added to 60 ml the proteinase solution in each glass 
cuvette. The working concentration of proteinase K was 10 mg/ml. 
6. To stop the reaction, tissue sections were incubated with 0.2 % glycine-PBS for 5 minutes at 
room temperature. 
7. Post-fixation was carried out in 4% paraformaldehyde (PFA) / 1xPBS for 4 minutes at room 
temperature. 
8. Tissue sections were washed in 1xPBS for 1 minute twice and subsequently washed in 
1xPBS+5 mM MgCl2 for 15 minutes at room temperature. 
Chapter three - Materials and Methods 
 
 52
9. Acetylation of tissue sections in 0.25% acetanhydride in 0.1M triethanolamine-DEPC-H2O, 
pH 7.5 for 10 minutes at room temperature. 
10. Tissue sections were washed in 1xPBS for 1 minute twice and then washed in 1xPBS for 
15 minutes once at room temperature. 
11. Prehybridization step was carried out by incubation of tissue sections with prehybridization 
mix (PHB-Mix) for at least one hour at 52 °C (see annex of preparation of PHB-Mix). For each 
49,5ml prehybridization mix (PHB-Mix), 0.5ml sodium salts DNA (ssDNA) from calf liver 
type IV (Sigma Aldrich, Germany), and 1.25ml RNA stocks solution (Sigma Aldrich, 
Germany) was added (see annex). 
12. Hybridization was performed by adding 40µl of the DIG-labeled probed on each slide. 
Slides were covered with Gel Bond® Film (Biozym, Germany), sealed with Fix-o-gum ® glue 
(Marabau, Germany). Slides were transferred to a humid chamber and were incubated at 52 °C 
in the oven overnight. 
13. After removing the Gel Bond® Film and Fix-o-gum ® glue from slides, post hybridization 
was carried out by washing tissue sections in  6xSSC+45 % formamide at 42 °C for 15 minutes 
twice and in 2xSSC for 5 minutes at room temperature twice. 
14. Tissue sections were incubated with RNAse solution (see annex) for 30 minutes at 37 °C 
15. Washing of tissue sections in 2xSSC twice for 5 minutes at room temperature followed by 
second washing in 0.2 x SSC for 15 minutes at 45 °C twice. 
16. Washing in buffer 1 (see annex) for 1 minutes once at room temperature. 
17. Washing in buffer 2 (blocking solution) (see annex) for 30 minutes at room temperature. 
18. Tissue sections were incubated with anti-DIG antibody (Roche GmbH, Germany) solution 
for 2 hours in a humified champer at RT in the dark. Two parallel lines were encircled around 
area of the tissue on each slide by PAP-Pen (Dako, Germany). A 300µl anti-DIG antibody 
solution was added to each slide. 
19. Washing in buffer 1 (see annex) for 15 minutes twice at room temperature. 
20. Washing in buffer 3 (see annex) for 2 minutes once at room temperature. 
21. Tissue sections were incubated with NBT/BCIP staining solution (see annex) in humified 
and dark environment for 18 hours at room temperature.  
22. The reaction of staining solution was stopped by washing of tissue sections in buffer 4 for 
10 minutes at room temperature in dark twice. 
23. Tissue sections were washed with bi-distilled water for 2 minutes twice followed by 
washing in tap water for 2 minutes at room temperature twice. 
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24. Tissue sections were mounted with Kaiser glycergel mounting medium (Merck, Germany) 
and then cleaned for examination under light microscope (Nikon, Germany). 
 
3.19. Cultivation of cockatiel blood cells 
3.19.1. Collection of blood samples 
Blood samples from the right jugular vein of healthy cockatiel were collected to demonstrate 
the isolation procedure. According to the permission number (499-M), blood samples were 
obtained directly after euthanization. Insulin syringe 0.5ml with 30 gauge needle (Braun, 
Germany) and heparinized micro tubes containing of 35 I.U lithium heparin/ml blood (Sarsted, 
Germany) were used to collect blood samples.  
 
3.19.2. Isolation of buffy coat (BC) cells from healthy cockatiels 
BC cells are white blood cells and thrombocytes. BC cells were prepared by centrifugation of 
the diluted blood at 3000 rpm for 15 minutes at room temperature. After that, we obtained 
three distinct layers, a layer of plasma lying in the top, a layer of red blood cells (RBC) located 
in the bottom, and a thin layer in between which represents the BC. BC cells contains of most 
of white blood cells and thrombocytes.  
 
3.19.2.1. Protocol of isolation of BC cells from whole blood 
The isolation the BC cells from the cockatiel blood was performed as follows: 
1. A 0.5ml blood sample was diluted in 2ml sterile 1xPBS and placed into sterile conical glass 
test tube. 
2. Heparinised blood samples were centrifuged by Rotina 48RC (Hettich,Germany) at 3000 
rpm for 15 minutes between 18-20°C. 
3. After 15 minutes, BC were gently collected and transferred to a new conical sterile glass test 
tube. 
4. BC cells then washed in 9 ml sterile 1xPBS and centrifuged at 2500 rpm for 10 minutes 
twice in order to remove RBCs contamination. 
5. BC cells were suspended in 3ml RPMI-1640 medium (PAA, Germany) and mixed by 
pipetting.  
6. Resuspended BC cells were propagated in RPMI-1640 medium in 6 wells cell culture plate 
(Nunclon brand TM Surface, Germany). 
7. A 50µl of cells were counted by using trypan blue assay under IX70 S8F inverted 
microscope (Olympus, USA). 
8. RPMI-1640 culture medium for BC cells had to be changed every four days. 
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3.19.3. Isolation of mononuclear cells (MNC) from healthy chicken 
Peripheral blood MNC are blood cells with a round shaped nucleus, such as monocytes, B-
lymphocytes, T-lymphocytes and NK cells. Isolation of MNC from whole blood was 
performed through using density gradient Ficoll-PaqueTM Premium (GE Healthcare, Germany) 
with a density 1.077g/ml. For characterization of the cockatiels immune cells by indirect 
immunofluorescence and by flow cytometry, chicken MNC served as positive control.  
 
3.19.3.1. Protocol of separation of chicken MNC 
Isolation of MNC was achieved as follows: 
1. Sterile conical glass test tubes were prepared and 3.5ml Ficoll®Paque TM premium was 
added into sterile conical glass test tubes. 
3. A 2 ml blood sample was diluted into 2.5ml of sterile 1xPBS. 
4. The diluted blood was carefully layered over Ficoll-PaqueTM Premium. 
5. Centrifuge at 3100 rpm for 15 minutes between 18-20°C. 
6. After centrifugation, three layers were obtained, an upper layer (plasma), a lower layer in the 
bottom (erythrocytes), and an intermediate layer located represents the mononuclear cells. 
7. MNC were pulled by sterile pipette and transferred to a clean glass test tube containing of 8 
ml sterile 1xPBS. 
8. Centrifuge at 2500 rpm for 15 minutes between 18-20°C to wash them twice to remove as 
much as possible of the contaminated RBC. 
9. MNC pellets were suspended in sterile RPMI-1640 culture medium (PAA, Germany) 
containing 1% penicillin/streptomycin (PAA, Germany), gentamycine (PAA, Germany) and 
fetal calve serum (PAA, Germany). 
10. Resuspended cells were propagated into 6 well tissue culture well plate (Sarsted Inc, USA) 
containing of 3 ml RPMI-1640 culture medium in each well. 
11. A 50µl of MNC were counted by using trypan blue assay under IX70 S8F inverted 
microscope (Olympus, USA). 
12. RPMI-1640 culture medium for MNC had to be changed every four days. 
 
3.20. Characterization of the immune cells in BC cells of cockatiel 
We employed two different methods to characterize the BC cells as follows: 
1. Indirect immunofluorescence (IIF) 
2. Flow cytometry (FC) 
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3.20.1. Characterization of cockatiels immune cells by (IIF) 
After successful isolation of BC cells, it was important to recognize B lymphocytes, T 
lymphocytes, monocytes, thrombocytes, CD4 and CD8 cells sub populations in BC cells. Due 
to the lack of specific antibodies that recognize the immune cells in cockatiel, we tested the 
cross reactivity of the antibodies from other species of animals (table 23). Moreover, we tested 
antibodies generated specific for human, chicken, and duck immune cells (table 24). 
Respective positive controls were also used for each cell surface marker. Feline gastrointestinal 
tract tissue sections of feline B-cell lymphoma, feline T-cell lymphoma cell line, feline lymph 
node, normal chicken bursa, and normal chicken spleen were used as positive control.  
 
3.20.1.1. Preparation and fixation of BC cells 
After isolation the BC cells, we smeared 150µl BC cells on poly-L-lysine coated slides 
(R.Langenbrinck, Germany). Each smear contains at least 1000 cells. Smear was air dried for 
20 minutes at room temperature. BC cells were fixed with ice cold 3% PFA for 15 minutes. 
PFA was diluted in sterile 1xPBS. An amount 100µl 3% PFA was added on each smear. 
 
3.20.1.2. Blocking 
We used 5% goat serum (Sigma-Aldrich, Germany), diluted in sterile 1xPBS.  
 
3.20.1.3. Control 
Chicken MNC served as positive control for recognizing CD4, CD8a, CD3 cells, B cells, 
monocytes and thrombocytes as given in table 24. Moreover, we prepared a negative control 
for each marker in which the primary antibody was not added.  
 
3.20.1.4. Evaluation of the positive signals 
We considered any cell having a collar-like staining around it as positive cell.  
 
3.20.1.5. Primary and secondary antibodies 
Primary and secondary antibodies are listed in table 23 and 24. 
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Table 23: List of antibodies tested for cross reactivity with cockatiels by IIF 
 
Primary antibodies  Dilutions  
in 1xPBS 
Secondary antibodies Dilutions  
in 1xPBS 
Blocking  
Rabbit anti-human 
CD3, Dako, Germany 
1:100  
1:300 
1:500  
Cy3 conjugate goat 
anti-rabbit IgG (H+L) 
Dianaova, USA 
1:50, 1:100, 
1:200, 1:300 
 
5% goat serum, 
diluted in 
1xPBS 
Mouse anti-human 
CD3, clone PC3, 
Dako, Germany  
1:100  
1:300 
1:500 
Cy3 conjugate goat
anti-mouse IgG (H+L)
Dianaova, USA 
1:50, 1:100, 
1:200, 1:300 
 
5% goat serum, 
diluted in 
1xPBS 
Mouse anti-human 
CD3, clone F7.2.38, 
Dako, Germany 
1:100 
1:300 
1:500 
1:1000 
Cy3 conjugate goat
anti-mouse IgG (H+L)
Dianaova, USA 
1:50, 1:100, 
1:200, 1:300 
 
5% goat serum, 
diluted in 
1xPBS 
Rat anti-human 
CD45R, clone B220, 
Dako, Germany 
1:100 
1:300 
1:500 
1:1000 
Cy3 conjugate goat
anti-rat IgG (H+L),
Dianaova, USA 
1:50, 1:100, 
1:200, 1:300 
 
5% goat serum, 
diluted in 
1xPBS 
Rabbit anti-dog 
IgG2a, Dako, 
Germany 
1:100  
1:200 
1:300 
1:500 
1:1000 
Cy3 conjugate goat 
anti-rabbit IgG (H+L) 
Dianaova, USA 
1:50, 1:100, 
1:200, 1:300 
 
5% goat serum, 
diluted in 
1xPBS 
 Mouse anti-human 
CD79α cy, clone, 
HM 57, Dako, 
Germany 
1:100 
1:300 
1:500 
1:1000 
Cy3 conjugate goat
anti-mouse IgG (H+L)
Dianaova, USA 
1:50, 1:100, 
1:200, 1:300 
 
5% goat serum, 
diluted in 
1xPBS 
 Mouse anti-human 
CD79α cy, clone, 
JBB117, Dako, 
Germany 
1:100 
1:300 
1:500 
1:1000 
Cy3 conjugate goat
anti-mouse IgG (H+L)
Dianaova, USA 
1:50, 1:100, 
1:200, 1:300 
 
5% goat serum, 
diluted in 
1xPBS 
 
(MNC) mononuclear cells, (PBS) phosphate buffer saline, (Cy3) cyanine 3 fluorescent 
conjugates dyes, maximal excitation wavelength of Cy3 dye (550 nanometer), maximal 
emission wavelength of Cy3 dye (570 nanometer), (H+L) heavy and light chain antibody. 
 
 
Chapter three - Materials and Methods 
 
 57
Table 24: List of antibodies that applied to characterize the immune cells in cockatiel BC 
 
Primary antibody Dilution Secondary antibody  Dilution  Blocking  Positive 
control 
Rat anti-human CD3, 
clone CD3-12, Biorad, 
Germany 
1:100 
in sterile 
1xPBS 
Cy3 conjugate goat
anti-rat IgG (H+L),
Dianaova, USA 
1:50 
in sterile 
1xPBS 
5% goat
serum, 
diluted in
1xPBS 
chicken 
MNC  
Mouse anti-chicken 
CD4, clone2-35, Biorad, 
Germany 
1:100 
in sterile 
1xPBS 
Cy3 conjugate goat
anti-mouse IgG (H+L),
Dianaova, USA 
1:50 
in sterile 
1xPBS 
5% goat
serum, 
diluted in
1xPBS 
chicken 
MNC  
Mouse anti-chicken 
CD8a, clone 11-39, 
Biorad, Germany 
1:100 
in sterile 
1xPBS 
Cy3 conjugate goat
anti-mouse IgG (H+L),
Dianaova, USA 
1:50 
in sterile 
1xPBS 
5% goat
serum, 
diluted in
1xPBS 
chicken 
MNC  
Mouse anti-duck IgY, 
clone14A3, Biorad, 
Germany 
1:50 
in sterile 
1xPBS 
Cy3 conjugate goat
anti-mouse IgG (H+L),
Dianaova, US 
1:50 
in sterile 
1xPBS 
5% goat 
serum, 
diluted in 
1xPBS 
chicken 
MNC 
Mouse anti-chicken 
thrombocytes, clone 
11C3, Biorad, Germany 
1:200 
in sterile 
1xPBS 
Cy3 conjugate goat
anti-mouse IgG (H+L),
Dianaova, USA 
1:50 
in sterile 
1xPBS 
5% goat 
serum, 
diluted in 
1xPBS 
chicken 
MNC 
Mouse anti-chicken 
monocytes, clone 
KUL01, Biorad, 
Germany 
1:50 
in sterile 
1xPBS 
Cy3 conjugate goat
anti-mouse IgG (H+L),
Dianaova, USA 
1:50 
in sterile 
1xPBS 
5% goat 
serum, 
diluted in 
1xPBS 
 
chicken 
MNC 
 
(MNC) mononuclear cells, (PBS) phosphate buffer saline, (Cy3) cyanine 3 fluorescent 
conjugates dyes, maximal excitation wavelength of Cy3 dye (550 nanometer), maximal 
emission wavelength of Cy3 dye (570 nanometer), (H+L) heavy and light chain antibody. 
 
 
3.20.1.6. General protocol for detection of CD3, CD4, CD8a, B cells, monocytes, and 
thrombocytes 
1. Cell pellets were prepared as a smear by placing 150µl BC cells on poly-lysine coated slides 
(R.Langenbrinck, Germany). 
2. BC cells were air dried for 20 minutes then fixed in ice cold 3% PFA. 
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3. BC cells were washed in ice cold sterile 1xPBS twice. 
4. BC cells were incubated with 5% goat serum (Sigma Aldrich, Germany) in sterile 1xPBS for 
30 minutes at room temperature. 
5. BC cells were incubated with the primary antibodies (listed in table 24), for one hour at RT. 
6. BC cells were washed with sterile ice cold 1xPBS twice. 
7. BC cells were incubated with the secondary antibodies (listed in table 24), in a humidified 
chamber for 1 hr at room temperature in the dark. 
8. BC cells were washed in ice cold sterile 1xPBS twice in the dark. 
9. BC cells were incubated with 1μg diamidino-2-phenylindole (DAPI) (Thermo Scientific, 
Germany) per 1ml 1xPBS for 10 minutes at room temperature in the dark. 
10. BC cells were washed in ice cold sterile 1xPBS twice in the dark. 
11. BC cells were rinsed in sterile distilled water once in the dark. 
12. BC cells were mounted with few drops of Entallen mounting medium (Merck, Germany) 
and then coated with coverslip (Roth, Germany). 
13. Slides were stored at 4°C in dark and examined under Nikon fluorescence microscope 
(Nikon, Germany). 
 
 
3.20.2. Characterization of the cockatiel immune cells in BC by flow cytometry (FC) 
To substantiate IIF results flow cytometry (FC) was also used to characterize cockatiel BC 
cells. We performed FC at the same day of isolation of BC cells. Flow cytometry experiments 
were performed in collaboration with Professor Carsten Staszyk, Institute of Veterinary 
Anatomy, Histology and Embryology, Justus-Liebig University-Giessen. Samples were 
analyzed by Acurri C6 Flow cytometer machine (BD Biosciences, Germany) immediately.  
 
3.20.2.1. Preparation of cells 
We prepared cell pellets from BC cells by centrifugation at 1500 rpm at room temperature. A 
100µl 1xPBS was added to the cell pellet and mixed gently. Then, we added 100µl of BC cells 
suspension in each well of the 96 well plate (cell star®, Germany). Each 100µl cells suspension 
contains of 1× 104 cells as assessed by trypan blue assay. Cell pellets were washed with 1xPBS 
twice to remove the culture medium followed by washing with washing buffer (WB) once. BC 
cells were not fixed with any fixative agents for the FC. We used live BC cells and we 
performed all steps of the FC experiment on ice. 
 
3.20.2.2. Blocking  
We used 5% goat serum (PAA, Germany), diluted in 1xPBS. 
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3.20.2.3. Washing 
A 15 ml washing buffer (WB) was prepared to wash cells pellet.  
 
3.20.2.4. Primary antibodies 
The same primary antibodies that were applied in IIF (listed in table 24). For the FC protocol, 
the primary antibodies were diluted with sterile 1xPBS and 50µl diluted primary antibody was 
added to each well in the well plate as given in table 25. 
Table 25: List of the primary antibodies 
 
Primary antibody Dilution 
Rat anti-human CD3, clone CD3-12 , Biorad, Germany 1:100 in sterile WB 
Mouse anti chicken CD4, clone2-35, Biorad, Germany 1:300 in sterile WB 
Mouse anti chicken CD8a, clone 11-39, Biorad, Germany 1:200 in sterile WB 
Mouse anti duck IgY, clone14 A3, Biorad, Germany 1:400 in sterile WB 
Mouse anti chicken thrombocytes, clone 11C3, Biorad, Germany 1:600 in sterile WB 
Mouse anti chicken monocytes, clone KUL01, Biorad, Germany 1:500 in sterile WB 
 
(IgY) is a marker for B cells, (WB) washing buffer.  
 
 
3.20.2.5. Secondary antibodies 
We used allophycocyanin (APC) conjugated goat anti-rat IgG1 (BD Bioscience, Germany) as 
secondary antibody for anti-CD3 antibody, diluted 1:400 in sterile washing buffer. We 
employed polyclonal phycoerythrin (PE) conjugated goat anti-mouse (BD Bioscience, 
Germany) as a secondary antibody for the mouse derived antibodies, diluted 1: 600 in sterile 
washing buffer. A 50µl diluted secondary antibody was added to each well in the well plate. 
 
3.20.2.6. Controls 
Chicken MNC were used as a positive control for CD3, CD4, CD8a, B cells, monocyte and 
thrombocyte markers. We employed three different negative controls (negative control for the 
primary antibody where only the primary antibody was added to the BC cells, negative control 
for the secondary antibody where only the secondary antibody was added to the BC cells, and 
negative control for BC cells where no antibodies added). For discriminating between live and 
dead BC cells, we incubated BC cells with 7-aminoactinomycin D (7-AAD) dye (Biosciences, 
Germany) in one well of the 96 well plate. The 7-AAD will mark the non-viable cells by 
binding to the nuclei of dead cells. Before measurement, we added 2µl 7-AAD dye to the well 
containing BC cells only, mixed well, incubated for 10 minutes and then analysed. 
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3.20.2.7. Flow cytometry protocol 
1. BC cells were propagated in 96 well plate (cell star®, Germany) and centrifuged by a 
universal 32 centrifuge (Hettich, Germany) at 1600 rpm at 4 °C for 5 minutes. 
2. All samples were washed in sterile washing buffer WB and then centrifuged at 1600 rpm for 
5 minutes at 4 °C. 
3. Supernatant was discarded and BC cells were washed in sterile WB and then centrifuged 
1600 rpm for 5 minutes at 4 °C. 
4. Supernatant was discarded and an amount of 100µl of 5% goat serum was added in each 
well. BC cells were incubated with 5%goat serum/1xPBS for 20 minutes at 4°C in refrigerator. 
5. Supernatant was then discarded and primary antibodies (see table 25) were added to each 
well. BC cells were incubated for 40 minutes in refrigerator at 4 °C. 
6. BC cells are washed with sterile WB twice and then centrifuged at 1600 rpm for 5 minutes at 
4 °C. 
7. BC cells were washed with sterile WB three times and then centrifuged at 1600 rpm for 5 
minutes at 4 °C. 
8. Supernatant was discarded and then secondary antibodies (see table 25) were added. The 
well plate was incubated for 40 minutes at 4 °C. 
9. Conical and round-bottom special tubes (BD Bioscience, Germany) were prepared and BC 
cells were suspended with 50µl sterile 1xPBS into FACS tubes. 
10. FC measurement was performed by Acurri C6 software, threshold 10,000 events, BD flow 
cytometer machine (BD Bioscience, Germany). 
 
3.21. Experimental infection of BC cells with ABV-4 one day post isolation  
3.21.1. Preparation of BC cells 
We isolated BC cells from healthy cockatiel.  After isolation of BC cells, we counted BC cells 
by trypan blue assay. We centrifuged the BC cells at 2500 rpm for 5 minutes to obtain a cell 
pellet. 
 
3.21.2. Infection with ABV-4 
We used ABV-4 to infect BC cells. ABV-4 was provided by Dr. Sybille Herzog from the 
Institute of Veterinary Virology, Faculty of Veterinary Medicine, Justus-Liebig-University-
Giessen and was obtained from infected quail fibroblast cell lines (CEC32) by Dr. Sybille 
Herzog. The titer of ABV-4 was 2×106 ID50/ml. Different dilutions of the cellular supernatant 
of ABV-4 suspension 1:100, 1:500 and 1:1000 with RPMI-1640 culture medium were applied. 
Before the infection, BC cells were counted by trypan blue assay. We added 2ml of the diluted 
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ABV-4 suspension for each 1.5×105cells/ml. We infected BC cells with ABV-4 one day post 
isolation. The experimental infection of BC was implemented as follows: 
1. BC cells were prepared by centrifugation at 2500 rpm for 5 minutes. 
2. BC cells were added into well plate, then gently mixed and incubated with 2 ml diluted 
ABV-4 suspension in the incubator at 37°C for one hour. 
3. ABV-4 infected BC cells were transferred to sterile glass conical test tubes for centrifugation 
at 2500 rpm for five minutes. 
4. The supernatant was discarded and cells were washed with RPMI-1640 culture medium 
once.  
5. BC cells were centrifuged at 2500 rpm for 5 minutes. 
6. The supernatant was discarded and cells were suspended in 2ml RPMI-1640 medium and 
propagated into Nunclon brandTMSurface 6 well plate (Sigma Aldrich, Germany). 
7. RPMI-1640 culture medium of infected cells was replaced every three days. 
8. BC cells were observed for 15 days post infection respectively and viability of BC cells was 
recorded by trypan blue every day. 
 
3.22. Demonstration of ABV antigen in BC cells by IIF 
We investigated the presence of ABV antigen in the BC cells at 3, 5, 9, and 15 days post 
infection (dpi) after ABV-4 infection.  
 
3.22.1. Preparation of BC cells 
Two mililiter of culture medium containing BC cells were collected and pull out into glass test 
tubes. BC cells were centrifuged at 1500 for 5 minutes. After obtaining cells pellet, 50µl cell 
pellet were subsequently smeared onto poly-lysine coated slides (R.Langenbrinck, Germany). 
BC cells were counted by trypan blue assay. Each smear contains of 1.5×103 cells.  The smear 
was dried at room temperature for 20 minutes. 
 
3.22.2. Fixation 
BC cells were fixed in ice cold 70% methanol for 15 minutes at room temperature.  
 
3.22.3. Blocking  
For blocking, 100µl 5% goat serum (Sigma Aldrich, Germany) diluted in sterile 1xPBS was 
used for each slide. BC cells were incubated with the blocking serum for 30 minutes at room 
temperature. 
 
3.22.4. Primary antibody 
We used polyclonal anti-Borna disease virus (BoDV) rat serum to investigate the presence of 
ABV in BC cells after ABV-4 infection. Polyclonal anti-borna disease virus (BoDV) rat serum 
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was proved to be cross reactive to detect ABV antigen (Herzog et al., 2010). The antibody was 
diluted 1:100 in 1xPBS. We added 50µl diluted rat serum onto each BC cells smear. BC cells 
were incubated with the primary antibody for 1 hr at room temperature. 
 
3.22.5. Secondary antibody 
We used Cy3 conjugate goat anti-rat (Dianova, USA) as a secondary antibody, diluted 1:50 in 
1xPBS. We added 50µl diluted goat anti rat onto each BC cells smear. BC cells were incubated 
with the secondary antibody in a humidified chamber for one hour in the dark at room 
temperature. 
 
3.22.6. Controls 
BoDV infected-MDCK cell line were used as positive control. None infected BC cells were 
incubated with the primary and secondary antibodies for comparison with infected BC cells. 
Moreover, infected BC cells were incubated with the secondary antibody only. 
 
3.22.7. IIF protocol for demonstration of ABV antigen  
The protocol was accomplished as follows: 
1. After preparation the BC cells smear, the end of the smear was marked with a circle by pap 
pen (Dako, Germany) to define the area of interest.  
2. BC cells were washed in ice cold sterile 1xPBS once. 
3. BC cells were incubated with 5% goat serum (Sigma Aldrich, Germany) in sterile 1xPBS for 
30 minutes at room temperature. 
4. BC cells were incubated with the polyclonal anti-BoDV rat serum for one hour at room 
temperature. 
5. BC cells were washed with sterile ice cold 1xPBS twice. 
6. BC cells smear was incubated with cy3 conjugate goat anti-rat (Dianova, USA) in a 
humidified chamber for one hour at room temperature in the dark. 
7. BC cells were washed in ice cold sterile 1xPBS twice in the dark. 
8. BC cells were incubated with 1μg/ml DAPI for 10 minutes in the dark at room temperature. 
9. BC cells were washed in ice cold sterile 1xPBS twice in the dark. 
10. BC cells were rinsed in sterile distilled water once in the dark. 
11. BC cells were mounted with few drops of Fluroshield mounting medium (Serva, USA) and 
then sealed with coverslip (Roth, Germany). 
12. Slides were stored at 4°C in the dark and examined under Nikon fluorescence microscope 
(Nikon, Germany). 
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3.23. Demonstration of ABV-4 RNA in BC cells  
For investigation of ABV-4 RNA in BC cells after ABV-4 infection, RNA from the isolated 
BC cells as well as from the ABV-4 suspension was isolated by specific kits for each. Then, 
the total RNA was reversely transcribed using random primers and cDNA applied to PCR. 
 
3.23.1. RNA extraction from BC cells 
We used the RNasey Mini kit (Qiagen, Germany) to isolate the total RNA from BC cells after 
ABV-4 infection. We also isolated the total RNA from the negative control (non infected BC 
cells) for comparison. Total RNA was extracted by the trizol-chloroform method using trizol 
(Ambion, Life Technologies, Germany). Isolation of total RNA from infected BC cells was 
performed according to the instructions of the manufacturer. After isolation, the concentration 
of RNA was measured by Nanodrop®2000 spectrophotometer (Thermo scientific GmbH, 
Germany). The RNA pellet was stored at - 80 °C until use. 
 
3.23.2. RNA extraction from ABV-4 suspension 
The Qiamp viral RNA mini kit (Qiagen, Germany) was used to isolate total RNA from the 
ABV-4 suspension. Isolation of ABV-4 RNA was carried out according to the instructions of 
the manufacturer. Concentration of total RNA was subsequently measured by Nanodrop®2000 
spectrophotometer. Total RNA was stored at - 80 °C until use. 
 
3.24. Reverse transcription reaction (RT) 
RNA extracted from BC cells and from ABV-4 suspension were washed with (7X) wipe out 
buffer for effective elimination of genomic DNA contamination from RNA samples. Reagents 
were gently mixed, subsequently incubated for 2 minutes at 42°C, followed by transferring 
immediately to ice box. Then, RNA extracted from BC cells and from ABV-4 suspension were 
reversely transcribed into cDNA by reverse transcriptase using QuantiTect Reverse 
Transcription kit (Qiagen, Germany) as given in table 26. 
 
Table 26: Reverse transcription reaction 
 
Component Volume µl Final concentration 
Quantiscript RT buffer  4 µl five times concentrated (5X) 
Quantitect reverse transcriptase   2 µl  
RT primer mixture     2 µl 0.7µM 
RNA template  12 µl 300 ng/µl 
 Total volume  20 µl  
 
ng/µl= nanogram per microliter, µM= micromolar 
 
Chapter three - Materials and Methods 
 
 64
Reagents were gently mixed and subsequently incubated in a PTC-200 Peltier thermal cycler 
(Biozyme, Germany). RT programme was run for 15 minutes at 42 °C, 3 minutes 95°C and at 
4°C. Afterwards, the cDNA was subsequently stored at -20°C.  
 
3.25. PCR for amplification of the ABV-4 RNA 
We amplified the cDNAs which are generated from total RNA extracted from BC cells and 
from ABV-4 suspension. ABV-4-forward and ABV-4-reverse primers were used. PCR was 
achieved in a thermocycler PTC-200 (Biozyme, Germany). For visualisation of the cDNA 
fragments, 2% agarose gel electrophoresis technique was subsequently performed. The power 
was set to 7 volt/cm electrodes distance for one hour. PCR was performed as given in tables 27 
and 28.  
Table 27: Composition of the PCR-reaction 
 
Reagent  Amount  µl Concentration 
Sterile H2O 16.7 µl  
Buffer containing MgCl2 (complete buffer) 2.5 µl 10X concentrated 
ABV-4-N-R    2 µl 10µM 
ABV-4-N-F 2 µl 10µM 
dNTP 0.5 µl 10µM 
BioThermTM DNA-polymease 0.3 µl 5U/µl 
cDNA                  1 µl  
Total volume per reaction         25 µl  
 
F= forward, R= reverse, µl= microliter, µM= micromolar, cDNA= complementary DNA 
Table 28: Conditions of the PCR-reaction 
 
Reaction  Time  Temperature in °C Cycles  
Initial denaturation 120 seconds 94 °C  
Denaturation  15 seconds 94 °C  
   35 cycles Annealing  30 seconds 55 °C 
Extension 45 seconds 72 °C 
Final extension 10 minutes 72 °C 
Cooling  ∞ 4°C  
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3.26. Demonstration of house keeping gene  
To confirm that the cDNA amplification was successful, amplification of the PGK1 
(phosphoglycerate kinase 1) gene was used. PGK1 gene was used as reference house keeping 
gene (accession number at the Genbank: NM_204985) for cockatiels by (Olias et al., 2014). 
PGK1-F and PGK1-R primers (Biomers, Germany) were used (table 29). PCR was achieved in 
a thermocycler PTC-200 (Biozyme, Germany). For visualisation of the amplicons, 2% agarose 
gel electrophoresis technique was subsequently performed. The power was set to 7 volt/cm 
electrodes distance for 90 minutes. PCR was performed as given in tables 30 and 31.  
Table 29: Sequences and orientation of PGK1 gene primers 
 
 Primers  Sequence (5'->3') Length (bases) 
PGK1-F 5´- AAAGTTCAGGATAAGATCCAGCTG -3´ 24 
PGK1-R 5´- GCCATCAGGTCCTTGACAAT-3´ 20 
 
PGK1= Phosphoglycerate kinase 1, F= forward, R= reverse 
 
Table 30: Composition of the PCR-reaction 
Reagent  Amount  µl Concentration 
Sterile H2O 13.7 µl  
Buffer containing MgCl2 (complete buffer) 2.5 µl 10X concentrated 
PGK1-R    1 µl 10µM 
PGK1-F 1 µl 10µM 
dNTP 0.5 µl 10µM 
BioThermTM DNA-polymease 0.3 µl 5U/µl 
cDNA of infected BC cells                  1 µl  
Total volume per reaction         20 µl  
 
F= forward, R= reverse, µl= microliter, µM= micromolar, cDNA= complementary DNA 
Table 31: Conditions of the PCR-reaction 
 
Reaction  Time  Temperature in °C Cycles  
Initial denaturation 120 seconds 94 °C  
Denaturation  15 seconds 94 °C  
   35 cycles Annealing  30 seconds 55 °C 
Extension 45 seconds 72 °C 
Final extension 10 minutes 72 °C 
Cooling  ∞ 4°C  
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3.27. Stimulation of BC cells with PHA-M mitogen 
BC cells were stimulated by phytohemagglutinin (PHA-M) (Sigma Aldrich, Germany) in vitro. 
PHA-M is a lectin extract from the red kidney bean (phaseolus vulgaris) contain potent, cell 
agglutinating and mitogenic activities. The main steps for stimulation of BC cells in vitro were 
accomplished as follows: 
 
3.27.1 Preparation of PHA-M mitogen 
PHA-M mitogen (5mg) was reconstituted with 5ml sterile 1xPBS and divided into 5 aliquots 
(1ml each) as stocks and then stored frozen in -20 °C until use. The reconstituted product was 
further diluted 1:100 in RPMI-1640 culture medium and then stored frozen in -20 °C until use. 
A 100µl of diluted PHA-M mitogen was added to each 1ml RPMI-1640 culture medium 
containing BC cells in each well of the Nunclon brandTMSurface 6 well plate (Sigma Aldrich, 
Germany), gently shaked and then buffy coat cells were incubated for 5 days at 37°C. 
 
3.27.2 Stimulation of cockatiels BC cells in vitro 
We applied a final concentration 10µg/ml of PHA-M in RPMI-1640 culture medium. BC cells 
were stimulated at the same day of isolation. Stimulated BC cells were observed under IX70 
S8F inverted microscope (Olympus, USA) for 5 days successively after stimulation with PHA-
M. In parallel, we prepared none stimulated BC cells similarly in order to count total number 
of cells by trypan blue assay for comparison with total count number of stimulating BC cells.  
 
3.28. Assessment of proliferating 
We applied two methods to investigate the stimulation of BC cells in vitro. Firstly, the total 
count number of stimulated BC cells by trypan blue assay was compared to the cells count of 
unstimulated BC cells. The second method was investigation of the bromodeoxyuridine (BrdU) 
incorporation in the proliferative BC cells by IIF. In the cells smear, we counted 400 stimulated 
BC cells and 400 unstimulated BC cells daily up to 5 days post stimulation. We investigated 
BrdU incorporation in the stimulated BC cells from 2 hours up to 12 days post stimulation by 
IIF. Results of both methods were compared.   
 
3.28.1. Trypan blue assay 
We investigated the total count number of BC cells by counting the stimulated BC cells under 
light microscope (Nikon, Germany). Shortly, we counted the total number of stimulated BC 
cells (400 cells per field) and compare it with total number of none stimulated BC cells (400 
cells per field) daily for 5 days respectively. 
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3.28.2. Detection of the Bromodeoxyuridine (BrdU) incorporation by IIF 
3.28.2.1. Preparation of BrdU 
BrdU (Sigma Aldrich, Germany) was used. BrdU was dissolved in sterile water at a 
concentration of 10 mg/ml as stocks. Each stock contained of BrdU 10µg/µl and was kept in 
the dark in -80°C until use. To reach a 10µM of Bromodeoxyuridine as a final treatment 
concentration, 6µl BrdU stock was added to 20ml RPMI-1640 medium containing stimulated 
BC cells in the well plate. BC cells were incubated for 6 hours in the dark at 37°C. 
 
3.28.2.2. Preparation of BC cells 
A 100µl stimulated BC cells was smeared onto poly-lysine coated slide (R.Langenbrinck, 
Germany), air dried for 20 minutes at room temperature followed by marking a circle around 
the dried smear by pap pen (Dako,Germany).  
 
 
3.28.2.3. Blocking 
5%goat serum (PAA, Germany) diluted in 1xPBS was used and 50μl was applied on the smear. 
Cells smear was incubated with the blocking solution for one hour at 37°C. 
 
3.28.2.4. Primary antibody 
Mouse anti-BrdU antibody (Santa Cruz Biotechnology, Germany) was used. The primary 
antibody was diluted 1:50 in 1xPBS/BSA and incubated overnight at 4°C and 50μl of the 
diluted primary antibody was added to each well of the plate. 
3.28.2.5. Secondary antibody 
Cy3 conjugated goat anti-mouse (Dianova, USA) was diluted 1:50 in 1xPBS/BSA and applied 
on the smear and incubated in a humidified chamber at 37°C in the incubator for one hour in 
the dark. A 50μl of the diluted secondary antibody was added to each well of the plate. 
 
3.28.2.6. DAPI staining  
BC ells were stained with DAPI. Concentration of DAPI was 1µg/ml. DAPI was diluted 
1:1000 in 1xPBS and 150μl diluted DAPI was added to the smear. BC cells were incubated 
with DAPI for 10 minutes at room temperature in the dark. 
 
 
3.28.2.7. Control 
The primary antibody was not added to the stimulated or the non stimulated BC cells as 
negative control.  
3.28.2.8. Assessment the positive signals 
Nuclear staining of stimulated BC cells with anti-BrdU antibody indicated to the positive 
results of this assay. 
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3.28.2.9. Indirect immunofluorescence for detection of BrdU 
1. A 6μl BrdU (10mg/ml) stock solution was added to 20ml RPMI-1640 medium and 
incubated with 10,000 stimulating BC cells at 37°C in the incubator for 6 hours in the dark. 
2. RPMI-1640 medium was pipetted out and cells were washed with sterile 1xPBS three times.  
3. BC cells were fixed with 70% ethanol for 30 minutes at room temperature. 
4. BC cells were washed with sterile 1xPBS three times. 
5. BC cells were permeabilized with 50 μl 0.3% triton X-100 (Serva GmbH, Germany) for 15 
minutes at room temperature. Triton X-100 was diluted in 1xPBS. 
6. For denaturation, 100µl 2M HCl was added to the cells smear followed by incubation of the 
slides for one hour at 37°C in the incubator. 
7. For neutralization of the acid, BC cells were neutralized with 100µl 0.1M sodium borate 
(Na2B4O7, pH 8.5) to the smear for 5 minutes at room temperature. 
8. BC cells were washed with sterile 1xPBS followed by washing with PBS Tween 20® (Sigma 
Aldrich, Germany)/1xPBS for 5 minutes three times at room temperature. 
9. BC cells were blocked with 5% goat serum/PBS at 37°C in the incubator for one hour. 
10. BC cells were incubated with the primary antibody at 4°C overnight. 
11. BC cells were washed with sterile 1xPBS for 5 minutes at room temperature.  
12. BC cells were incubated with secondary antibody at 37°C in the incubator for one hour. 
13. BC cells were washed in sterile 1xPBS three times, 5 minutes each. Then DAPI was added 
to the cells in the final wash to stain the DNA. 
14. BC cells were mounted with Fluroshield mounting medium (Serva, USA) and then sealed 
with coverslip (Roth, Germany). 
15. Slides were stored at 4°C in the dark and examined under Nikon fluorescence microscope 
(Nikon, Germany). 
 
3.29. Experimental infection of stimulated BC cells at the same day of isolation 
BC cells were stimulated with PHA-M and then infected with ABV-4 at the same day of 
isolation (Fig. 6). In parallel, we prepared non stimulated BC cells and infected them with 
ABV-4 as a control.  
 
3.29.1. Demonstration of BrdU in stimulated BC cells  
By IIF, we investigated the stimulation through detecting BrdU in proliferating BC cells for up 
to 5 days post stimulation and post infection respectively as shown in Fig. 6.  
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3.29.2. Demonstration of ABV antigen in stimulated BC cells  
Presence of ABV-4 antigen in stimulated BC cells was investigated from day 0 until 5 dpi by 
IIF shown in Fig. 6. Polyclonal serum from rats experimentally infected with BoDV was used.  
 
3.29.3. Demonstration of ABV-4 RNA in stimulated BC cells  
By RT-PCR, total RNA extracted from stimulated BC cells was detected from day 0 until day 
5 dpi respectively (see Fig. 6). At day 0, we investigated the stimulation and the ABV-4 RNA 
in the stimulated BC cells 10 hours post stimulation and post infection. For comparison, we 
also investigated the stimulation and presence of ABV-4 RNA in the non stimulated BC cells.  
 
3.30. Experimental infection of stimulated BC cells at day 3 post stimulation 
BC cells were isolated and stimulated with PHA-M at day 1, then, infected with ABV-4 at day 
3 post isolation and stimulation as shown in Fig. 7. BrdU incorporation and presence of ABV-4 
RNA were analyzed in the stimulated BC cells at day 4, 6, 8, 10, 12, and 14 post stimulation 
respectively. For comparison, we also investigated the presence of ABV-4 RNA in the negative 
control (non stimulated BC cells) at days 4, 6, 8, 10, 12 and 14 post stimulation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter three - Materials and Methods 
 
 70
 
Fig. 6: Schematic diagram for the experimental infection of stimulated BC cells at day 1 post 
stimulation.  
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Fig. 7: Schematic diagram for the experimental infection of stimulated BC cells at day 3 post 
stimulation. 
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3.31. Description of the statistical analysis of the data 
The statistical analysis was carried out by Dr. Failling, Institute of Biomathematics, Faculty of 
Veterinary Medicine, Justus-Liebig-University-Giessen. Mostly, the computations were made 
by means of the statistical software package BMDP/Dynamic, Release 8.1, (DIXON 1993). 
Furthermore the program package StatXact, Cytel Studio Vers. 9.0.0 (2010) was used for exact 
statistical calculation methods. For the description of quantitative, approximately normal 
distributed data, the arithmetic mean ( x ), standard deviation (s), minimum (xmin), maximum 
(xmax) and sample size (n) were calculated. To test the differences between the infection with 
ABV-2 and ABV-4 genotypes, the infection routes within the organ systems regarding the day 
post infection as a covariate, a two-way analysis of covariance (ANCOVA) was calculated 
using the program BMDP2V. For the investigation of the relationship between the severity of 
inflammation and the distribution of viral antigen a correlation analysis was done by the use of 
the program BMDP6D, also this program was used for the estimation of the regression line for 
each group between the score values of the organ systems and time post infection. For the 
correlation analysis of graded variables the Spearman's correlation test with the program 
“StatXact” (Cytel software corporation, USA) was calculated. At all analyses a statistical 
significance level of α = 0.05 was used and results with p-values  0.05 were regarded to 
indicate statistical significance.  
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4. Results 
4.1. Clinical signs 
All data of clinical signs were obtained and recorded by Anne Piepenbring, Clinic for Birds, 
Reptiles, Amphibians and Fishes, Justus Liebig University Giessen as a part of her doctoral 
thesis dealing with the clinical signs and diagnostics of ABV infections (Piepenbring et al., in 
revision). If a bird displayed clinical signs typical for PDD (emaciation, undigested seed in 
the faeces, neurologic signs) and if its general condition was reduced, it was euthanized. 
4.1.1. Clinical signs after ABV-2 infection 
First symptoms occurred on day 22 after ABV-2 infection (Piepenbring et al., in revision). In 
total, 12/18 inoculated birds exhibited clinical signs (10 birds exhibited gastrointestinal, 2 
birds exhibited gastrointestinal and neurological clinical signs) as shown in table 32. 
Gastrointestinal clinical signs consisted of reduced general condition, diarrhea, emaciation, 
and undigested seed in the faeces while neurological clinical sign were mainly ataxia. 
Moreover, 4/18 inoculated birds remained clinically healthy until end of the experiment at 
231 dpi. Also, 2/18 inoculated birds died suddenly without exhibiting clinical signs. 
Table 32: List of cockatiels which showed clinical signs after ABV-2 infection 
 
 
 
Bird 
ID 
 
 
Gender 
 
 
Route of  
infection 
 
Birds with clinical signs 
 
gastrointestinal 
signs 
neurological 
signs 
Death Euthanasia 
days p.i days p.i dpi dpi 
N39 female ic 22  32  
N 32 female iv 45  46  
N 25 female iv 46  50  
N 24 female ic 40 32  68 
N 34 female iv 57   76 
N 47 male ic 83  84  
N 27 female ic 71 85 86  
N 45 male iv 78   88 
N 19 male iv 104   120 
N 48 female iv 121  137  
N 30 female ic 139   172 
N 46 female ic 86   231 
 
 
(iv) intravenous, (ic) intracereberal, (dpi) days post infection. ABV-2 infection, early time 
points (32-86) dpi, mid time points (87-172) dpi, and late time points (173-231) dpi. 
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4.1.2. Clinical signs after ABV-4 infection 
First symptoms occurred on day 33 after ABV-4 infection (Piepenbring et al., 2012). In total, 
5/18 inoculated birds displayed clinical signs (2 birds exhibited neurological, 2 birds exhibited 
gastrointestinal signs, and one bird displayed neurological and gastrointestinal clinical signs) 
as shown in table 33. Moreover, 11/18 inoculated birds remained healthy during the whole 
investigation period until the end of the experiment at 230 dpi. Also, 2/18 inoculated birds 
died suddenly without exhibiting clinical signs. 
Table 33: List of cockatiels which showed clinical signs after ABV-4 infection 
 
 
 
Bird 
ID 
 
 
Gender  
 
 
Route of  
infection 
 
     Birds with clinical signs 
 
gastrointestinal  
signs 
neurological  
signs 
Death Euthanasia 
days p.i days p.i dpi dpi 
N15 female ic 37 41  60 
N 13 male iv 116   116 
N 11 female ic  199  206 
N 10 female iv 126   229 
N 22 female iv  159  229 
 
(iv) intravenous, (ic) intracereberal, (dpi) days post infection. ABV-4 infection, early time 
points (37-66) dpi, mid time points (67-126) dpi, and late time points (127-230) dpi. 
 
4.1.3. Comparison of the clinical observation 
Five birds of the ABV-4 infected groups exhibited symptoms consistent with PDD, of which 
the five birds showed neurological signs. In contrast after ABV-2 infection, 12 birds displayed 
clinical signs typical for PDD. Within the ABV-2 infected groups, clinical signs consisted of 
mostly gastrointestinal clinical signs. 
 
4.2. Gross lesions  
4.2.1. Gross lesions after ABV-2 infection  
Necropsy revealed a dilatation of proventriculus in 10/18 birds with severe dilatation in five 
birds, moderate dilatation in four birds and mild dilatation in one bird after ABV-2 infection 
(Fig. 8). 
 
4.2.2. Gross lesions after ABV-4 infection  
Proventriculi were dilated in 7/18 birds, with severe dilatation in one bird, moderate dilatation 
in four birds and mild dilatation in two birds after ABV-4 infection (Piepenbring et al., 2012). 
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4.2.3. Comparison of gross lesions 
Proventriculi were enlarged in 10/18 birds after ABV-2 infection and in 7/18 birds after ABV-
4 infection. In the ABV-2 group, 5 birds had a severely dilated proventriculus in contrast to 
one bird in the ABV-4 group (Fig. 8). After ABV-2 or ABV-4 infection, the correlation 
between clinical signs and gross lesions could be divided as follows:  
1) The ABV-2 or ABV-4 infected birds that exhibited gastrointestinal and/or neurological 
clinical signs, also displayed moderate to severe dilatation of proventriculus.  
2) The ABV-2 or ABV-4 infected birds that did not exhibit clinical signs, also did not display 
dilatation of proventriculus.  
However, one ABV-2 infected bird exhibited gastrointestinal and neurological clinical signs 
but dilatation of proventriculus was not found. Moreover, one ABV-2 infected bird did not 
exhibit clinical signs but it displayed a mild dilatation of proventriculus. One ABV-4 infected 
bird exhibited neurological clinical signs but dilatation of proventriculus was not found. Two 
ABV-4 infected birds did not exhibit clinical signs but it displayed a mild dilatation of 
proventriculus. Severity of gross lesions associated with clinical signs but in mild cases it 
could vary. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8: Typical gross lesions with dilatation of proventriculus in cockatiels after ABV-2 and 
ABV-4 infection. (A) Proventriculus, severe dilatation of proventriculus (arrow), after ABV-2 
infection, 68 dpi. (B) Proventriculus, severe dilatation of proventriculus (arrow), after ABV-4 
infection, 60 dpi. 
 
     
A B  
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4.3. Histological findings 
4.3.1. Histological lesions after ABV-2 infection 
In the CNS, gliosis was detected in the brain in 13/18 experimentally ABV-2 infected birds. 
Gliosis was not found in the brain in 5/18 birds but mild gliosis was detected in it in 11/18 
birds, and moderate gliosis in 2/18 experimentally ABV-2 infected birds. No obvious 
inflammatory infiltrates were found in the brain in 18/18 experimental ABV-2 infected 
animals (Fig. 9). No inflammatory lesions were found in the spinal cord in 7/18 birds but mild 
inflammatory lesions were detected in it in 5/18 experimentally ABV-2 infected birds. Spinal 
cord was not present in 6/18 experimentally ABV-2 infected birds (table 34). Inflammatory 
lesions were detected in the eye in 3/18 experimentally ABV-2 infected birds. Inflammatory 
lesion were not detected in the eye in 14/18 birds but mild inflammatory lesions were detected 
in it in 2/18 birds, and moderate lesions in 1/18 experimentally ABV-2 infected birds (table 
34). The eye was autolytic in 1/18 birds. Inflammatory lesions were detected at the first time 
point investigated in the CNS at 46 dpi until the end of the investigation period. 
The kinetic of gliosis generally revealed that gliosis was mild or moderate at early time points 
(32-84 dpi), then decreased to only mild from mid time points (86-172 dpi) until late time 
points 231 dpi in the 13/18 experimentally ABV-2 infected birds. Nevertheless, there was 
variability in the kinetic of gliosis. At early time points (32-84 dpi), one bird had no gliosis 
(bird ID: 47) and one additional bird had no inflammatory lesion in the spinal cord (bird ID: 
25) at early time points. At mid time points (86-172 dpi), two birds had no gliosis (bird ID: 27 
and 30) and two additional birds had no inflammatory lesion in the spinal cord (bird ID: 45 
and 30) at mid time points. At late time points 231 dpi, two birds had no gliosis (bird ID: 49 
and 29) and no inflammatory lesions in the spinal cord at late time points. 
In the GIT, inflammatory lesions were detected in all comparable GIT organs but mainly in 
the intestine and proventriculus. Inflammatory lesions in the GIT consisted of mononuclear 
cells infiltrates in the intestinal mucosa and /or submucosa, lamina muscularis as well as 
around nerves and ganglia or in the ganglia and nerve fibers of gizzard, proventriculus, 
intestine and crop (Fig. 10).  
Inflammatory lesions were not detected in the crop in 3/18 birds but mild inflammatory 
lesions were detected in it in 14/18 birds (table 34). The crop was autolytic in 1/18 birds. 
Inflammatory lesions were not detected in the gizzard in 2/18 birds but mild inflammatory 
lesions were detected in it in 11/18 birds, moderate lesions in 4/18 experimentally ABV-2 
infected birds. The gizzard was autolytic in 1/18 birds. Inflammatory lesions were not 
detected in the proventriculus in 4/18 birds but mild inflammatory lesions were detected in it 
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in 7/18 birds, moderate in 4/18 birds, and severe in 2/18 birds (table 34). The proventriculus 
was autolytic in 1/18 birds. Inflammatory lesions were not detected in the intestine in 2/18 
birds but mild inflammatory lesions were found in it in 11/18 birds, moderate in 2/18 birds, 
and severe in 1/18 birds (table 34). The intestine was autolytic in 2/18 birds. 
The kinetic of inflammatory lesions in the GIT was variable. In the crop, inflammatory 
lesions were mild from early time points at 32-86 dpi until late time points at 231 dpi in the 
14/18 experimentally ABV-2 infected birds (table 34). In the gizzard, inflammatory lesions 
were mild or moderate from early time points at 32-86 dpi until late time points at 231 dpi in 
the 15/18 experimentally ABV-2 infected birds (table 34). In the proventriculus, inflammatory 
lesions were mild and moderate at early time points at 32-86 dpi. However, inflammatory 
lesions were severe in the proventriculus in only 1/18 birds at early time points.  At mid time 
points 88-172 dpi, inflammatory lesions decreased in the proventriculus to mild only. At late 
time points, inflammatory lesions were mild, moderate and severe at 231 dpi. In the intestine, 
inflammatory lesions were variable in severity during the whole investigation period. 
In the peripheral organs, inflammatory lesions were mainly found in the kidney, liver, 
spleen and skin. Inflammatory lesions in the peripheral organs were found as infiltration of 
mononuclear cells, sometimes with follicular shape-like appearance. Periganglionitis and/or 
perineuritis were also detected in the peripheral organs. Infiltration of mononuclear cells in 
the heart was always detected in the adjacent ganglia but not in the heart itself. Infiltrations of 
mononuclear cells in the liver were found as follicular shape-like aggregations around the 
central veins or bile ducts. Infiltrations of mononuclear cells in the kidney were detected 
around ganglia, or as follicular shape-like aggregations around blood vessels. Infiltrations of 
mononuclear cells in the pancreas were found as follicular shape-like aggregations around 
blood vessels, interlobular ducts, acini and islets. Infiltrations of mononuclear cells in the skin 
were detected around feather follicles (Fig. 11).  
Inflammatory lesions were not detected in the heart in 4/18 birds but mild inflammatory 
lesions were detected in it in 11/18 birds, and moderate in 2/18 birds. The heart was autolytic 
in 1/18 birds. Inflammatory lesions were not detected in the liver in 4/18 birds but mild 
inflammatory lesions were detected in it in 9/18 birds, and moderate in 4/18 birds (table 34). 
The liver was autolytic in 1/18 birds. Inflammatory lesions were not detected in the kidney in 
1/18 birds but mild inflammatory lesions were detected in it in 7/18 birds, moderate in 5/18 
birds, and severe in 4/18 birds. The kidney was autolytic in 1/18 birds. Inflammatory lesions 
were not detected in the spleen in 1/18 birds but mild inflammatory lesions were detected in it 
in 4/18 birds, moderate in 7/18 birds, and severe in 1/18 birds. The spleen was not present in 
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5/18 birds. Inflammatory lesions were not detected in the pancreas in 10/18 birds but mild 
inflammatory lesions were detected in it in 6/18 birds. The pancreas was not found in 2/18 
birds. Inflammatory lesions were not detected in the adrenal gland in 1/18 birds but mild 
inflammatory lesions were detected in it in 2/18 birds, moderate in 1/18 birds, and severe in 
2/18 birds. The adrenal gland was not found in 12/18 birds. Inflammatory lesions were not 
detected in the skin in 6/18 birds but mild inflammatory lesions were detected in it in 5/18 
birds, and moderate in 4/18 birds (table 34). The skin was not found in 3/18 birds. 
Inflammatory lesions were not detected in the muscles in 18/18 experimentally ABV-2 
infected birds. 
The kinetic of inflammatory lesion in the peripheral organs revealed that inflammatory lesions 
neither decreased nor increased in all the peripheral organs from early time points until late 
time points at 231 dpi and could be of variable in severity. 
In the sentinel group, mild gliosis was detected in the brain. Moreover, follicular shape-like 
infiltrates were detected in the GIT and in some of the peripheral organs in the sentinel bird. 
Inflammatory lesions in the sentinel group were not found in or around the nerves or in the 
ganglia of the GIT and peripheral organs. 
In the mock group, no gliosis was found in the brain. Moreover, mild follicular shape-like 
aggregations were detected in the GIT but not in the nerves or ganglia in only 1/4 birds. Mild 
follicular shape-like aggregations were also detected in some of the peripheral organs of the 
mock group but not in the nerves or ganglia. 
Interestingly, the follicular shape-like infiltrates in the GIT and in some of the peripheral 
organs in the sentinel bird and mock group were smaller in size than in the infected birds. 
 
4.3.2. Histological lesions after ABV-4 infection 
In the CNS, inflammatory lesions in the CNS consisted of perivascular infiltration of 
mononuclear cells as well as gliosis in 17/17 experimentally ABV-4 infected birds (Fig. 9). 
Inflammatory lesions were detected in the brain in 17/17 birds. The brain was not available in 
1/18 birds. Inflammatory lesions were detected in the spinal cord in 11/18 experimentally 
ABV-4 infected birds. Inflammatory lesions were found in the eye in 9/18 experimentally 
ABV-4 infected birds. Inflammatory lesions were detected in the CNS at the first time point 
investigated at 60 dpi until the end of the investigation period.  
Mild inflammatory lesions were detected in the brain in 9/18 birds, moderate in 7/18, and 
severe in 1/18 bird. Mild inflammatory lesions were detected in the spinal cord in 9/18 birds, 
and moderate in 2/18 birds. Spinal cord was not available in 6/18 experimentally ABV-4 
infected birds (table 35). Inflammatory lesions were not detected in the eye in 7/18 birds but 
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mild inflammatory lesions were detected in it in 4/18 birds, and moderate in 5/18 birds (table 
35).  
The kinetic of inflammatory lesions in the CNS was variable in severity. In the brain, 
inflammatory lesions were mild and moderate from early time points until 230 dpi. In the 
spinal cord, inflammatory lesions were mild at early time points and mid time points in most 
majority of birds but then increased to moderate at late time points in only 2 birds. In the eye, 
inflammatory lesions were mild and moderate at early and mid time points in most majority of 
birds but inflammatory lesions were not detected at late time points also in most majority of 
birds. However, two birds had mild inflammatory lesions in the eye at 229 dpi. 
In the GIT, inflammatory lesions were detected in all comparable GIT organs but mainly in 
the proventriculus. Inflammatory lesions in the GIT consisted of mononuclear cells infiltrates 
in the intestinal mucosa and /or submucosa, lamina muscularis as well as around nerves and 
ganglia or in the ganglia and nerve fibers of gizzard, proventriculus, intestine and crop (Fig. 
10). 
Inflammatory lesions were not detected in the crop in 5/18 birds but mild inflammatory 
lesions were detected in it in 7/18 birds, and moderate in 3/18 birds (table 35). The crop was 
not available in 3/18 birds. Inflammatory lesions were not detected in the gizzard in 10/18 
birds but mild inflammatory lesions were detected in it in 2/18 birds, and moderate in 1/18 
experimentally ABV-4 infected bird (table 35). The gizzard was not available in 3/18 birds. 
The gizzard was autolytic in 2/18 birds. Inflammatory lesions were not detected in the 
proventriculus in 4/18 birds but mild inflammatory lesions were detected in it in 6/18 birds, 
moderate in 2/18 birds, and severe in 2/18 birds (table 35). The proventriculus was not 
available in 2/18 birds. Inflammatory lesions were not detected in the intestine in 5/18 birds 
but mild inflammatory lesions were detected in it in 4/18 birds, moderate in 3/18 birds, and 
severe in 4/18 birds (table 35). The intestine was not available in 1/18 birds. The intestine was 
autotyic in 1/18 birds.  
The kinetic of inflammatory lesions in the GIT revealed that inflammatory lesions decreased 
in all GIT organs at 230 dpi in most majority of experimentally ABV-4 infected birds. 
In the peripheral organs, inflammatory lesions were mainly found in the liver, kidney, heart, 
pancreas, and skin. Inflammatory lesions in the peripheral organs were found as infiltration of 
mononuclear cells, sometimes with follicular shape-like aggregations. Periganglionitis and/or 
perineuritis were also detected in the peripheral organs (Fig. 11).  Infiltration of mononuclear 
cells in the heart was detected in the myocardium and in the pericardial ganglia. Infiltrations 
of mononuclear cells were also detected as follicular shape-like aggregations in the liver, 
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kidney, and pancreas. Infiltrations of mononuclear cells were detected around feather follicles 
in the skin.  
Inflammatory lesions were not detected in the heart in 7/18 birds but mild inflammatory 
lesions were detected in it in 8/18 birds, moderate in 1/18, and severe in 1/18 experimentally 
ABV-4 infected birds (table 35). The heart was not available in 1/18 birds. Inflammatory 
lesions were not detected in the liver in 5/18 birds but mild inflammatory lesions were 
detected in it in 8/18 birds, moderate in 2/18 birds, and severe in 3/18 birds (table 35). 
Inflammatory lesions were not detected in the kidney in 2/18 birds but mild inflammatory 
lesions were detected in it in 5/18 birds, moderate in 5/18 birds, and severe in 5/18 birds. The 
kidney was not available in 1/18 bird (table 35). Mild inflammatory lesions were detected in 
the spleen in 2/18 birds, moderate in 7/18 birds, and severe in 4/18 birds. The spleen was not 
available in 5/18 birds. Inflammatory lesions were not detected in the pancreas in 5/18 birds 
but mild inflammatory lesions were detected in 7/18 birds, moderate in 2/18 birds, and severe 
in 1/18 birds. The pancreas was not available in 3/18 birds. Mild inflammatory lesions were 
detected in the adrenal gland in 2/18 birds. The adrenal gland was not available in 16/18 birds. 
Inflammatory lesions were not detected in the skin in 6/18 birds but mild inflammatory 
lesions were detected in 6/18 birds, moderate in 4/18 birds, and severe in 2/18 birds (table 35). 
Inflammatory lesions were not detected in the muscles in 16/18 birds but mild inflammatory 
lesions were detected only in 1/18 birds. The muscles were not available in 1/18 bird. 
The kinetic of inflammatory lesion in the peripheral organs was variable in severity among 
the peripheral organs in most majority of birds. Inflammatory lesions could be mild in the 
heart, moderate in the pancreas, and severe in the kidney at early time points (60 and 66 dpi). 
At mid time points, inflammatory lesions were mild and severe in the heart, moderate and 
severe in the liver, mild, moderate, and severe in the kidney and spleen. At late time points 
230 dpi, mild, moderate, and severe inflammatory lesions were detected in the kidney, spleen, 
liver and skin. Inflammatory lesions were not detected in the skin at early time points (60 and 
66 dpi) but inflammatory lesions increased as mild and moderate at mid time points at 88-137 
dpi and then as mild, moderate and severe at late time points at 230 dpi in the 18/18 
experimentally ABV-4 infected birds (table 35). 
In the sentinel group, mild gliosis was detected in the brain. Mild follicular shape-like 
aggregations were also detected in some of the GIT organs but not in the nerves or around 
ganglia. Moreover, moderate and severe follicular shape-like aggregations were found in the 
peripheral organs of the sentinel group but not in the nerves or around ganglia. 
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4.3.3. Comparison of histological lesions after ABV-2 and ABV-4 infection 
In the CNS, gliosis was detected but no obvious perivascular cuffing in the brain at the first 
time point investigated at 46 dpi in 13/18 experimentally ABV-2 infected birds. Gliosis was 
detected as mild and moderate in 13/18 experimentally ABV-2 infected birds. Mild 
inflammatory lesions were detected in the spinal cord in 5/18 experimentally ABV-2 infected 
birds. Mild inflammatory lesions were detected in the eye in 2/18 birds, and moderate in 1/18 
experimentally ABV-2 infected birds (table 34). There was a correlation between clinical 
signs, gross lesions, and gliosis at early time points (32-84 dpi) and mid time points (86-172 
dpi) but not at late time points at 231 dpi after ABV-2 infection. If birds exhibited 
gastrointestinal and/or neurological signs, and had moderate to severe dilatation of 
proventriculus, they also had mild to moderate gliosis after ABV-2 infection and that 
occurred at early time points (32-84 dpi) and mid time points (86-172 dpi). However, one bird 
displayed gastrointestinal and neurological signs but it had no dilatation of proventriculus and 
had no gliosis at early time points (32-84 dpi). If birds did not exhibit clinical signs, and had 
no dilatation of proventriculus, they also had only mild gliosis after ABV-2 infection and that 
occurred at late time points at 231 dpi after ABV-2 infection. 
After ABV-4 infection, perivascular cuffings of mononuclear cells were detected in the brain 
at the first time points investigated at 60 dpi in 2/18 experimentally ABV-4 infected birds. 
Inflammatory lesions and gliosis were detected in the brain as mild, moderate, and severe in 
the 17/18 experimentally ABV-4 infected birds. Mild inflammatory lesions were detected in 
the spinal cord in 9/18 birds, and moderate in 2/18 experimentally ABV-4 infected birds. Mild 
inflammatory lesions were detected in the eye in 4/18 birds, and moderate in 5/18 
experimentally ABV-4 infected birds (table 35). The correlation between clinical signs, gross 
lesions, and inflammatory lesions in the brain after ABV-4 infection was somehow variable. 
If birds exhibited gastrointestinal and/or neurological signs, and had moderate to severe 
dilatation of proventriculus, they also had mild to moderate inflammatory lesions in the brain 
after ABV-4 infection and that occurred at early time points 60 and 66 dpi and mid time 
points 115, 116, and 120 dpi. However, one bird exhibited gastrointestinal and neurological 
signs, and had severe dilatation of proventriculus but it had only mild inflammatory lesions in 
the brain at early time points (60 and 66 dpi). Another bird at the same time points did not 
exhibit clinical signs, and had no dilatation of proventriculus but it had moderate 
inflammatory lesions in the brain. If birds did not exhibit clinical signs, and had no dilatation 
of proventriculus, they also had mild inflammatory lesions in it after ABV-4 infection and that 
occurred at late time points at 230 dpi after ABV-4 infection. However, two birds did not 
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exhibit clinical signs, and had mild dilatation of proventriculus but they had moderate or 
severe inflammatory lesions in the brain respectively. 
By comparison between kinetic of inflammatory lesions in the CNS, we found that there was 
variability in the kinetic of gliosis from early time points (32-84 dpi) until late time points 231 
dpi in the 13/18 experimentally ABV-2 infected birds. Mild and moderate gliosis was 
detected at early time points (32-84 dpi). However, one bird had no gliosis at early time points 
(32-84 dpi). At mid time points (86-172 dpi), only mild gliosis was detected. However, two 
birds had no gliosis at mid time points (86-172 dpi). At late time points at 230 dpi, only mild 
gliosis was also detected. However, two birds had no gliosis at 230 dpi. After ABV-4 
infection, the kinetic of inflammatory lesions in the brain was mild and moderate in the 17/18 
birds during the whole investigation period. However, one bird had severe inflammatory 
lesions in the brain at 116 dpi. 
In the GIT, inflammatory lesions were detected in the crop as mild in 14/18 experimentally 
ABV-2 infected birds. After ABV-4 infection, inflammatory lesions were detected in the 
crop as mild and moderate in 9/18 experimentally ABV-4 infected birds. Inflammatory 
lesions were detected in the gizzard as mild and moderate in 15/18 experimentally ABV-2 
infected birds. Inflammatory lesions were detected in the gizzard as mild in 2/18, and 
moderate in 1/18 experimentally ABV-4 infected birds. Inflammatory lesions were detected in 
the proventriculus in 13/18 experimentally ABV-2 infected birds. Inflammatory lesions were 
detected in the proventriculus in 10/18 experimentally ABV-4 infected birds. Inflammatory 
lesions were detected in the intestine in 14/18 experimentally ABV-2 infected birds. 
Inflammatory lesions were detected in the intestine in 11/18 experimentally ABV-4 infected 
birds.  
After ABV-2 infection, there was variable correlation in severity between clinical signs and 
gross lesions with inflammatory lesions in the GIT. If birds exhibited clinical signs, and had 
dilatation of proventriculus, they also had inflammatory lesions in all GIT organs after ABV-
2 infection. Moreover, if birds did not exhibit clinical signs, and did not display dilatation of 
proventriculus, they could also have inflammatory lesions in all GIT organs after ABV-2 
infection.  
After ABV-4 infection, the correlation between clinical signs and gross lesions with 
inflammatory lesions in the GIT was variable. If birds exhibited clinical signs, and had 
dilatation of proventriculus, they could also have inflammatory lesions in all GIT organs after 
ABV-4 infection. However, one bird had inflammatory lesions in some but not all GIT 
organs. Moreover, if birds did not exhibit clinical signs, and did not display dilatation of 
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proventriculus, they could also have inflammatory lesions in some of the GIT organs but not 
all after ABV-4 infection. However, one bird had no clinical signs, and exhibited dilatation 
of proventriculus and inflammatory lesions were detected only in the crop and proventriculus 
in this bird. 
By comparison between kinetic of inflammatory lesions in the GIT, we found that 
inflammatory lesions in the GIT after ABV-2 infection were variable. Mild inflammatory 
lesions were detected in the crop, mild and moderate in the gizzard during the whole 
investigation period. Moreover, mild, moderate, and severe inflammatory lesions were 
detected in the proventriculus during the whole investigation period. Mild, moderate, and 
severe inflammatory lesions were detected in the intestine at early and mid time points 88-137 
dpi but then decreased to mild inflammatory lesions in it at late time points at 231 dpi. After 
ABV-4 infection, we found that inflammatory lesions in the GIT were variable in severity at 
early and mid time points but then decreased at late time points 230 dpi in experimentally 
ABV-4 infected birds (table 35). 
In the peripheral organs, inflammatory lesions were predominantly detected in the liver, 
kidney, spleen and skin after ABV-2 infection (table 34) while inflammatory lesions were 
mainly detected in the, liver, kidney, heart, pancreas, and skin after ABV-4 infection (table 
35). Inflammatory lesions were detected in neurons of the adjacent ganglia of the heart but not 
in the heart itself in 11/18 experimentally ABV-2 infected birds. Inflammatory lesions were 
not only detected in neurons of the pericardial ganglia but also in the myocardium in 10/18 
experimentally ABV-4 infected birds. Inflammatory lesions were detected in the heart as mild 
and moderate in 13/18 experimentally ABV-2 infected birds. Inflammatory lesions were 
detected in the heart as mild, moderate, and severe in 10/18 experimentally ABV-4 infected 
birds. Inflammatory lesions were detected in the liver as mild and moderate in 14/18 
experimentally ABV-2 infected birds. Inflammatory lesions were detected in the liver as mild, 
moderate and severe in 13/18 experimentally ABV-4 infected birds. Inflammatory lesions in 
the kidney and spleen did show the same severity after ABV-2 infection as in the kidney and 
spleen after ABV-4 infection. Inflammatory lesions were detected in the pancreas as mild in 
5/18 experimentally ABV-2 infected birds. Inflammatory lesions were detected in the 
pancreas as mild, moderate and severe in 10/18 experimentally ABV-4 infected birds. 
Inflammatory lesions were detected in the skin as mild and moderate in 9/18 experimentally 
ABV-2 infected birds. Inflammatory lesions were detected in the skin as mild, moderate and 
severe in 12/18 experimentally ABV-4 infected birds. 
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There was variable correlation in severity between clinical signs and gross lesions with 
inflammatory lesions in the peripheral organs after ABV-2 infection and after ABV-4 
infection. If birds exhibited clinical signs, and had dilatation of proventriculus, they could 
also have inflammatory lesions in the peripheral organs after ABV-2 infection and after 
ABV-4 infection. Moreover, if birds did not exhibit clinical signs, and did not display 
dilatation of proventriculus, they could also have inflammatory lesions in peripheral organs 
after ABV-2 infection and after ABV-4 infection. Nevertheless there were some exceptions, 
one bird (bird ID: 16) did not exhibit clinical signs, and displayed mild dilatation of 
proventriculus but inflammatory lesions were not detected in all the peripheral organs except 
in the kidney of this bird after ABV-4 infection. Another interesting finding, one bird (bird 
ID: 30) did not exhibit clinical signs, and did not display dilatation of proventriculus and 
severe inflammatory lesions were detected in the liver, kidney, pancreas, and skin of this bird 
after ABV-4 infection. 
The kinetic of inflammatory lesion in the peripheral organs revealed that inflammatory lesions 
neither decreased nor increased in the heart, liver, spleen from early time points until late time 
points at 231 dpi after ABV-2 infection. Inflammatory lesions increased in the kidney at mid 
time point and at late time point after ABV-2 infection. 
After ABV-4 infection, the kinetic of inflammatory lesion was variable in severity in the 
peripheral organs. For example in the heart, mild inflammatory lesions were detected in the 
heart at early time points after ABV-4 infection. However, inflammatory lesions were not 
found in the heart in one bird at early time points after ABV-4 infection. Mild inflammatory 
lesions were detected in the heart at mid time point after ABV-4 infection. However, 
inflammatory lesion were not found in the heart in two birds at mid time point after ABV-4 
infection. Moreover, severe inflammatory lesion were detected in the heart in one bird at mid 
time point after ABV-4 infection. We also found the same variability in the kinetic of 
inflammatory lesions in the peripheral organs after ABV-4 infection. 
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Table 34: Scores of inflammatory lesions after ABV-2 infection 
 
 
 
 
 
Table 35: Scores of inflammatory lesions after ABV-4 infection 
 
 
CNS= central nervous system, s.cord= spinal cord, N.A= not available, Prov.= proventriculus, 
dpi= days post infection, A= autolytic organ,  
 
 = CNS, 
 
 = GIT, 
 
 = peripheral 
organs 
CNS= central nervous system, s.cord= spinal cord, N.A= not available, Prov.= proventriculus, 
dpi= days post infection,   
 
 = CNS, 
 
 = GIT, 
 
 = peripheral organs 
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Fig. 9: Inflammatory lesions in the brain after experimental infection with ABV-2 and ABV-4 
in cockatiels. (A) Gliosis, after ABV-2 infection (black arrow), 68 dpi. (B) Perivascular 
infiltrates in the brain after ABV-4 infection (blue arrow), 60 dpi.  H & E staining. Scale bar 
100µm. 
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Fig. 10: Inflammatory lesions in the GIT organs after experimental infection with ABV-2 and 
ABV-4 in cockatiels. (A) Periganglionic infiltration of mononuclear cells in the enteric 
ganglia of the crop after ABV-2 infection (arrow), 86 dpi. (B) Perineural infiltration of 
mononuclear cells in the nerve of proventriculus after ABV-2 infection (arrow), 172 dpi. (C) 
Gizzard, infiltration of mononuclear cells in lamina muscularis after ABV-4 infection (arrow), 
116 dpi. (D) Intestine, follicular shape-like aggregation of immune cells in the intestinal 
mucosa after ABV-4 infection (arrow), 115 dpi. H & E staining. Scale bar 100µm.  
 
 
 
 
 
 
 
 
 
 
 
    
 
 
 
    
ABV-2 ABV-2 
ABV-4 ABV-4 
Crop, enteric ganglia Proventriculus, nerve 
Gizzard Intestine  
A B  
C  
D  
Chapter four - Results 
 
 88
 
 
 
 
 
 
 
 
 
 
 
Fig. 11: Inflammatory lesions in the peripheral organs after experimental infection with ABV-
2 and ABV-4 in cockatiels. (A) Skin, infiltration of mononuclear cells around feather follicles 
after ABV-2 infection (arrow), 231 dpi. (B) Heart ganglia, infiltration of mononuclear cells 
around heart ganglia after ABV-4 infection (arrow), 229 dpi. H & E staining. Scale bar 
100µm. 
 
4.4. Characterization of the infiltrating immune cells after ABV infection 
By IHC, we characterized the immune cell infiltration in all organs after ABV-2 and ABV-4 
infection. We detected CD3-positive cells in the GIT and peripheral organs but not in the CNS 
after ABV-2 infection (Fig. 12). Moreover, we detected CD3-positive cells in the CNS, GIT 
and peripheral organs after ABV-4 infection (Fig. 12). We detected infiltrations of CD3-
positive cells in the brain after ABV-4 infection as well as in gizzard, proventriculus and 
intestine after ABV-2 and ABV-4 infection and in kidney, liver and skin after ABV-2 and 
ABV-4 infection (Fig. 12). The identification of cockatiel B cells and macrophage was not 
successful because B cells and macrophage markers did not cross react with cockatiel immune 
cells by immunohistochemistry.  
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Fig. 12: Demonstration of CD3-positive cells in the brain, GIT and peripheral organs of 
experimentally ABV-2 and ABV-4 infected birds by IHC. (A) Brain, CD3-positive cells were 
not found after ABV-2 infection, 137 dpi. (B) Brain, CD3-positive cells found in the 
perivascular cuffing in it, ABV-4 infection, 116 dpi. (C) Crop, CD3-positive cells found 
around ganglia in the lamina muscularis, ABV-2 infection (arrow), 172 dpi. (D) Crop, CD3-
positive cells found in / and around ganglia in the lamina muscularis, ABV-4 infection,  116 
dpi. (E) Kidney, CD3-positive cells found in the follicular shape-like infiltrates, ABV-2 
infection, 86 dpi. (F) Liver, CD3-positive cells found in the follicular shape-like infiltrates, 
ABV-4 infection (arrow), 230 dpi. Polyclonal rabbit anti-human CD3 antibody, DAB 
staining, Papanicolaou counterstaining, Scale bar 100µm. 
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4.5. Demonstration of ABV antigen 
4.5.1. Distribution pattern of ABV antigen after ABV-2 infection 
In the CNS, viral antigen was detected in the brain in 14/18, in the spinal cord in 3/18 birds 
and in the eye in 9/18 experimentally ABV-2 infected birds (table 36). Viral antigen was 
detected in the nucleus and/or cytoplasm of neurons (Fig. 13) as well as in nerve fibers or 
cellular processes of neurons of the cerebrum or cerebellum e.g. Purkinje cells and also glial 
cells (Fig. 13). Viral antigen was also detected in the neurons of retina and in the optic nerve 
in the eye (Fig. 14). ABV antigen was found at the first time points investigated at 46 dpi 
until the end of the investigation period. 
Viral antigen was not detected in the brain in 4/18 birds but was detected as score 1 in 7/18 
birds, score 2 in 6/18 birds and score 3 in 1/18 birds (table 36). Viral antigen was not detected 
in the spinal cord in 1/18 birds but was detected as score 1 in 2/18 birds, and score 3 in 1/18 
birds (table 36). Spinal cord was not available in 14/18 experimentally ABV-2 infected birds 
(table 36). Viral antigen was not detected in the eye in 8/18 birds but was detected as score 1 
in 5/18 birds, score 2 in 1/18 bird and score 3 in 3/18 birds (table 36). The eye was autolytic 
in 1/18 birds. 
The kinetic of viral antigen detection in the CNS revealed variability (table 36). In the brain, 
viral antigen was detected as score 1 and score 2 during the whole investigation period. 
However, some variability in detection of viral antigen in the brain was also found. Viral 
antigen was not detected in the brain in two birds at early time points 46-86 dpi, in one bird at 
mid time points 88-137 dpi, and in one bird at late time points 231 dpi. The kinetic of viral 
antigen detection in the eye was also variable. It was not detected in the eye at early time 
points 46-86 dpi, then it was detected as score 1 up to score 3 at mid time points 88-137 dpi 
and at late time points 231 dpi. However, viral antigen was not detected in the eye in 2 birds 
at mid time points and in one bird at late time points. In the spinal cord, it was not possible to 
investigate the kinetic of viral antigen detection in it due to unavailability of spinal cord in 
14/18 birds (table 36). 
In the GIT, viral antigen was detected in all GIT organs mainly in gizzard and 
proventriculus. Nucleus and cytoplasm of neurons of the enteric ganglia in the lamina 
muscularis of gizzard (Fig. 15) and proventriculus and also nerve fibers mainly harbored viral 
antigen. Nucleus of the epithelium of the crop, the glandular epithelium of gizzard as well as 
of the proventriculus and smooth muscle fibers in the lamina muscularis of all GIT organs 
also showed positive immunostaining. 
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Viral antigen was not detected in the crop in 1/18 birds but was found as score 1 in 10/18 
birds, score 2 in 5/18 birds and score 3 in 1/18 bird (table 36). The crop was autolytic in 1/18 
birds. Viral antigen was detected in the gizzard as score 1 in 8/18 birds, score 2 in 6/18 birds 
and score 3 in 1/18 bird (table 36). The gizzard was autolytic in 1/18 birds. The gizzard was 
not available in 2/18 birds. Viral antigen was detected in the proventriculus as score 1 in 
10/18 birds, score 2 in 5/18 birds and score 3 in 2/18 birds (table 36). The proventriculus was 
autolytic in 1/18 birds. Viral antigen was not detected in the intestine in 7/18 birds but was 
detected as score 1 in 6/18 birds, score 2 in 1/18 bird and score 3 in 2/18 birds (table 36). The 
intestine was autolytic in 2/18 birds. 
The kinetic of viral antigen detection in the GIT revealed that viral antigen detection was 
detected as score 1 and score 2 in all GIT organs during the whole investigation period 231 
dpi. However, some variability was also found in detection of viral antigen in the GIT organs. 
Viral antigen was not found in the crop in 1/18 bird at early time points (46-86 dpi). In 
another bird at late time points 231 dpi, viral antigen was detected in the crop as score 3 in 
1/18 bird. Viral antigen was found in the gizzard as score 3 in 1/18 bird at 231 dpi. Viral 
antigen was found in the proventriculus as score 3 in 1/18 bird at mid time points (88-137 dpi) 
and as score 3 in 1/18 bird at late time points at 231 dpi. 
In the peripheral organs, viral antigen was detected in the heart, liver, kidney, pancreas, and 
skin. Viral antigen detection was detected in liver cells, neurons of adjacent ganglia in the 
heart (Fig. 16) and nerve fibers, epithelium of renal tubules, epithelial cells of the pancreas, 
cells with features of red pulp macrophages in the spleen, epithelial cells around feather follicles 
in the skin, and muscle fibers and nuclei in the heart and muscle fibers in the skeletal muscles. 
Viral antigen was not detected in the heart in 5/18 birds but it was detected as score 1 in 11/18 
birds, and score 2 in 1/18 birds (table 36). The heart was autolytic in 1/18 birds. Viral antigen 
was not detected in the liver in 10/18 birds but was detected as score 1 in 6/18 birds, and score 
2 in 1/18 birds (table 36). The liver was autolytic in 1/18 birds. Viral antigen was not detected 
in the kidney in 5/18 birds but it was detected as score 1 in 1/18 birds, score 2 in 7/18 birds 
and score 3 in 4/18 birds (table 36). The kidney was autolytic in 1/18 birds. Viral antigen was 
detected in the spleen as score 1 in 4/18 birds, and score 2 in 3/18 birds (table 36).  The spleen 
was not available in 11/18 birds. Viral antigen was not detected in the pancreas in 1/18 birds 
but was detected as score 1 in 9/18 birds and score 2 in 6/18 birds (table 36). The pancreas 
was not available in 2/18 birds. Viral antigen was detected in the adrenal gland as score 2 in 
2/18 birds, and score 3 in 1/18 bird. Adrenal gland was not available in 15/18 birds. Viral 
antigen was not detected in the skin in 6/18 birds but was detected as score 1 in 6/18 birds, 
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score 2 in 2/18 birds and score 3 in 1/18 birds (table 36). The skin was not available in 3/18 
birds. Viral antigen was not detected in the skeletal muscles in 16/18 experimentally ABV-2 
infected birds. Viral antigen was found in muscle fibers of the skeletal muscles as score 1 in 
2/18 birds. 
The kinetic of viral antigen detection in the peripheral organs revealed variability. Viral 
antigen increased in the liver and kidney at late time points 231 dpi. Moreover, it increased in 
the skin at only mid time points 88-137 dpi. It was detected in the heart as score 1, and in the 
pancreas as score 1 and score 2 during the whole investigation period. Viral antigen was 
detected in the heart as score 3 in 1/18 bird at late time points. Viral antigen was not detected 
in the liver at early time points 46-86 dpi but was detected as score 1 in only 1/18 bird at early 
time points. 
In the sentinel group, viral antigen was not found in the CNS. Viral antigen was not detected 
in the nerves or enteric ganglia of all GIT organs in the sentinel bird. Viral antigen was not 
detected in the nerves or ganglia of the heart, kidney, skin as well as in the skeletal muscles in 
the sentinel. 
In the mock group, viral antigen was not found in the CNS in all birds of the mock group. 
Viral antigen was not detected in the nerves or enteric ganglia of all GIT organs in the mock 
group. Moreover, viral antigen detection was not found in the nerves or ganglia in all 
peripheral organs in the mock group.  
Unspecific background of the polyclonal anti-p24 antibody was also obtained in the intestinal 
epithelium and smooth muscle fibers only in 2/4 mock birds. 
 
4.5.2. Distribution pattern of ABV antigen after ABV-4 infection 
In the CNS, viral antigen was detected in the brain in 17/18, in the spinal cord in 11/18 and in 
the eye in 9/18 experimentally ABV-4 infected birds (table 37). Viral antigen was detected 
intranuclearly or intracytoplasmically in the neurons (Fig.13). It was also detected in nerve 
fibers and/or cellular processes of neurons of the cerebrum or cerebellum e.g. Purkinje cells, 
and glial cells (Fig. 14), in the neurons of retina and in the optic nerve in the eye (Fig.14). 
ABV antigen was found at the first time points investigated at 60 dpi until the end of the 
investigation period at 230 dpi. 
Viral antigen was detected in the brain as score 1 in 9/18 birds, score 2 in 7/18 birds and score 
3 in 1/18 experimentally ABV-4 infected birds (table 37). The brain was not available in 1/18 
birds. Viral antigen was not detected in the spinal cord in 1/18 but was detected as score 1 in 
9/18 birds, score 2 in 2/18 birds. Spinal cord was not available in 6/18 birds (table 37). Viral 
antigen was not detected in the eye in 7/18 birds but was detected as score 1 in 3/18 birds, 
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score 2 in 5/18 bird and score 3 in 1/18 birds. The eye was not available in 2/18 birds (table 
37).  
The kinetic of viral antigen detection in the CNS was variable. Viral antigen was detected in 
the brain as score 1 and score 2 during the whole investigation period. However, viral antigen 
detection was detected as score 3 in the brain in 1/18 birds at mid time points 116 dpi. In the 
spinal cord, viral antigen was detected as score 1 from early time points at 60 and 66 dpi until 
late time points at 230 dpi. However, viral antigen was detected as score 2 in the spinal cord 
in 2/18 birds at 229 dpi. The kinetic of viral antigen detection in the eye revealed as score 2 at 
early and mid time points, then decreased at late time points. 
In the GIT, viral antigen was detected in all GIT organs mainly in intestine and 
proventriculus. Nucleus and cytoplasm of neurons of the enteric ganglia in the lamina 
muscularis of gizzard and proventriculus and also nerve fibers mainly harbored viral antigen. 
Nucleus of the epithelium of all GIT organs and smooth muscle fibers in the lamina muscularis 
of all GIT organs could also harbor viral antigen (Fig. 15). 
Viral antigen was not detected in the crop in 5/18 birds but it was found as score 1 in 7/18 
birds, score 2 in 3/18 birds (table 37). The crop was not available in 3/18 birds. Viral antigen 
was not detected in the gizzard in 9/18 birds but it was found as score 1 in 2/18 birds and 
score 2 in 2/18 birds. The gizzard was not available in 3/18 birds. The gizzard was autolytic in 
1/18 birds. Viral antigen was not detected in the proventriculus in 3/18 birds but it was found 
as score 1 in 6/18 birds, score 2 in 3/18 birds, and score 3 in 2/18 birds (table 37). The 
proventriculus was not available in 2/18 birds. The proventriculus was autolytic in 2/18 birds. 
Viral antigen was not detected in the intestine in 5/18 birds but it was found as score 1 in 4/18 
birds, score 2 in 3/18 birds, and score 3 in 4/18 birds (table 37). The intestine was not 
available in 1/18 birds. The intestine was autolytic in 1/18 birds. 
The kinetic of viral antigen detection in the GIT revealed that viral antigen was decreased in 
all GIT organs at late time points at 230 dpi in most majority of birds or could be negative in 
experimentally ABV-4 infected birds. 
In the peripheral organs, viral antigen was mainly detected in the heart, liver, kidney and 
spleen. Viral antigen detection was detected in liver cells, neurons of adjacent ganglia in the 
heart (Fig. 16) and nerve fibers, smooth muscle layer in the aorta, epithelium of renal tubules, 
epithelial cells of the pancreas, cells with features of red pulp macrophages in the spleen, 
epithelial cells around feather follicles in the skin, and muscle fibers and nuclei in the heart 
and muscle fibers in the skeletal muscles. 
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Viral antigen was not detected in the heart in 7/18 birds but it was found as score 1 in 8/18 
birds, score 2 in 1/18 birds and score 3 in 1/18 birds (table 37). The heart was not available in 
1/18 birds. Viral antigen was not detected in the liver in 5/18 birds but it was found as score 1 
in 7/18 birds, score 2 in 2/18 birds and score 3 in 4/18 birds (table 37). Viral antigen was not 
detected in the kidney in 2/18 birds but it was found as score 1 in 4/18 birds, score 2 in 6/18 
birds and score 3 in 5/18 birds (table 37). The kidney was not available in 1/18 birds. Viral 
antigen detection was detected in the spleen as a score 1 in 2/18 birds, score 2 in 7/18 birds 
and score 3 in 4/18 birds (table 37). The spleen was not available in 5/18 birds. Viral antigen 
was not detected in the pancreas in 5/18 birds but it was found as score 1 in 7/18 birds, score 2 
in 1/18 birds and score 3 in 1/18 birds (table 37). The pancreas was not available in 4/18 
birds. Viral antigen was detected in the adrenal gland as score 1 in 2/18 birds. Adrenal gland 
was not available in 16/18 birds. Viral antigen was not detected in the skin in 5/18 birds but it 
was found as score 1 in 7/18 birds, score 2 in 4/18 birds and score 3 in 2/18 birds (table 37). 
Viral antigen was not detected in the skeletal muscles in 15/18 birds. Viral antigen was only 
detected in muscle fibers in 2/18 experimentally ABV-4 infected birds. Skeletal muscles were 
not available in 1/18 birds. 
The kinetic of viral antigen in the peripheral organs revealed variability. Viral antigen was 
detected in the liver, kidney, and spleen as score 1, score 2, and score 3 during the whole 
investigation period at 230 dpi. Viral antigen was detected in the pancreas as score 1 during the 
whole investigation period of 230 dpi in most of majority of birds. However, it was detected in 
the pancreas as score 2 in 1/18 birds at early time points and as score 3 at late time points. Viral 
antigen was not detected in the skin at early time points but was found as score 1 and score 2 at 
mid time points and then increased up to score 3 at late time points. 
In the sentinel group, viral antigen was not found in the CNS. Viral antigen was not detected 
in the nerves or enteric ganglia of all GIT organs in the sentinel bird. Viral antigen was not 
detected in the nerves or ganglia of the heart, liver, kidney, skin as well as skeletal muscles in 
the sentinel. 
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4.5.3. Comparison of ABV antigen distribution after ABV-2 and ABV-4 infection 
In the CNS, viral antigen detection was detected in the CNS at the first time point 
investigated at 46 dpi until the end of the investigation period at 231 dpi after ABV-2 
infection. Viral antigen was not detected in the brain in 4/18 birds but viral antigen detection 
was detected as score 1 and score 2 in 13/18 birds and score 3 in 1/18 birds during the whole 
investigation period after ABV-2 infection. 
Viral antigen was detected in the CNS at the first time point investigated at 60 dpi until the 
end of the investigation period at 230 dpi after ABV-4 infection. Viral antigen was detected in 
the brain as score 1 and score 2 in 16/18 birds and score 3 in 1/18 birds during the whole 
investigation period after ABV-4 infection. The brain was not available in 1/18 birds after 
ABV-4 infection. 
The distribution of viral antigen detection in the CNS was the same and also intracellular 
localization was the same after ABV-2 infection and after ABV-4 infection. Viral antigen 
was distributed and detected in neurons, glial cells, Purkinje cells in the cerebrum or 
cerebellum as well as in neurons of retina and in the optic nerve in the eye after ABV-2 
infection and after ABV-4 infection. 
The kinetic of viral antigen detection in the CNS revealed that viral antigen detection was 
detected as score 1 and score 2 during the whole investigation period after ABV-2 infection 
and after ABV-4 infection. Nevertheless, viral antigen was not detected in the brain in 2/18 
birds at early time points 46-86 dpi, in 1/18 bird at mid time points 88-137 dpi, and in 1/18 
bird at late time points 231 dpi after ABV-2 infection. 
There was variable correlation between clinical signs, gross lesions with viral antigen 
detection in the CNS after ABV-2 infection. If birds exhibited gastrointestinal and/or 
neurological signs, and had moderate to severe dilatation of proventriculus, they could have 
viral antigen in the CNS after ABV-2 infection. However, 1/18 birds did not exhibit clinical 
signs, and had not dilatation of proventriculus but viral antigen was detected in the brain as 
score 3 at 231 dpi after ABV-2 infection. If birds did not exhibit clinical signs, and did not 
display dilatation of proventriculus, they could also have viral antigen in the CNS after ABV-
2 infection. 
After ABV-4 infection, there was variable correlation between clinical signs, gross lesions 
with viral antigen detection in the CNS. If birds exhibited gastrointestinal and/or neurological 
signs, and had dilatation of proventriculus, they could have viral antigen in the CNS after 
ABV-4 infection. If birds did not exhibit clinical signs, and did not display dilatation of 
proventriculus, they could also have viral antigen in the CNS after ABV-4 infection. 
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In the GIT, viral antigen was detected in all GIT organs mainly in gizzard and proventriculus 
after ABV-2 infection. Viral antigen was detected as score 1 and score 2 in all GIT organs 
during the whole investigation period in most majority of birds after ABV-2 infection. 
However, an exception in detection of viral antigen in the GIT was also found. For example in 
the intestine, viral antigen was detected in it as score 3 in 1/18 bird at early time points, and as 
score 3 in 2/18 birds at late time points after ABV-2 infection.  
After ABV-4 infection, viral antigen was detected in all GIT organs mainly in intestine and 
proventriculus. Viral antigen was detected as score 1, score 2 in the crop and gizzard at early 
time points and mid time points after ABV-4 infection. Moreover, viral antigen was detected as 
score 1, score 2, and score 3 in the intestine and proventriculus at early time points and mid 
time points after ABV-4 infection. Viral antigen was not found in the gizzard at late time 
points 230 dpi after ABV-4 infection. 
The distribution of viral antigen detection in the GIT was the same and also intracellular 
localization was the same after ABV-2 infection and after ABV-4 infection. Viral antigen 
was distributed and detected in neurons of the enteric ganglia of the GIT, nerve fibers and 
smooth muscle vessels, GIT epithelium, and smooth muscle fibers of the GIT. 
The kinetic of viral antigen detection in the GIT revealed that viral antigen was detected as 
score 1 and score 2 during the whole investigation period after ABV-2 infection. After 
ABV-4 infection, viral antigen detection decreased in all GIT organs at late time points of 
230 dpi in most majority of birds. 
After ABV-2 infection, there was no clear correlation between clinical signs, gross lesions 
with viral antigen detection in the GIT. If birds exhibited gastrointestinal and/or neurological 
signs, and had moderate to severe dilatation of proventriculus, they could also viral antigen as 
score 1 and score 2 in the GIT after ABV-2 infection. However, 4/18 birds exhibit 
gastrointestinal and/or neurological signs, and had dilatation of proventriculus but viral 
antigen was detected in the GIT as score 3 after ABV-2 infection. If birds did not exhibit 
clinical signs, and did not display dilatation of proventriculus, they could also have viral 
antigen in the GIT after ABV-2 infection. 
After ABV-4 infection, there was no clear correlation between clinical signs, gross lesions 
with viral antigen detection in the GIT. If birds exhibited gastrointestinal and/or neurological 
signs, and had moderate to severe dilatation of proventriculus, they could also viral antigen as 
score 1 and score 2 in the GIT after ABV-4 infection. If birds did not exhibit clinical signs, 
and did not display dilatation of proventriculus, they could also have viral antigen in some but 
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not all GIT organs after ABV-4 infection. However, viral antigen detection was detected as 
score 2 and score 3 in the GIT in 1/18 bird without exhibiting clinical and gross lesions. 
In the peripheral organs, viral antigen was predominantly detected in the heart, liver, 
kidney, pancreas, spleen and skin after ABV-2 infection (table 36) while viral antigen was 
mainly detected in the heart, liver, kidney and spleen after ABV-4 infection (table 37). Viral 
antigen was detected in neurons of the adjacent ganglia but not in the heart itself in 12/18 
birds after ABV-2 infection. After ABV-4 infection, viral antigen detection was not only 
found in neurons of the pericardial ganglia but also in muscle fibers and smooth muscle layer 
in the aorta, myocardial fibers and Purkinje fibers in 10/18 birds. 
Viral antigen was detected in the liver at early time points and mid time points in only 1/18 
bird and in 2/18 birds at mid time points after ABV-2 infection. Viral antigen was not 
detected in the liver in 10/18 birds after ABV-2 infection. After ABV-4 infection, viral 
antigen was detected in the liver as score 1, score 2, and score 3 during the whole 
investigation period 230 dpi in most majority of birds in 18/18 birds after ABV-4 infection. 
By comparison between kinetic of viral antigen detection in the peripheral organs, we found 
that viral antigen detection decreased in all the peripheral organs at late time point 231dpi in 
most majority of birds after ABV-2 infection. After ABV-4 infection, viral antigen detection 
increased in all the peripheral organs at mid time points 88-137 dpi until late time points 231 
dpi in most majority of experimentally ABV-4 infected birds. 
After ABV-2 infection, the correlation between clinical signs, gross lesions with viral antigen 
detection in the peripheral organs was variable. If birds exhibited gastrointestinal and/or 
neurological signs, and had moderate to severe dilatation of proventriculus, they could also 
have viral antigen in the heart, kidney, pancreas, skin but not in the liver at early time points. 
If birds did not exhibit clinical signs, and did not display dilatation of proventriculus, they 
could also have viral antigen in all the peripheral organs mainly in kidney, pancreas, and skin 
after ABV-2 infection. 
After ABV-4 infection, the correlation between clinical signs, gross lesions with viral antigen 
detection in the peripheral organs was also variable. If birds exhibited gastrointestinal and/or 
neurological signs, and had moderate to severe dilatation of proventriculus, they could also 
have viral antigen in the heart, liver, kidney, spleen, and pancreas but not in the skin at early 
time points. If birds did not exhibit clinical signs, and did not display dilatation of 
proventriculus, they could also have viral antigen in all the peripheral organs mainly in 
kidney, liver, and spleen after ABV-4 infection. 
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Table 36: Scores of viral antigen detection after ABV-2 infection 
 
 
 
 
 
Table 37: Scores of viral antigen detection after ABV-4 infection 
 
 
 
 
CNS= central nervous system, s.cord= spinal cord, N.A= not available, Prov.= proventriculus, 
dpi= days post infection, A= autolytic organ,  
 
 = CNS, 
 
 = GIT, 
 
 = peripheral 
organs 
CNS= central nervous system, s.cord= spinal cord, N.A= not available, Prov.= proventriculus, 
dpi= days post infection, A= autolytic organ,  
 
 = CNS, 
 
 = GIT, 
 
 = peripheral 
organs 
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Fig. 13: Demonstration of ABV antigen in the brain by IHC. (A) Cerebrum, viral antigen was 
found in the nucleus (black arrow) and cytoplasm (blue arrow) of neurons after ABV-2 
infection, 84 dpi. (B) Cerebrum, viral antigen found in the nucleus of neurons (red arrow) and 
in glial cells (green arrow) after ABV-4 infection, 60 dpi. Polyclonal rabbit anti-BoDV-P (p24) 
antibody, DAB staining, Papanicolaou counterstaining. Scale bar 100µm. 
 
 
 
 
 
 
 
v 
 
 
 
 
 
Fig. 14: Demonstration of ABV antigen in the CNS by IHC. (A) Cerebellum, viral antigen was 
found in Purkinje neurons after ABV-2 infection (arrow), 120 dpi. (B) Eye, retina, viral antigen 
found in neurons of retina in different layers, in nerve fiber layer (green arrow), photoreceptors 
(black arrow), and in the neurons located in the outer nuclear layers of the retina (blue arrow), 
115 dpi. Polyclonal rabbit anti-BoDV-P (p24) antibody, DAB staining, Papanicolaou 
counterstaining. Scale bar 100µm. 
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Fig. 15: Demonstration of ABV antigen in the GIT by IHC. (A) Gizzard, viral antigen was 
found in neurons of enteric ganglia after ABV-2 infection (arrow), 137 dpi. (B) Crop nerve, 
viral antigen found in the nerve of the crop after ABV-4 infection (arrow), 116 dpi. Polyclonal 
rabbit anti-BoDV-P (p24) antibody, DAB staining, Papanicolaou counterstaining. Scale bar 
100µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 16: Demonstration of ABV antigen in the peripheral organs by IHC. (A) Heart ganglia, 
viral antigen found in neurons of it (arrow), 231 dpi. (B) Kidney nerve, viral antigen was found 
in the nerve fibers and neurons (arrow), 230 dpi. Polyclonal rabbit anti-BoDV-P (p24) 
antibody, DAB staining, Papanicolaou counterstaining. Scale bar 100µm. 
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4.6. Generation of ABV-2 specific probes for the ISH 
4.6.1. Amplification of the oligonucleotides of ABV-2 N region fragments 
After performing the PCR to obtain the DNA template from two oligonucleotides of the ABV-
2-N region, a fragment of 230 bp in length was expected (Fig. 17). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 17: Amplification of the ABV-2 N oligonucleotides. (M) pUC Mix marker, 8 as a DNA 
size marker. 2% agarose, 6 volt/cm electrodes distance, one hour. 
 
4.6.2. Amplification of ligated DNA 
After ligation of the amplicon of the ABV-2 N region into the TOPO vector, the ligated DNA 
was amplified. PCR products containing ABV-2 N segments were used as template to generate 
the ABV-2-N sense and antisense probes for in vitro transcription. From T7 promotor until 
ABV-2-N reverse priming site, the ABV-2 N sense probe was generated. From T7 promotor 
until ABV-2-N forward priming site, the ABV-2 N antisense probe was synthesized (Fig. 18). 
The expected size of sense and anti sense of ABV-2 templates was 265 bp (Fig. 18).  
 
 
 
 
 
 
 
             
 
Chapter four - Results 
 
 102
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 18: Amplification of the ligated DNA. (M) pUC Mix Marker, 8 as a DNA size marker. 
Lane 1= Amplified DNA fragment for generation of the sense probe of ABV-2 N gene. Lane 
2= Amplified DNA fragment for generation of the antisense probe of ABV-2 N gene. 2% 
agarose, 6 volt/cm electrodes distance, one hour. 
 
4.7. Generation of ABV-4 specific probes for the ISH  
4.7.1. Amplification of the cloned ABV-4-N-DNA  
The cloned ABV-4-N-DNA was successfully amplified (Fig. 19). A combination of M13-F 
and ABV-4-N-R primers with the cloned ABV-4-N-DNA produced a template for the sense 
probe while combination of M13-R and ABV-4-N-F primers with the cloned ABV-4-N-DNA 
resulted in a template for the antisense probe. The expected size of sense and anti sense of 
ABV-4 templates was 478 bp (Fig. 19). 
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Fig. 19: Amplification of the fragments carrying the ABV-4 N gene. (M) pUC Mix Marker, 8. 
Lane 1 and 3= no fragment control. Lane 2= DNA amplicon (PCR products) which was 
utilized to generate the sense probe. Lane 4= DNA amplicon (PCR products) which were 
employed to generate the antisense probe. 2% agarose, 6 volt/cm electrodes distance, one hour. 
 
 
4.8. Determination of labelling of ABV-2 and ABV-4 specific probes 
A spot test was used to quantify the labelling of the ISH probes with digoxigenin. Results 
showed that ABV-2 and ABV-4 probes were succefully labelled with digoxigenin. 
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4.9. Demonstration of ABV RNA 
4.9.1. Distribution pattern of the ABV-2 RNA after ABV-2 infection 
In the CNS, in some birds, ABV-2 genome but not ABV-2 mRNA was detected in the CNS. 
In other birds, ABV-2 mRNA but not ABV-2 genome was detected in the CNS. ABV-2 
genome was detected in the brain in 12/18 birds. Moreover, ABV-2 mRNA was detected in 
the brain in 10/18 birds. However, ABV-2 genome and ABV-2 mRNA were detected 
simultaneously in many other birds in 4/18 birds after ABV-2 infection. 
ABV-2 genome and ABV-2 mRNA were detected only in neurons and glial cells in the brain, 
nerve fibers and neurons of retina and in the optic nerve in the eye. ABV-2 genome was only 
detected intranuclearly within affected cells. ABV-2 mRNA was detected intranuclearly and 
intracytoplasmically within affected cells (Fig. 20).  
ABV-2 genome was not detected in the brain in 6/18 birds but it was detected as score 1 in 
10/18 birds, and score 2 in 2/18 birds (table 38). ABV-2 mRNA was not detected in the brain 
in 8/18 birds but it was detected as score 1 in 9/18 birds, and score 3 in 1/18 birds (table 39). 
ABV-2 genome was not detected in the spinal cord in 2/18 birds but it was detected as score 1 
in 1/18 bird, and score 2 in 1/18 bird (table 38). ABV-2 mRNA was not detected in the spinal 
cord in 1/18 birds but it was detected as score 1 in 3/18 birds (table 39). Spinal cord was not 
available in 14/18 birds. ABV-2 genome was not detected in the eye in 2/18 birds but it was 
detected as score 1 in 6/18 birds, and score 2 in 2/18 birds, and score 3 in 5/18 birds (table 
38). ABV-2 mRNA was not detected in the eye in 10/18 birds but it was detected as score 1 in 
5/18 birds (table 39). The eye was not available in 12/18 birds. The eye was autolytic in 1/18 
birds. 
The kinetic of ABV-2 RNA detection in the brain revealed that ABV-2 genome and ABV-2 
mRNA were detected mainly as score 1 during the whole investigation period (table 38 and 
39). However, some variability in detection of ABV-2 genome was found. ABV-2 genome was 
detected in the brain as score 2 in only 1/18 bird at early time points 46-86 dpi and also as 
score 2 only in 1/18 bird at late time points 231 dpi. Moreover, ABV-2 genome was not found 
in the brain only in 1/18 birds at early time points 46-86 dpi, in 2/18 birds at mid time points 
88-172 dpi, and in 2/18 birds at late time points 231 dpi. Variability in detection of ABV-2 
mRNA was also found. ABV-2 mRNA was not found in the brain in 3/18 birds at early time 
point, in 2/18 birds at mid time point, and in 2/18 birds at late time point. Moreover, ABV-2 
mRNA was detected as score 3 in 1/18 birds at early time points. 
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In the GIT, ABV-2 genome was detected in all GIT organs during the whole investigation 
period of 231 dpi in 17/18 birds. ABV-2 genome was also detected in all GIT organs during 
the whole investigation period of 231 dpi in 17/18 birds. The GIT organs were autolytic in 
1/18 birds. 
ABV-2 genome and ABV-2 mRNA were detected in the glandular epithelium of gizzard and 
proventriculus, muscle fibers and nuclei in the lamina muscularis in crop, intestine, gizzard 
and proventriculus in 17/18 birds. Neurons of the enteric ganglia in the lamina muscularis of 
gizzard and proventriculus, nerve fibers, epithelial cells mainly harbor ABV-2 genome and 
viral mRNA in the nucleus or in the nucleus and cytoplasm respectively (Fig. 21).  
ABV-2 genome was not found in the crop in 1/18 birds but it was detected as score 1 in 13/18 
birds, and score 2 in 3/18 birds (table 38). ABV-2 mRNA was not found in the crop in 1/18 
birds but it was detected as score 1 in 7/18 birds, score 2 in 5/18 birds, and score 3 in 4/18 
birds (table 39). The crop was autolytic in 1/18 birds. ABV-2 genome was detected in the 
gizzard as score 1 in 9/18 birds, and score 2 in 8/18 birds (table 38). ABV-2 mRNA was not 
found in the gizzard in 1/18 birds but it was detected as score 1 in 1/18 birds, score 2 in 11/18 
birds, and score 3 in 4/18 birds (table 39). The gizzard was autolytic in 1/18 birds. ABV-2 
genome was detected in the proventriculus as score 1 in 10/18 birds, score 2 in 4/18 birds, and 
score 3 in 3/18 birds (table 38). ABV-2 mRNA was detected in the proventriculus as score 1 
in 5/18 birds, score 2 in 7/18 birds, and score 3 in 5/18 birds (table 39). The proventriculus 
was autolytic in 1/18 birds. ABV-2 genome was detected in the intestine as score 1 in 14/18 
birds, and score 2 in 2/18 birds (table 38). ABV-2 mRNA was detected in the intestine as 
score 1 in 7/18 birds, score 2 in 7/18 birds, and score 3 in 2/18 birds (table 39). The intestine 
was autolytic in 2/18 birds. 
The kinetic of ABV-2 RNA detection in the GIT revealed that ABV-2 genome was detected 
in the crop, gizzard, and proventriculus as score 1, score 2 or rarely score 3 during the whole 
investigation period of 231 dpi. However, variability in detection of ABV-2 genome in the 
crop and proventriculus was found. ABV-2 genome was not found in the crop in 1/18 birds at 
early time points 46-86 dpi. Moreover, ABV-2 genome was detected in the proventriclus as 
score 3 in 3/18 birds at late time points. The kinetic of ABV-2 mRNA was also variable in the 
GIT. ABV-2 mRNA was detected in the crop as score 1 and score 2 at early and mid time 
points but increased up to score 3 at late time points. ABV-2 mRNA was detected in the 
gizzard and proventriculus and intestine as score 1, score 2 and score 3 during the whole 
investigation period of 231 dpi. 
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In the peripheral organs, ABV-2 genome and ABV-2 mRNA were detected in most of the 
peripheral organs in 18/18 experimentally ABV-2 infected birds. ABV-2 genome was 
detected as score 1, score 2, and score 3 in all the peripheral organs during the whole 
investigation period of 231 dpi. ABV-2 mRNA was detected as score 1, score 2 and score 3 in 
heart and liver, and it was detected in the kidney and skin as score 1 during the whole 
investigation period 231 dpi. 
ABV-2 genome and viral mRNA were detected in liver cells, neurons of the pericardial 
ganglia, smooth muscle layer in the aorta, cardiomyocytes, nerve fibers, epithelial cells of 
renal tubules, epithelial cells of the pancreas, cells with features of red pulp macrophages in the 
spleen, epithelial cells around feather follicles in the skin, and smooth muscle fibers and nuclei 
in the heart and muscle fibers in the skeletal muscles (Fig. 22). 
ABV-2 genome was not found in the heart in 3/18 birds but it was detected as score 1 in 1/18 
bird, score 2 in 9/18 birds, and score 3 in 4/18 birds (table 38). ABV-2 mRNA was not found 
in the heart in 3/18 birds but it was detected as score 1 in 2/18 birds, score 2 in 5/18 birds, and 
score 3 in 7/18 birds (table 39). ABV-2 genome and ABV-2 mRNA were detected in the heart 
simultaneously in 14/18 birds. The heart was autolytic in 1/18 birds. ABV-2 genome was not 
found in the liver in 2/18 birds but it was detected as score 1 in 7/18 birds and score 2 in 8/18 
birds (table 38). ABV-2 mRNA was not found in the liver in 2/18 birds but it was detected as 
score 1 in 2/18 birds, score 2 in 8/18 birds, and score 3 in 5/18 birds (table 39). ABV-2 
genome and ABV-2 mRNA were detected in the liver simultaneously in 15/18 birds. The liver 
was autolytic in 1/18 birds. ABV-2 genome was not found in the kidney in 4/18 birds but it 
was detected as score 1 in 3/18 birds, score 2 in 4/18 birds, and score 3 in 6/18 birds (table 
38). ABV-2 mRNA was not found in the kidney in 10/18 birds but it was detected as score 1 
in 6/18 birds and score 2 in 1/18 birds (table 39). ABV-2 genome and ABV-2 mRNA were 
detected in the kidney simultaneously in 8/18 birds. The kidney was autolytic in 1/18 bird. 
ABV-2 genome was not found in the spleen in 3/18 birds but it was detected as score 1 in 
2/18 birds and score 2 in 2/18 birds (table 38). ABV-2 mRNA was not found in the spleen in 
7/18 birds (table 39). The spleen was not available in 11/18 birds. ABV-2 genome was not 
found in the pancreas in 1/18 bird but it was detected as score 1 in 6/18 birds, score 2 in 7/18 
birds and score 3 in 2/18 birds (table 38). ABV-2 mRNA was not found in the pancreas in 
13/18 birds but it was detected as score 1 in 2/18 birds, and score 3 in 1/18 bird (table 39). 
ABV-2 genome and ABV-2 mRNA were detected in the pancreas simultaneously in 3/18 
birds. The pancreas was not available in 2/18 birds. ABV-2 genome was detected in the 
adrenal gland as score 2 in 2/18 birds and score 3 in 1/18 birds (table 38). ABV-2 mRNA was 
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not found in the adrenal gland in 1/18 birds but it was detected as score 1 in 2/18 birds (table 
39). ABV-2 genome and ABV-2 mRNA were detected in the adrenal gland simultaneously in 
2/18 birds. The adrenal gland was not available in 15/18 birds. ABV-2 genome was not found 
in the skin in 1/18 bird but it was detected as score 1 in 7/18 birds, score 2 in 6/18 birds and 
score 3 in 1/18 birds (table 38). ABV-2 mRNA was not found in the skin in 7/18 birds but it 
was detected as score 1 in 8/18 birds (table 39). ABV-2 genome and ABV-2 mRNA were 
detected in the skin simultaneously in 7/18 birds. The skin was not available in 3/18 birds. 
ABV-2 genome was not found in the skeletal muscles in 16/18 birds but it was detected in 
muscle fibers as score 1 in 2/18 birds (table 38). ABV-2 mRNA was not found in the skeletal 
muscles in 16/18 birds but it was detected in muscle fibers as score 1 in 2/18 birds (table 39). 
ABV-2 genome and ABV-2 mRNA were detected in the skeletal muscles simultaneously in 
2/18 birds. 
The kinetic of ABV-2 RNA in the peripheral organs revealed that detection of ABV-2 
genome was variable. ABV-2 genome neither decreased nor increased in the heart, liver, 
kidney in most majority of birds and was detected as score 1, score 2 and score 3 during the 
whole investigation period of 231 dpi. ABV-2 genome increased in the pancreas at late time 
points 231 dpi while it increased in the skin at only mid time points 88-172 dpi. Likewise, the 
kinetic of ABV-2 mRNA neither decreased nor increased in the heart and kidney during the 
whole investigation period of 231 dpi. However, some variability in detection of ABV-2 
mRNA in the heart and kidney was also found. ABV-2 mRNA was not detected in the heart 
and kidney in 2/18 birds at early time points 46-86 dpi. The kinetic of ABV-2 mRNA in the 
liver, pancreas, and skin decreased at late time points (231 dpi). 
ABV-2 genome and ABV-2 mRNA were not found in the CNS, GIT, and peripheral organs in 
the sentinel bird. In the mock group, ABV-2 genome and ABV-2 mRNA were also not found 
in all organs in 4/4 birds.  
 
4.9.2. Distribution pattern of the ABV-4 RNA after ABV-4 infection 
In the CNS, ABV-4 genome and ABV-4 mRNA were detected in the CNS in experimentally 
ABV-4 infected birds. ABV-4 genome and ABV-4 mRNA were detected in the brain in 18/18 
birds. ABV-4 genome and ABV-4 mRNA were also detected in the spinal cord in 12/18 birds. 
The spinal cord was not available in 6/18 birds. 
ABV-4 genome and ABV-4 mRNA were detected in the cerebrum and cerebellum. Neurons, 
glial cells, nerve fibers, neurons of retina and in the optic nerve in the eye, Purkinje neurons 
could harbour ABV-4 genome and ABV-4 mRNA. ABV-4 genome was only detected 
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intranuclearly while ABV-4 mRNA was detected intranuclearly and intracytoplasmically 
within affected cells (Fig. 20).  
ABV-4 genome was detected in the brain as score 1 in 12/18 birds and score 2 in 6/18 birds 
(table 40). ABV-4 mRNA was detected in the brain as score 2 in 6/18 birds and score 3 in 
12/18 birds (table 41). ABV-4 genome was detected in the spinal cord as score 1 in 11/18 
birds and score 2 in 1/18 birds (table 40). ABV-4 mRNA was detected in the spinal cord as 
score 2 in 9/18 birds and score 3 in 3/18 birds (table 41). The spinal cord was not available in 
6/18 birds. ABV-4 genome was not found in the eye in 7/18 birds but it was detected as score 
1 in 5/18 birds and score 2 in 4/18 birds (table 40). ABV-4 mRNA was not found in the eye in 
16/18 birds (table 41). The eye was not available in 2/18 birds. 
The kinetic of ABV-4 RNA in the CNS revealed that ABV-4 genome neither increased nor 
decreased in the brain and was detected as score 1 and score 2 during the whole investigation 
period 230 dpi. Moreover, ABV-4 mRNA neither increased nor decreased in the brain and 
was detected as score 2 and score 3 during the whole investigation period 230 dpi. The kinetic 
of ABV-4 genome in the spinal cord was detected mainly as score 1 during the whole 
investigation period 230 dpi. However, it was detected in the spinal cord as score 2 in only 
1/18 birds at mid time points 115 dpi. ABV-4 mRNA in the spinal cord was detected as score 
2 and score 3 during the whole investigation period of 230 dpi. 
In the GIT, ABV-4 genome and ABV-4 mRNA were detected in all GIT organs in 14/18 
experimentally ABV-4 infected birds. ABV-4 genome and ABV-4 mRNA were detected in 
the nuclei of glandular epithelium of gizzard and proventriculus, muscle fibers and nuclei in 
the lamina muscularis in the crop, intestine, gizzard and proventriculus. Neurons of the enteric 
ganglia in the lamina muscularis of gizzard and proventriculus, and nerve fibers mainly 
harbor ABV-4 genome and ABV-4 mRNA (Fig. 21). ABV-4 genome was detected in all GIT 
organs as score 1, score 2 and score 3 while ABV-4 mRNA was detected in the GIT organs as 
only score 1 and score 2 during the whole investigation period in experimentally ABV-4 
infected birds. 
ABV-4 genome was not found in the crop in 5/18 birds but it was detected as score 1 in 7/18 
birds, score 2 in 2/18 birds and score 3 in 1/18 birds (table 40). ABV-4 mRNA was not found 
in the crop in 6/18 birds but it was detected as score 1 in 8/18 birds and score 2 in 1/18 birds 
(table 41). The crop was not available in 3/18 birds. ABV-4 genome and ABV-4 mRNA were 
detected in the crop simultaneously in 10/18 birds. ABV-4 genome was not found in the 
gizzard in 9/18 birds but it was detected as score 1 in 2/18 birds and score 2 in 2/18 birds 
(table 40). ABV-4 mRNA was not found in the gizzard in 10/18 birds but it was detected as 
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score 1 in 3/18 birds (table 41). ABV-4 genome and ABV-4 mRNA were detected in the 
gizzard simultaneously in 3/18 birds. The gizzard was not available in 3/18 birds. The gizzard 
was autolytic in 2/18 birds. ABV-4 genome was not found in the proventriculus in 3/18 birds 
but it was detected as score 1 in 3/18 birds, score 2 in 4/18 birds and score 3 in 4/18 birds 
(table 40). ABV-4 mRNA was not found in the proventriculus in 6/18 birds but it was 
detected as score 1 in 7/18 birds, score 2 in 1/18 birds (table 41). ABV-4 genome and ABV-4 
mRNA were detected in the proventriculus simultaneously in 7/18 birds. The proventriculus 
was not available in 2/18 birds. The proventriculus was autolytic in 2/18 birds. ABV-4 
genome was not found in the intestine in 5/18 birds but it was detected as score 1 in 3/18 
birds, score 2 in 7/18 birds and score 3 in 1/18 birds (table 40). ABV-4 mRNA was not found 
in the intestine in 10/18 birds but it was detected as score 1 in 6/18 birds (table 41). ABV-4 
genome and ABV-4 mRNA were detected in the intestine simultaneously in 6/18 birds. The 
intestine was not available in 1/18 birds. The intestine was autolytic in 1/18 birds. 
The kinetic of ABV-4 RNA in the GIT revealed that ABV-4 genome and ABV-4 mRNA 
decreased in all GIT organs at late time points (230 dpi). 
In the peripheral organs, ABV-4 genome was detected in all the peripheral organs in 
experimentally ABV-4 infected birds. ABV-4 mRNA was found but in some of the peripheral 
organs. ABV-4 genome and ABV-4 mRNA were detected in liver cells, nucleus of neurons of 
the pericardial ganglia, smooth muscle layer in the aorta, cardiomyocytes, nerve fibers, 
epithelial cells of renal tubules, epithelial cells of the pancreas, cells with features of red pulp 
macrophages in the spleen, epithelial cells around feather follicles in the skin, and smooth 
muscle fibers and nuclei in the heart and muscle fibers in the skeletal muscles (Fig. 22). 
ABV-4 genome was not found in the heart in 7/18 birds but it was detected as score 1 in 3/18 
birds, score 2 in 4/18 birds and score 3 in 3/18 birds (table 40). ABV-4 mRNA was not found 
in the heart in 13/18 birds but it was detected as score 1 in 4/18 birds (table 41). ABV-4 
genome and ABV-4 mRNA were detected in the heart simultaneously in 4/18 birds. The heart 
was not available in 1/18 birds. ABV-4 genome was not found in the liver in 5/18 birds but it 
was detected as score 1 in 5/18 birds, score 2 in 5/18 birds and score 3 in 3/18 birds (table 40). 
ABV-4 mRNA was not found in the liver in 13/18 birds but it was detected as score 1 in 5/18 
birds (table 41). ABV-4 genome and ABV-4 mRNA were detected in the liver simultaneously 
in 5/18 birds. ABV-4 genome was not found in the kidney in 2/18 birds but it was detected as 
score 1 in 8/18 birds, score 2 in 4/18 birds and score 3 in 3/18 birds (table 40). ABV-4 mRNA 
was not found in the kidney in 1/18 birds but it was detected as score 1 in 16/18 birds (table 
41). ABV-4 genome and ABV-4 mRNA were detected in the kidney simultaneously in 15/18 
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birds. The kidney was not available in 1/18 bird. ABV-4 genome was detected in the spleen as 
score 1 in 13/18 birds (table 40). ABV-4 mRNA was detected in the spleen as score 1 in 9/18 
birds and score 2 in 4/18 birds (table 41). ABV-4 genome and ABV-4 mRNA were detected 
in the spleen simultaneously in 13/18 birds. The spleen was not available in 5/18 birds. ABV-
4 genome was not found in the pancreas in 7/18 birds but it was detected as score 1 in 7/18 
birds (table 40). ABV-4 mRNA was not found in the pancreas in 6/18 birds but it was 
detected as score 1 in 8/18 birds (table 41). ABV-4 genome and ABV-4 mRNA were detected 
in the pancreas simultaneously in 7/18 birds. The pancreas was not available in 4/18 birds. 
ABV-4 genome was detected in the adrenal gland as score 1 in 1/18 birds and score 2 in 1/18 
birds (table 40). ABV-4 mRNA was detected in the adrenal gland as score 1 in 1/18 birds and 
score 2 in 1/18 birds (table 41). ABV-4 genome and ABV-4 mRNA were detected in the 
adrenal gland simultaneously in 2/18 birds. The adrenal gland was not available in 16/18 
birds. ABV-4 genome was not found in the skin in 5/18 birds but it was detected as score 1 in 
7/18 birds, score 2 in 4/18 birds and score 3 in 2/18 birds (table 40). ABV-4 mRNA was not 
found in the skin in 4/18 birds but it was detected as score 1 in 13/18 birds and score 2 in 1/18 
birds (table 40). ABV-4 genome and ABV-4 mRNA were detected in the skin simultaneously 
in 13/18 birds. ABV-4 genome was not found in the skeletal muscles in 14/18 birds but it was 
detected as score 1 in 1/18 birds, score 2 in 1/18 birds and score 3 in 1/18 birds (table 40). 
ABV-4 mRNA was not found in the skeletal muscles in 16/18 birds but it was detected as 
score 1 in 1/18 birds (table 40). ABV-4 genome and ABV-4 mRNA were detected in the 
skeletal muscles simultaneously in 1/18 birds. Skeletal muscles were not available in 1/18 
birds. 
The kinetic of ABV-4 RNA in the peripheral organs revealed that ABV-4 genome increased 
in the heart, liver, pancreas and skin at mid time points (115,116,120 dpi) until late time 
points at 230 dpi. ABV-4 genome in the kidney was detected as score 1, score 2 and score 3 
during the whole investigation period of 230 dpi. The kinetic of ABV-4 mRNA neither 
decreased nor increased in all peripheral organs after ABV-4 infection. 
In the sentinel bird, ABV-4 genome and ABV-4 mRNA were not found in all organs of the 
sentinel bird. 
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4.9.3. Comparison of ABV RNA distribution after ABV-2 and ABV-4 infection 
In the CNS after ABV-2 infection, ABV-2 genome and/or ABV-2 mRNA were detected in 
the brain simultaneously in 4/18 experimentally ABV-2 infected birds. ABV-2 genome and 
ABV-2 mRNA were detected in the cerebrum only. ABV-2 genome and ABV-2 mRNA were 
detected in neurons of the brain, glial cells, and neurons of retina and in the optic nerve in the 
eye. 
The kinetic of ABV-2 genome was detected as score 1 and score 2 during the whole 
investigation period (table 38). However, ABV-2 genome was not found in the CNS in some 
birds at early time points, mid time points and late time points 231 dpi. The kinetic of ABV-2 
mRNA was detected as score 1 during the whole investigation period (table 39). However, 
ABV-2 mRNA was detected in the CNS as score 3 in only 1/18 birds at early time point. 
In the CNS after ABV-4 infection, ABV-4 genome and ABV-4 mRNA were detected in the 
brain simultaneously in 18/18 experimentally ABV-4 infected birds. ABV-4 genome and 
ABV-4 mRNA were detected in the cerebrum and cerebellum. ABV-4 genome and ABV-4 
mRNA were detected in neurons of the brain, glial cells, neurons of retina and in the optic 
nerve in the eye, and Purkinje neurons. 
The kinetic of ABV-4 genome in the CNS showed a consistency as score 1 and score 2 during 
the whole investigation period of 230 dpi (table 40). The kinetic of ABV-4 mRNA in the CNS 
showed a consistency as score 2 and score 3 during the whole investigation period 230 dpi 
(table 41). 
Taking together, more positive cells that harbor viral mRNA than genomic RNA in the CNS 
in experimentally ABV-4 infected birds than experimentally ABV-2 infected birds. 
In the GIT after ABV-2 infection, ABV-2 genome and ABV-2 mRNA were detected in all 
GIT organs during the whole investigation period of 231 dpi. However, ABV-2 mRNA was 
not found in the gizzard in only 1/18 birds. 
The kinetic of ABV-2 RNA in the GIT was variable. In the crop and gizzard, the kinetic of 
ABV-2 genome showed a consistency as score 1 and score 2 during the whole investigation 
period of 231 dpi. In the proventriculus, ABV-2 genome increased at late time points 231 dpi 
but it decreased in the intestine at late time points 231 dpi. The kinetic of ABV-2 mRNA 
showed a consistency as score 1, score 2 and score 3 in the crop, gizzard and proventriculus 
during the whole investigation period of 231 dpi. In the intestine, ABV-2 mRNA decreased at 
mid time points until late time points 231 dpi. 
In the GIT after ABV-4 infection, ABV-4 genome and ABV-4 mRNA were detected in the 
GIT organs but with some variability. ABV-4 genome was not found in the crop in 5/18 birds, 
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in the gizzard in 9/18 birds, in the proventriculus in 3/18 birds, and in the intestine in 5/18 
birds after ABV-4 infection. Moreover, ABV-4 mRNA was not found in the crop in 6/18 
birds, in the gizzard in 10/18 birds, in the proventriculus in 6/18 birds, and in the intestine in 
10/18 birds after ABV-4 infection. 
The kinetic of ABV-4 RNA in the GIT revealed that ABV-4 genome and ABV-4 mRNA 
decreased in all GIT organs at late time point 230 dpi. 
Taking together, more positive cells that harbor genomic RNA in the GIT in experimentally 
ABV-2 infected birds than genomic RNA in experimentally ABV-4 infected birds. Moreover, 
more positive cells that harbor viral mRNA in the GIT in experimentally ABV-2 infected 
birds than viral mRNA in experimentally ABV-4 infected birds. 
In the peripheral organs after ABV-2 infection, ABV-2 genome and ABV-2 mRNA were 
detected in all the peripheral organs in all birds. 
ABV-2 genome was detected as score 1, score 2, and score 3 in all the peripheral organs 
during the whole investigation period of 231 dpi. ABV-2 mRNA was detected as score 1, 
score 2 and score 3 in heart and liver, and it was detected in the kidney and skin as score 1 
during the whole investigation period of 231 dpi. 
The kinetic of ABV-2 genome neither decreased nor increased in the heart, liver, kidney 
during the whole investigation period of 231 dpi while it increased in the pancreas at late time 
point 231 dpi and in the skin at only mid time points 88-172 dpi. The kinetic of ABV-2 
mRNA neither decreased nor increased in the heart and kidney during the whole investigation 
period of 231 dpi while it decreased in the liver, pancreas, and skin at late time points 231 dpi. 
In the peripheral organs after ABV-4 infection, ABV-4 genome and ABV-4 mRNA were 
detected in most of the peripheral organs. 
ABV-4 genome was detected as score 1, score 2 and score 3 in the heart, liver, kidney, 
pancreas, adrenal gland, and skin during the whole investigation period 230 dpi. ABV-4 
mRNA was only detected as score 1 in the peripheral organs.  
The kinetic of ABV-4 genome increased in the heart, liver, pancreas and skin at mid time 
point (115,116,120 dpi) until late time point at 230 dpi. The kinetic of ABV-4 genome in the 
kidney was detected as score 1, score 2 and score 3 during the whole investigation period 230 
dpi. The kinetic of ABV-4 mRNA neither decreased nor increased in the peripheral organs. 
Taking together, the genomic RNA was comparable in the peripheral organs after ABV-2 
infection. More viral mRNA was found in the peripheral organs after ABV-2 infection. After 
ABV-4 infection, more genomic RNA than viral mRNA was found in the peripheral organs 
after ABV-4 infection. 
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Table 38: Scores of genomic RNA detection of ABV-2 after ABV-2 infection 
 
 
 
 
 
Table 39: Scores of mRNA detection of ABV-2 after ABV-2 infection 
 
 
 
 
CNS= central nervous system, s.cord= spinal cord, N.A= not available, Prov.= proventriculus, 
dpi= days post infection, A= autolytic organ,  
 
 = CNS, 
 
 = GIT, 
 
 = peripheral 
organs 
CNS= central nervous system, s.cord= spinal cord, N.A= not available, Prov.= proventriculus, 
dpi= days post infection, A= autolytic organ,  
 
 = CNS, 
 
 = GIT, 
 
 = peripheral 
organs 
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Table 40: Scores of genomic RNA detection of ABV-4 after ABV-4 infection 
 
 
 
 
 
Table 41: Scores of mRNA detection of ABV-4 after ABV-4 infection 
 
 
 
 
 
 
 
CNS= central nervous system, s.cord= spinal cord, N.A= not available, Prov.= proventriculus, 
dpi= days post infection, A= autolytic organ,  
 
 = CNS, 
 
 = GIT, 
 
 = peripheral 
organs 
CNS= central nervous system, s.cord= spinal cord, N.A= not available, Prov.= proventriculus, 
dpi= days post infection, A= autolytic organ,  
 
 = CNS, 
 
 = GIT, 
 
 = peripheral 
organs 
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Fig. 20: Demonstration of genomic RNA and mRNA of ABV-2 or of ABV-4 in the CNS by 
ISH. (A) Brain, genomic RNA of ABV-2 was found in the neurons after ABV-2 infection, 
ABV-2 genome was found as intranuclear positive signals in the cells (arrow) 86 dpi. (B) 
Brain, mRNA of ABV-2 found in neurons after ABV-2 infection, ABV-2 mRNA was found as 
intranuclear positive signals (red arrow) as well as intracytoplasmic positive signals (blue 
arrow) in the cells, 86 dpi. (C) Brain, genomic RNA of ABV-4 was found in neurons after 
ABV-4 infection, ABV-4 genome was found as intranuclear positive signals in the cells 
(arrow), 120 dpi. (D) Brain, mRNA of ABV-4 found in neurons after ABV-4 infection, ABV-4 
mRNA was found as intranuclear positive signals (red arrow) as well as intracytoplasmic 
positive signals (blue arrow) in the cells, 120 dpi. DIG-labelled RNA probes, NBT/X-
phosphate staining. Scale bar 100µm. 
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Fig. 21: Demonstration of genomic RNA and mRNA of ABV-2 or of ABV-4 in the GIT by 
ISH. (A) Crop, genomic RNA of ABV-2 was found in the nuclei of neurons of the enteric 
ganglia after ABV-2 infection (black arrow), and in smooth muscle nuclei (blue arrow), 137 
dpi. (B) Crop, mRNA of ABV-2 was found in the neurons of the enteric ganglia after ABV-2 
infection (arrow), 137 dpi. (C) Proventriculus, genomic RNA of ABV-4 was found in the 
epithelial cells of compound glands in the proventriculus after ABV-4 infection (arrow), 231 
dpi. (D) Proventriculus, mRNA of ABV-4 was found in the epithelial cells of compound 
glands in the proventriculus after ABV-4 infection (arrow), 231 dpi. DIG-labelled RNA 
probes, NBT/X-phosphate staining. Scale bar 100µm. 
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Fig. 22: Demonstration of genomic RNA and mRNA of ABV-2 or of ABV-4 in the peripheral 
organs by ISH.  (A) Heart ganglia, genomic RNA of ABV-2 was found in neurons of the heart 
ganglia after ABV-2 infection (arrow), 231 dpi. (B) Heart ganglia, mRNA of ABV-2 was 
found in neurons of the heart ganglia after ABV-2 infection (arrow), 231 dpi. (C) Kidney, 
genomic RNA of ABV-4 was found in the epithelial cells of renal tubules after ABV-4 
infection (arrow), 231 dpi. (D) Kidney, mRNA of ABV-4 was found in the epithelial cells of 
renal tubules after ABV-4 infection (arrow). DIG-labelled RNA probes, NBT/X-phosphate 
staining. Scale bar 100µm. 
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4.10. General comparison between ABV-2 and ABV-4 infection 
By analyzing data in tables 30-33, we found statistically significant differences (P<0.05) in 
the mean scores of inflammatory lesions as well as in the mean scores of viral antigen 
detection in all organs according to the ABV genotype (Fig. 23 and 24).  
In the CNS, the mean scores of inflammatory lesions were higher after ABV-4 infection than 
ABV-2 infection (Fig. 23). The mean scores of viral antigen detection were higher in the CNS 
after ABV-4 infection than ABV-2 infection (Fig. 24). In the GIT, the mean scores of 
inflammatory lesions were the same after ABV-2 and ABV-4 infection (Fig. 23). The mean 
scores of viral antigen detection in the (ic) group were higher in the GIT after ABV-2 
infection than in the (iv) group after ABV-2 infection (Fig. 24). In the peripheral organs, the 
mean scores of inflammatory lesions were higher in the (ic) group after ABV-2 infection than 
in the (ic) group ABV-4 infection (Fig. 23) but lower in the (iv) group after ABV-2 infection 
than in the in the (iv) group after ABV-4 infection. The mean scores of viral antigen detection 
were higher in the peripheral organs after ABV-4 infection than ABV-2 infection (Fig. 24). 
Furthermore, our results also showed that there were no significant differences (P<0.05) in the 
mean scores of inflammatory lesions as well as in the mean scores of ABV antigen detection 
in all organs according to the route of infection after ABV-2 infection (Fig. 23 and 24). The 
same was true for ABV-4 infection.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 23: Comparison of scores of inflammatory lesions in all organs between ABV-2 and 
ABV-4. (ic) intracerebral, (iv) intravenous, (P) probability, scale bar (standard deviation). 
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Fig. 24: Comparison of scores of viral antigen detection in all organs between ABV-2 and 
ABV-4. (ic) intracerebral, (iv) intravenous, (P) probability, scale bar (standard deviation). 
 
 
4.11. Relationship between inflammatory lesions and viral antigen detection 
By analyzing data in tables 30-33, we found that there was a moderate correlation (r= 0.60) 
between gliosis and viral antigen detection in the CNS after ABV-2 infection. Moreover, there 
was a moderate correlation (r= 0.60) between inflammatory lesions and viral antigen 
detection in the CNS after ABV-4 infection but not for ABV-2 infection (Fig. 25). The data 
obtained in tables 30-33, showed no correlation (r = 0.033) between inflammatory lesions and 
viral antigen detection in the GIT after ABV-2 and ABV-4 infection. The data obtained in 
tables 30-33, showed a mild correlation (r = 0.38) between inflammatory lesions and viral 
antigen detection in the peripheral organs after ABV-2 and after ABV-4 infection (Fig. 26).  
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Fig. 25: Correlation between inflammatory lesions and viral antigen detection in the CNS. (P) 
probability, (r) regression, (N) number of birds. Each dot in the figure represents an 
intersection of at least two observations of the mean scores of inflammatory lesions and viral 
antigen detection in the CNS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 26: Correlation between inflammatory lesions and viral antigen detection in the peripheral 
organs. (P) probability, (r) regression, (N) number of birds. Each dot in the figure represents an 
intersection of at least two observations of the mean scores of inflammatory lesions and viral 
antigen detection in the peripheral organs. 
 
 
r = 0.60 
P value = 0.001 
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4.12. Comparison of histological findings, gross lesions, ABV antigen and ABV-2 RNA 
after ABV-2 infection 
After ABV-2 infection, birds exhibited gastrointestinal and/or neurological signs, had 
moderate to severe dilatation of proventriculus, they had also viral antigen and ABV-2 RNA 
in the CNS, GIT and in the peripheral organs. Moreover, birds did not exhibit gastrointestinal 
or neurological signs, did not display dilatation of proventriculus, they could also have viral 
antigen and ABV-2 RNA in the CNS, GIT and in the peripheral organs. 
Some variability was also detected. No inflammatory lesions were found in the brain but only 
detected in the GIT and peripheral organs in 1/18 bird which died suddenly at 84 dpi, had 
gastrointestinal clinical signs, and had not dilatation of proventriculus. Viral antigen and 
ABV-2 RNA were detected in the CNS, GIT and peripheral organs of this bird.  
 
4.13. Comparison of histological findings, gross lesions, ABV antigen and ABV-4 RNA 
after ABV-4 infection 
After ABV-4 infection, birds exhibited gastrointestinal and/or neurological signs, had 
moderate to severe dilatation of proventriculus, they had also viral antigen and ABV-4 RNA 
in the CNS, GIT and in the peripheral organs. Moreover, birds did not exhibit gastrointestinal 
or neurological signs, did not display dilatation of proventriculus, they could also have viral 
antigen and ABV-4 RNA in the CNS, GIT and peripheral organs. 
Some variability was also detected. Inflammatory lesions, viral antigen and ABV-4 RNA 
were detected in the CNS, GIT and peripheral organs in 1/18 birds which died suddenly 
without exhibiting clinical signs, and displayed moderate dilatation of proventriculus. 
Moreover, inflammatory lesions, viral antigen and ABV-4 RNA were also detected in the 
CNS, GIT and peripheral organs in 1/18 birds which died suddenly without exhibiting clinical 
signs, and did not display dilatation of proventriculus. 
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4.14. Isolation and characterization of cockatiel blood cells 
4.14.1. Isolation of cockatiel blood cells 
BC cells and MNC were successfully isolated from cockatiels (Fig. 27). After optimization of 
the isolation, the maximum life span of the population of the isolated cells in vitro was 
evaluated. After isolation, buffy coat was found mostly as an incomplete thin layer between 
red blood cells and plasma. Mononuclear cells were isolated either as a complete or 
incomplete layer. Number of BC cells ranged 300,000 to 500,000 cells/ml while number of 
MNC ranged 100,000 to 200,000 cells/ml directly after isolation. Cell viability decreased over 
time, starting from day 3 until day 15 post isolation (table 42). BC cells were shiny, most 
predominantly single cells of different types, rounded cells and oval shaped cells (Fig. 27) of 
different sizes (Fig. 27). Others remained floating in culture medium for many days. 
Mononuclear cells looked like small to large single cells, with rounded shape without any 
aggregates of the cells in culture medium at all.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 27: Isolated blood cells from cockatiels. (A) Buffy coat cells isolated from cockatiel 
blood by centrifugation. Notice that there are different cell shapes of buffy coat cells (black 
arrows) and types (red arrows). (B) Peripheral blood mononuclear cells. MNC isolated by 
Ficoll-PaqueTM Premium. Magnification 20x. 
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Table 42: Viability of BC cells by trypan blue assay 
 
Cell type Days after isolation Total number of cells  Viable cells  Cells 
viability 
 
 
 
 
 
 
BC cells 
Day 1 500,000 cells 500,000 cells 100 % 
Day 2 500,000 cells 500,000 cells 100 % 
Day 3 490,000 cells 410,000 cells 83 % 
Day 4 460,000 cells 350,000 cells 76 % 
Day 5 410,000 cells 300,000 cells 73 % 
Day 6 390,000 cells 280,000 cells 71 % 
Day 7 350,000 cells 210,000 cells 60 % 
Day 8 310,000 cells 180,000 cells 58 % 
Day 9 290,000 cells 160,000 cells 55 % 
Day 10 230,000 cells 120,000 cells 52 % 
Day 11 180,000 cells 90,000 cells 50 % 
Day 12 140,000 cells 60,000 cells 42 % 
Day 13 90,000 cells 33,000 cells 36 % 
Day 14 30,000 cells 8,000 cells 26 % 
Day 15 10,000 cells 500 cells 5 % 
 
0.4% trypan blue in 1xPBS. IX70 S8F inverted microscope (Olympus, USA) 
 
4.14.2. Characterization of immune cells in cockatiel BC by IIF 
Due to lack of specific antibodies that recognize immune cells in psittacine birds, we tested cell 
surface markers from other species for identifying immune cells in cockatiels. By IIF, we 
characterized immune cells of cockatiels in BC cells by using cross reactive cell surface 
markers successfully (Fig. 28). IIF results showed that anti-CD3 (rat anti-human CD3), anti-
CD4 (mouse anti-chicken CD4), anti-CD8a (mouse anti-chicken CD8a), IgY (mouse anti-duck 
IgY), anti-thrombocytes (mouse anti-chicken thrombocytes) and anti-monocytes (mouse anti-
chicken monocytes) antibodies were cross reactive with cockatiel blood CD3-positive cells, 
CD4-positive cells, CD8a-positive cells, B cells, thrombocytes and monocytes (Fig. 28). Ring-
like immunostaining surrounded the targeted cells as a positive plasmamembrane staining (Fig. 
28). After counting positive and negative cells in each smear under fluorescence microscope 
manually, our findings showed that the estimated percentage of positive cells for (monocytes 
3%, thrombocytes 20%, B cells 9%, CD4-positive cells 36%, CD8a-positive cells 11%, and 
CD3-positive cells 71%) in cockatiel BC cells at day one after isolation. 
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Fig. 28: Indirect immunofluorescence (IIF) for characterization of BC cells from cockatiels. 
(A) Monocytes in BC, mouse anti chicken monocytes, cy3 conjugate goat anti-mouse. (B) 
Thrombocytes in BC, mouse anti-chicken thrombocytes, cy3 conjugate goat anti-mouse. 
(C) B cells in BC, mouse anti-duck IgY, cy3 conjugate goat anti-mouse.(D) CD4-positive 
cells in BC, mouse anti-chicken CD4, cy3 conjugate goat anti-mouse. (E) CD8a-positive 
cells in BC, mouse anti-chicken CD8a, cy3 conjugate goat anti-mouse. (F) CD3-positive 
cells in BC, rat anti-human CD3, cy3 conjugate goat anti-rat. Ring-like form surrounding 
the cells (green arrow) indicated positive cells. DAPI staining. Scale bar 100µm. 
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4.14.3. Characterization of immune cells in cockatiel BC by flow cytometry 
After optimization of the FC protocol, we tried to characterize the immune cells in cockatiel 
BC cells also by flow cytometry (Fig. 29 and 30). We found cockatiel B cells, CD4-positive 
cells, CD8a-positive cells, monocytes, thrombocytes only in low percentages but we did not 
find CD3-positive cells in BC cells. We detected positive immunofluorescence signals in the 
positive control of every cell surface marker except for the positive control of CD3 cells. Cell 
counting in each sample was performed by the automated flow cytometer. The obtained results 
showed that low percentage of positive cells for (monocytes 3.3%, thrombocytes 3.2%, B cells 
3.8%, CD4-positive cells 7.3%, CD8a-positive cells 6.2%, CD3-positive cells 0.2%) in 
cockatiel BC cells at day one after isolation (Fig. 29 and 30). 
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Fig. 29: Characterization of monocytes, thrombocytes and B cells in buffy coat of cockatiels 
by flow cytometry. Mouse anti-chicken monocytes, mouse anti-chicken thrombocytes and 
mouse anti-duck IgY antibodies were used as primary antibodies. Phycoerythrin (PE) 
conjugate goat anti-mouse IgG was used as a secondary antibody. Monocytes, thrombocytes, 
and B cells were detected in FL2-A channel of the flow cytometer, indicating positive cells. 
BD accuri C6 software, BD acurri C6 flow cytometer (BD Biosciences, Germany). 
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Fig. 30: Characterization of CD4 and CD8a-positive cells in buffy coat of cockatiels by flow 
cytometry. Mouse anti-chicken CD4, mouse anti-chicken CD8a were used as primary 
antibodies. Phycoerythrin (PE) conjugate goat anti-mouse IgG was used as secondary 
antibody for anti-CD4 and anti-CD8a antibodies. CD4 and CD8a were detected in FL2-A 
channel of the flow cytometer, indicating positive cells. Rat anti-human CD3 was used as 
primary antibody. Allophycocyanin (APC) conjugate goat anti-rat IgG was used as secondary 
antibody for anti CD3 antibody. CD3 was not detected in FL4-A channel of the flow 
cytometer, indicating negative results. BD accuri C6 software, BD acurri C6 flow cytometer 
(BD Biosciences, Germany). 
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4.15. Experimental infection of BC cells with ABV-4 and demonstration of ABV antigen 
and ABV-4 RNA at early time point (3 and 5 dpi) 
4.15.1. Demonstration of ABV antigen in BC cells  
We examined infected and non infected BC cells every day and investigated the viability. One 
day p.i, cell viability was 99% (table 40). Two days p.i, 70% of cells were viable and appeared 
as clumps or cells aggregates. Four days p.i. cell viability was 65%, then declined gradually 
until 15 days post infection (table 43). ABV antigen was not found in cockatiel BC cells at 3 
and 5 dpi by IIF. By IIF, we found intranuclear positive signals in the positive control but not 
in cockatiel BC cells.  
 
Table 43: Viability of infected and non BC cells after ABV-4 infection 
 
Cell type Days after isolation Cells viability of BC cells  
 Non infected   Infected with ABV-4 
 
 
 
 
 
 
BC cells 
Day 1 100 % 99 % 
Day 2 99 % 70 % 
Day 3 79 % 69 % 
Day 4 73 % 65 % 
Day 5 71 % 63 % 
Day 6 69 % 60 % 
Day 7 63 % 57 % 
Day 8 60 % 51 % 
Day 9 52 % 48 % 
Day 10 49 % 44 % 
Day 11 45 % 39 % 
Day 12 42 % 32 % 
Day 13 30 % 23 % 
Day 14 22 % 12 % 
Day 15 8 % 5 % 
 
0.4% trypan blue in 1xPBS. IX70 S8F inverted microscope (Olympus, USA) 
 
4.15.2. Demonstration of ABV-4 RNA in BC cells  
ABV-4 RNA was not detected in cockatiel BC cells after ABV-4 infection. We found ABV-4 
RNA only in the positive control (cDNA of the ABV-4 suspension) but not in BC cells after 
ABV-4 infection.  
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4.16. Experimental infection of BC cells with ABV-4 and demonstration of ABV antigen 
and ABV-4 RNA at early time point (9 and 15 dpi) 
 
4.16.1. Demonstration of ABV antigen in BC cells  
ABV antigen detection was not positive in BC cells at late time points (9 and 15 dpi) after 
infection with ABV-4 (Fig. 31).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 31: Indirect immunofluorescence (IIF) for demonstration of ABV antigen in BC cells at 
day 9 and 15 after ABV-4 infection. (A) BDV infected MDCK H1766 cell line (positive 
control), red intranuclear inclusions indicate BDV infected cells (green arrow). (B) BC cells, 
9 dpi, absence of intranuclear positive signals in BC cells after ABV-4 infection. (C) BC cells, 
15 dpi, absence of intranuclear positive signals in BC cells after ABV-4 infection. Polyclonal 
anti-BoDV rat serum (primary antibody), Cy3 conjugate goat anti-rat (H and L) (secondary 
antibody). Scale bar 25 µm. 
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4.16.2. Demonstration of ABV-4 RNA in BC cells  
By PCR, ABV-4 RNA was not found in BC cells at day 9 and 15 after ABV-4 infection (Fig. 
32).  ABV-4 RNA could also not be detected in non infected BC cells. However, ABV-4 
RNA was amplified in the positive control (ABV-4 suspension). Taking together, ABV-4 
RNA was not found in the BC cells after ABV-4 infection. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 32: Polymerase chain reaction (PCR) for detection of ABV-4 in BC cells at day 9 and 15 
after ABV-4 infection. (M) pUC19 DNA/MspI (HpaII) Marker, 23 (Thermo Scientific, 
Germany). Lane 1= PCR products of infected BC cells at day 9 in culture. Lane 2= PCR 
products of non infected BC cells at day 9 in culture. Lane 3= PCR products of infected BC 
cells at day 15 in culture. Lane 4= PCR products of non infected BC cells at day 15 in culture. 
Lane 5 and 6= cDNA amplificated from ABV-4 suspension (positive control). 2% agarose, 6 
volt/cm electrodes distance, one hour. 
 
4.17. Experimental infection of BC cells after stimulation with PHA-M mitogen 
4.17.1. Stimulation of BC cells with PHA-M  
After optimizing the stimulation conditions of BC cells in vitro, we stimulated BC cells with 
phytohemagglutinin M (PH-M) mitogen successfully (Fig. 33). Comparison of trypan blue 
assay and IIF methods to investigate the percentage of stimulated BC cells proved that BC 
cells were stimulated and the proliferation rate increased over the time (table 44). Both 
methods showed that stimulated BC cells reached the maximal rate of the proliferative 
response at day 3 post stimulation with PHA-M mitogen. By IIF, we investigated the 
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proliferative rate of stimulated BC cells at day 0 post stimulation in order to monitor the 
starting point of the stimulation. Presence of distinct intranuclear positive signals to anti-
bromodeoxyuridine (BrdU) antibodies in the stimulated BC cells was an indicator for the BC 
cell proliferation (Fig. 34). We found that stimulated BC cells started to proliferate 2 hours 
post stimulation (2 hours= 8 %, 4 hours= 15 %, 6 hours= 19 %, 8 hours= 23 %, and 10 hours= 
29 %). At day 0, the maximal percentage of the proliferating BC cells was 10 hour post 
stimulation. Moreover, we found that the percentage of proliferating BC cells increased over 
time (day 1= 40%, day 2= 64%, day 3= 88%, day 4= 86%, day 5= 81%, day 6= 74%, day 7= 
71%, and day 8= 68%) as shown in table 44. The stimulated BC cells reached the maximal 
proliferative rate at day 3 post stimulation. The percentage of proliferating BC cells decreased 
from day 9 until day 15 post stimulation (day 9= 55%, day 10= 51%, day 11= 46%, day 12= 
31%, day 13= 19%, day 14= 4%, and day 15= 1%) as shown in table 44. Microscopically, we 
found that stimulated BC cells agglutinated post stimulation with PHA-M mitogen indicating 
successful stimulating of BC cells. Most of the stimulated BC cells agglutinated as clumps at 
day one after stimulation and did not separate anymore over the time of stimulation. Results 
of counting stimulated BC cells in the IIF corresponded to data of counting of stimulated BC 
cells by trypan blue assay (table 44). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 33: Buffy coat cells from cockatiels after stimulation with PHA-M mitogen. BC cells 
agglutinated in culture medium one day post stimulation by PHA-M mitogen (blue arrow). 
(A) Stimulated BC cells at day one. (B) Stimulated BC cells at day two. Magnification 20x. 
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Fig. 34: IIF for demonstration of BrdU in BC cells after stimulating with PHA-M mitogen. 
Red intranuclear signals indicate BC cells stimulation and proliferation (green arrow). (A) 
Detection of BrdU 10 hours post stimulation. (B) Detection of BrdU one day post stimulation. 
(C) Detection of BrdU two days post stimulation. (D) Detection of BrdU three days post 
stimulation. (E) Detection of BrdU four days post stimulation. (F) Detection of BrdU five 
days post stimulation. Mouse anti-BrdU antibody (primary antibody), cy3 conjugate goat anti 
mouse (secondary antibody), scale bar 100µm. 
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   Table 44: Comparison between stimulated and non stimulated BC cells  
Days post 
stimulation 
BC cells Trypan blue assay IIF (400 cells / smear field) 
Total count 
number  
Percentage of 
stimulation 
Total count 
number  
Percentage of 
stimulation 
The day of 
isolation  
Stimulated  632,000 cells  
29% 
120 cells  
30% Non stimulated  490,000 cells 280 cells 
 Day 1 Stimulated cells 686,000 cells  
40% 
160 cells  
40% Non stimulated  490,000 cells 240 cells 
Day 2 Stimulated cells 801,000 cells  
64% 
220 cells  
55% Non stimulated  489,000 cells 180 cells 
 Day 3 Stimulated  885,000 cells  
88% 
336 cells  
84% Non stimulated  471,000 cells 64 cells 
Day 4 Stimulated  827,000 cells  
86% 
340 cells  
85% Non stimulated  445,000 cells 60 cells 
Day 5 Stimulated  706,000 cells  
81% 
316 cells  
79% Non stimulated  390,000 cells 84 cells 
Day 6 Stimulated  643,000 cells  
74% 
288 cells  
72% Non stimulated  370,000 cells 112 cells 
Day 7 Stimulated  588,000 cells  
71% 
280 cells  
70% Non stimulated  344,000 cells 120 cells 
Day 8 Stimulated  527,000 cells  
68% 
256 cells  
64% Non stimulated  314,000 cells 144 cells 
Day 9 Stimulated  465,000 cells  
55% 
204 cells  
51% Non stimulated  300,000 cells 196 cells 
Day 10 Stimulated  362,000 cells  
51% 
152 cells  
38% Non stimulated  240,000 cells 248 cells 
Day 11 Stimulated  277,000 cells  
46% 
160 cells  
40% Non stimulated  190,000 cells 240 cells 
Day 12 Stimulated  209,000 cells  
31% 
108 cells  
27% Non stimulated  160,000 cells 292 cells 
Day 13 Stimulated  95,000 cells  
19% 
44 cells  
11% Non stimulated  80,000 cells 356 cells 
Day 14 Stimulated  20,800 cells  
4% 
24 cells  
6% Non stimulated  20,000 cells 376 cells 
Day 15 Stimulated  4,040 cells  
1% 
12 cells  
3% Non stimulated  4,000 cells         388 cells 
 
0.4% trypan blue in 1xPBS. BC cells= Buffy coat cells, IIF= indirect immunofluorescence 
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4.17.2. Experimental infection of stimulated BC cells at day 1 post isolation 
4.17.2.1. Demonstration of BrdU incorporation from 0 – 5 dpi and stimulation 
By IIF, we investigated the BrdU incorporation in stimulated BC cells. We found that BC 
cells proliferated from day 0 until the end of the observation at day 5 post stimulation with 
PHA-M (Fig. 34). By IIF, percentage of BrdU positive BC cells was 40% at day 1, increased 
to 64% at day 2, and reached maximal percentage of BrdU positive BC cells (88% and 86%) 
at day 3 and day 4, respectively. At day 5, percentage of BrdU positive BC cells decreased to 
81%. The highest percentage of proliferating BC cells were counted at day 3 and day 4. By 
comparison between results of IIF and results of trypan blue assay in stimulated BC cells, we 
did not find a difference between counting the stimulated BC cells by trypan blue assay and 
the percentage of positive cells which were labelled with anti-BrdU antibody, indicating that 
both methods were equivalent (table 44). 
 
4.17.2.2. Demonstration of ABV antigen from 0 – 5 days post infection, and stimulation 
ABV antigen detection was not found in stimulated and non stimulated BC cells at day 0, 1, 2, 
3, 4, and 5 after ABV-4 infection (Fig. 35).  
 
4.17.2.3. Demonstration of ABV-4 RNA from 0 – 5 days post infection, and stimulation 
We investigated the presence of ABV-4 RNA in stimulated BC cells at 10 hours post 
stimulation and infection with ABV-4. We also investigated the presence of ABV-4 RNA at 
day 1, 2, 3, 4 and 5 post stimulation and infection with ABV-4.  ABV-4 RNA has not been 
found in stimulated and in non stimulated BC cells from day 0 until day 5 by RT-PCR (Fig. 
36 and 37). 
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Fig. 35: IIF of stimulated BC cells after ABV-4 infection. BC cells were stimulated with 
PHA-M at day of isolation. (A) BoDV infected MDCK cell line (positive control), red 
intranuclear inclusions represent viral antigen (green arrow). (B, C, D, E, and F) Stimulated 
BC cells after ABV-4 infection, no viral antigen detected. Polyclonal anti-borna disease virus 
rat serum (primary antibody), cy3 conjugate goat anti-rat (secondary antibody), scale bar 
100µm. 
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Fig. 36: Amplification of cDNA of stimulated BC cells at day 4 after ABV-4 infection. (M) 
pUC19 DNA/MspI (HpaII) Marker, 23 (Thermo Scientific, Germany). Lane 1= PCR products 
of stimulated, infected BC cells (4 days in culture), lane 2= PCR products of non stimulated, 
infected BC cells (4 days in culture), lane 3= PCR products of stimulated, non infected BC 
cells, lane 4= PCR products of non stimulated, non infected BC cells. Lane 5 and 6 =ABV-4 
suspension (positive control). 2% agarose, 6 volt/cm electrodes distance, one hour. 
 
4.17.3. Experimental infection of stimulated BC cells at day 3 post stimulation 
4.17.3.1. Demonstration of BrdU incorporation from 4 – 14 days post stimulation 
By IIF, we investigated the synthesis of BrdU in stimulated BC cells from 4-15 days post 
stimulation. We found that BC cells were stimulated with PHA-M. By counting BrdU 
positive BC cells, proliferating BC cells increased over time. Proliferating BC cells decreased 
in their number from day 9 onward. By IIF, we detected few proliferating BC cells (not more 
than 4%) in the slide smear at day 14 post stimulation. At day 15, we did not detect stimulated 
BC cells indicating the end of stimulation phase at this time point. 
 
 
 
 
 
 
 
 
 
 
 
      4 days post stimulation              4 dpi 
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4.17.3.2. Demonstration of ABV-4 RNA from 4 – 14 days post stimulation 
By RT-PCR, we investigated the presence of ABV-4 RNA in stimulated BC cells from day 4 
until day 14 post stimulation and infection. We infected the stimulated BC cells with ABV-4 
where they had high cells proliferation rate at day 3 post stimulation. ABV-4 RNA was not 
detected in stimulated BC cells at day 4, 6, 8, 10, 12 and 14 post stimulation (Fig. 37 and 38).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 37: Amplification of cDNA of stimulated BC cells at day 4 post stimulation, after ABV-4 
infection. (M) pUC19 DNA/MspI (HpaII) Marker, 23 (Thermo Scientific, Germany). Lane 
1=PCR products of stimulated, infected BC cells (4 days post stimulation, 1 dpi), lane 2= PCR 
products of non stimulated, infected BC cells, lane 3= PCR products of stimulated, non 
infected BC cells, lane 4= PCR products of non stimulated, non infected BC cells. Lane 
5=ABV-4 suspension (positive control). 2% agarose, 6 volt/cm electrodes distance, one hour. 
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Fig. 38: Amplification of cDNA of stimulated BC cells at day 6 post stimulation, after ABV-4 
infection. (M) pUC19 DNA/MspI (HpaII) Marker, 23 (Thermo Scientific, Germany). Lane 
1=PCR products of stimulated, infected BC cells (6 days post stimulation, 3 dpi), lane 2= PCR 
products of non stimulated, infected BC cells, lane 3= PCR products of stimulated, non 
infected BC cells, lane 4= PCR products of non stimulated, non infected BC cells. Lane 
5=ABV-4 suspension (positive control). 2% agarose, 6 volt/cm electrodes distance, one hour. 
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5. Discussion 
PDD is fatal inflammatory disease which affects the central, autonomic, and peripheral 
nervous system disease mainly in psittacine. PDD is characterized by non purulent 
ganglioneuritis and encephalitis (Berhane et al., 2001). In 2008, two independent research 
groups are reported that avian Borna virus (ABV) is the causative agent of PDD (Honkavuori 
et al., 2008; Kistler et al., 2008). The pathogenesis of ABV infection is still incompletely 
understood. To date, fourteen ABV genotypes have been detected in both psittacine and non 
psittacine birds (Kuhn et al., 2015). Whether differences in the pathogenicity among the 14 
ABV genotypes exist is largely unknown. Distribution pattern of ABV in naturally PDD 
affected birds were characterized in many previous studies using immunohistochemistry 
(IHC), reverse transcription polymerase chain reaction (RT-PCR) and Western blotting assay 
(Honkavuori et al., 2008; Gancz et al., 2009; Kistler et al., 2010; Lierz et al., 2009; Ouyang et 
al., 2009; Weissenböck et al., 2009; Lierz et al., 2010; Raghav et al., 2010; Reßmeyer et al., 
2010; Wünschmann et al., 2011; Rubbenstroth et al., 2013). We characterized the distribution 
pattern of inflammatory lesions, ABV antigen, ABV-2 RNA, and ABV-4 RNA in 
experimentally ABV-2 and ABV-4 infected cockatiels respectively in order to get insight in 
potential different pathogenicity of the ABV genotypes. ABV-2 and ABV-4 induced a 
persistent infection via intracerebral and intravenous inoculation after experimental infection 
with ABV-2 and ABV-4 in cockatiels (Piepenbring et al., in revision). After 22 days post 
ABV-2 infection, and 33 days post ABV-4 infection, the infected animals developed typical 
clinical symptoms for PDD via different routes of infection especially when inoculated via the 
intravenous route. This finding payed attention that blood cells might be a target for ABV in 
psittacine birds and let us to hypothesize that blood cells might have a role for the spread of 
the ABV infection within organs. ABV belongs phylogenetically to Bornaviridae but for the 
mammalian Borna disease virus, the intravenous route of infection was not successful. 
Carbone and colleagues, (1987) mentioned that Borna disease virus (BoDV) failed to induce 
infection in experimentally infected rats via intravenous and oral route of infection. Findings 
of this study (Carbone et al., 1987) showed that inoculated rats developed clinical Borna 
disease via the intraceberal, intranasal, intramuscular and subcutaneous inoculation. It is 
unclear whether ABV and mammalian borna disease virus have the same biological properties 
to invade the body cells and spread throughout the body. The mode of dissemination of ABV 
to all organs after ABV infection is still debated and need further investigations. To 
investigate the potential role of blood cells after ABV infection, therefore, another aim of the 
study was to analyze whether blood cells could be infected with ABV.  
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5.1. Comparison of the clinical observations 
After experimental infection with ABV-2 and ABV-4 in cockatiels, 5/18 birds of the ABV-4 
infected groups exhibited symptoms on day 33 dpi consistent with PDD, mostly neurological 
signs in contrast to 12/18 birds of the ABV-2 infected groups (Piepenbring et al., 2012). 
Within the ABV-2 infected groups, clinical signs occurred on day 22 dpi and consisted of 
mostly gastrointestinal clinical signs. This is in line with (Kistler et al., 2008; Honkavouri et 
al., 2008) and many subsequent studies where ABV was identified as the aetiological agent 
for PDD in psittacines since 2008. The onset of clinical signs appeared earlier in the 
experimentally infected birds after ABV-2 infection than ABV-4 infection. That means, 
ABV-2 could have more rapid onset of clinical signs (22 dpi) in comparison to experimentally 
ABV-4 infected birds (33 dpi) and more gastrointestinal signs were induced. This might 
indicate that ABV-2 has more tropism to the GIT. In contrast, ABV-4 seems to have more 
tropism toward the CNS. 
 
5.2. Comparison of gross lesions 
Proventriculi were enlarged in 10/18 birds after ABV-2 infection and in 7/18 birds after ABV-
4 infection. In the ABV-2 group, 5 birds had a severely dilated proventriculus in contrast to 
one bird in the ABV-4 group. This might indicate that gross lesions were more severe in the 
experimentally ABV-2 infected cockatiels than after experimental infection with ABV-4 
(Piepenbring et al., 2012). It was reported that the clinical presentation of gastrointestinal 
dysfunction is secondary within the enteric nervous system (Shivaprasad et al., 1995; Berhane 
et al., 2001; Schmidt et al., 2003; Kistler et al., 2008; Ouyang et al., 2009; Gray et al., 2010).  
 
5.3. Histological findings  
Since the discovery of ABV as the etiological agent for PDD, histopathological lesions 
associated with ABV infection were described in many previous studies in naturally ABV-
infected psittacines which suffered from PDD (Kistler et al., 2008; Lierz et al., 2009; Ouyang 
et al., 2009; Raghav et al., 2010; Wünschmann et al. 2011; Delnatte et al., 2013).  
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5.3.1. Histological findings after ABV-2 infection 
In the CNS, mild and moderate gliosis was detected in the brain in 13/18 experimentally 
ABV-2 infected birds. No obvious inflammatory infiltrates were found in the brain in 18/18 
birds. The kinetic of gliosis decreased at mid time point (86-172 dpi) until late time point 231 
dpi in the 13/18 birds. This might indicate that ABV-2 is less pathogenic to the CNS and the 
gliosis could represent a reaction pattern of the CNS which can also been seen after ABV-4 
infection. 
In the GIT, inflammatory lesions were detected in all GIT organs most severely in intestine 
and proventriculus, indicating that these organs were the most affected GIT organs after 
ABV-2 infection. Inflammatory lesions in the GIT consisted of mononuclear cells infiltrates 
in the intestinal mucosa, lamina muscularis as well as around nerves and ganglia of gizzard 
proventriculus, and intestine or in the ganglia and nerve fibers of crop. These findings are in 
line with previous reports (Ouyang et al., 2009: Raghav et al., 2010; Staeheli et al., 2010: 
Delnatte et al., 2013) where the lymphoplasmacytic myenteric ganglioneuritis was detected in 
the GIT organs in psittacines suffering from PDD. An independent study has also shown that 
lymphoplasmacytic infiltrates in the gizzard and proventriculus are highly characteristic for 
PDD (reviewed in Staeheli et al., 2010). The kinetic of inflammatory lesions in the GIT 
showed variability. It showed a consistency in severity of the inflammatory lesions in the crop 
and gizzard during the whole investigation period 231 dpi. In the proventriculus, it decreased 
at mid time point (88-172 dpi) but it increased late time point at 231 dpi. In the intestine, it 
was variable during the whole investigation period. We still do not know the reasons behind 
the variability of inflammatory lesions in the GIT after ABV-2 infection. 
In the peripheral organs, inflammatory lesions were mainly found in the kidney, liver, 
spleen and skin. Inflammatory lesions in the peripheral organs were found as infiltration of 
mononuclear cells, sometimes with follicular shape-like appearance. This could be normal 
activation reaction of the immune system as also present in the mock and sentinel birds.  
Periganglionitis and/or perineuritis were also detected in the peripheral organs. This is typical 
lesion and this lesion was already detected in many previous studies (Kistler et al., 2008; 
Honkavouri et al., 2008; Gray et al., 2009). Peripheral neuritis was also detected in most of 
the peripheral organs in psittacine birds affected with PDD (Shivaprasad et al., 1995; Berhane 
et al., 2001; Rinder et al., 2009; Raghav et al., 2010). The lymphocytic infiltrates are not 
restricted to neural tissue of the gastrointestinal tract and may also be seen in conduction 
fibers of the heart, the adrenal gland in naturally occurring PDD affected psittacines. We also 
detected mononuclear infiltration in the ganglia adjacent to the heart and kidney after ABV-2 
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infection. These findings are in accordance with observations of Raghav et al., 2010 in 
psittacine with PDD. The kinetic of inflammatory lesions did not change markedly in all 
peripheral organs during the whole investigation period of 231 dpi. 
 
5.3.2. Histological lesions after ABV-4 infection 
In the CNS, mild, moderate and severe inflammatory lesions were detected in the brain in 
17/18 experimentally ABV-4 infected birds. Inflammatory lesions were also detected in the 
spinal cord as mild and moderate in 11/18 birds. The perivascular cuffing of mononuclear 
cells has already been described as typical histopathological lesion in the CNS in naturally 
ABV infected birds in many of previous studies (Kistler et al., 2008; Honkavouri et al., 2008; 
Delnatte et al., 2013; Ouyang et al., 2009; Raghav et al., 2010). We detected the mononuclear 
encephalitis with multifocal perivascular cuffing mainly in the cerebrum after ABV-4 
infection. The data presented here were supported by the similar results obtained by Ouyang 
et al., 2009 where the perivascular cuffing mainly was detected in the cerebrum and brain 
stem in ABV infected birds. The kinetic of inflammatory lesions in the CNS increased at late 
time point, indicating an active induction of immune response in the CNS. 
In the GIT, inflammatory lesions were detected in all GIT organs most severely in gizzard 
and proventriculus, indicating that these organs were the most affected GIT organs after 
ABV-4 infection. The kinetic of inflammatory lesions in the GIT revealed that inflammatory 
lesions decreased in all GIT organs at 230 dpi in experimentally ABV-4 infected birds. This 
might indicate a resolution of inflammation in the GIT started at late time point 230 dpi after 
ABV-4 infection. 
In the peripheral organs, inflammatory lesions were mainly found in the liver, kidney, heart, 
spleen, and pancreas. Infiltrations of mononuclear cells were also detected as follicular shape-
like aggregations in the liver, kidney, and pancreas. Such infiltrates were also detected in the 
mock and sentinel birds. These findings are in line with (Gray et al., 2009). Periganglionitis 
and/or perineuritis were also detected as typical lesion in the peripheral organs. Our results are 
in accordance with findings of Raghav et al., 2010 who detected characteristic 
lymphoplasmacytic infiltrates in the ganglia adjacent to the adrenal gland, heart, liver, kidney, 
CNS and also in the GIT organs in 16 psittacine birds suffered from PDD. Last and colleagues 
(2012) detected ABV-4 in PDD affected captive bred blue and gold macaws (Araara rauna) 
in South Africa. Findings of the study showed that lymphoplasmacytic encephalitis, 
gastrointestinal myenteric gangioneuritis and leiomyositis were detected in the PDD affected 
birds. Our results are also in accordance with this study (Last et al., 2012). The kinetic of 
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inflammatory lesion in the peripheral organs was variable. We do not know why the kinetic 
inflammatory lesions in the peripheral organs showed variability after ABV-4 infection. 
 
5.3.3. Comparison of histological lesions after ABV-2 and ABV-4 infection 
In the CNS, gliosis was detected but no obvious inflammatory lesions in the brain in 13/18 
experimentally ABV-2 infected birds. After ABV-4 infection, perivascular cuffings was 
detected in the brain in 17/18 experimentally ABV-4 infected birds. This could be explained 
that induction the immune response in the brain differs after ABV-2 and ABV-4 infection. 
The kinetic of gliosis decreased at mid time point (86-172 dpi) until 231 dpi after ABV-2 
infection while the kinetic of inflammatory lesions in the brain showed consistency as mild 
and moderate during the whole investigation period 230 dpi after ABV-4 infection. The 
variability between gliosis and inflammatory lesions remained unclear. The reason for that has 
to be investigated in future studies. It might indicate a different induction of immune response 
after ABV-2 and ABV-4 infection.  
In the GIT, inflammatory lesions were detected in the crop as mild in 14/18 experimentally 
ABV-2 infected birds. After ABV-4 infection, inflammatory lesions were detected in the crop 
as mild and moderate in 9/18 experimentally ABV-4 infected birds. This means that the 
severity of inflammatory lesions in the crop after ABV-4 infection were higher than after 
ABV-2 infection. Inflammatory lesions were detected in the gizzard as mild and moderate in 
15/18 experimentally ABV-2 infected birds. Inflammatory lesions were detected in the 
gizzard as mild and moderate in 3/18 experimentally ABV-4 infected birds. This means that 
inflammatory lesions in the gizzard after ABV-2 infection were more severe than after ABV-4 
infection. Inflammatory lesions have been detected as mild, moderate and severe in the 
proventriculus and intestine after ABV-2 and after ABV-4 infection. This means that 
inflammatory lesions in the proventriculus and intestine after ABV-2 infection were 
comparable severity. The kinetic of inflammatory lesions in the GIT showed variability after 
ABV-2 infection but it decreased in all GIT organs at 230 dpi after ABV-4 infection. It is still 
unclear why the kinetic of inflammatory lesions in the GIT was variable after ABV-2 and 
decreased in the GIT after ABV-4 infection. This might indicate that induction of immune 
response is different and infection with both genotypes needs to be further studied. 
In the peripheral organs, inflammatory lesions were predominantly detected in the liver, 
kidney, spleen and skin after ABV-2 infection while inflammatory lesions were mainly 
detected in the, liver, kidney, heart, spleen, pancreas and skin after ABV-4 infection. These 
data indicate that inflammatory lesions were found in more peripheral organs after ABV-4 
than after ABV-2 infection but can occur in principle in all peripheral organs. These findings 
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are in line with (Rinder et al., 2009; Weissenböck et al., 2009; Wünschmann et al., 2011). We 
found that the kinetic of inflammatory lesion in the peripheral organs after ABV-2 infection 
was not the same as after ABV-4 infection. The kinetic of inflammatory lesion in the 
peripheral organs was more severe after ABV-4 infection than after ABV-2 infection. These 
data indicate that there is variability in the severity of inflammatory lesions in the peripheral 
organs after ABV-2 and ABV-4 infection. It might indicate to a different induction of immune 
response. The statistical analysis showed significant differences (P<0.05) in the mean scores 
of inflammatory lesions in the CNS, GIT and in the peripheral organs according to the ABV 
genotype. Our results showed no significant differences (P<0.05) in the mean scores of 
inflammatory lesions in the CNS, GIT and peripheral organs according to the route of 
inoculation. That means that ABV-2 and ABV-4 initiated infection in cockatiels regardless to 
the route of inoculation and differences in inflammatory lesions are rather due to the used 
ABV genotype than due to the route of infection. 
 
5.4. Characterization of the infiltrating immune cells after ABV infection 
Characterization of the immune cell infiltration in the experimentally ABV-2 and ABV-4 
infected cockatiels was hampered due to unavailability of specific cell surface markers that 
recognize cockatiel immune cells. By immunohistochemistry, only CD3-positive cells could be 
stained but not B cells or macrophages in the cellular infiltrates after ABV-2 and ABV-4 
infection. We detected CD3-positive cell in the CNS (in the brain) and other organs such as 
liver, kidney, skin, gizzard, proventriculus, intestine and spleen as it known for the mammalian 
BoDV infection (reviewed in Herden et al., 2013). This is the first report of characterization of 
the immune cell infiltrations in organs after ABV-2 and ABV-4 infection. Our findings are in 
accordance with Stitz et al., 2002 that T cells mediated the immune response in mammalian 
BoDV infection. Whether ABV infection induced a comparable delayed type hypersensitivity 
reaction (Richt et al., 1994; Stitz et al., 2002; reviewed in Herden., 2013). This needs to be 
further investigated. ABV genotype, genetic host factors, and immune response might play a 
role in the outcome of the ABV infection. The immunopathogenesis of ABV genotypes is still 
unknown. Further investigations about whether immunopathologic mechanisms that are based 
on a T cell–mediated immune reaction, as known for BoDV infection are needed for ABV 
infection. 
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5.5. Distribution patterns of ABV antigen 
Immunohistochemistry (IHC) has already been performed to study the tissue distribution and 
localization of ABV in PDD affected psittacines (Rinder et al., 2009; Weissenböck et al., 2009; 
Ouyang et al., 2009). In the present study, it was shown that polyclonal rabbit anti-Borna 
disease virus antibody was cross reactive antibody with ABV as described by Herzog et al., 
2010 and Piepenbring et al., 2012. We found that the distribution patterns of ABV-2 in 
experimentally ABV-2 infected cockatiels was similar to the distribution patterns of naturally 
ABV-infected psittacines (Rinder et al., 2009; Gancz et al., 2009; Lierz et al., 2009; Ouyang et 
al., 2009; Weissenböck et al., 2009; Lierz et al., 2010; Raghav et al., 2010; Wünschmann et al., 
2011; Rubbenstroth et al., 2013). We found that ABV-2 was mainly localized in the GIT and 
peripheral organs. That is in accordance with findings of a previous study (Kistler et al., 2010) 
in which ABV-2 distribution pattern was predominately restricted to the GIT organs in 
naturally ABV-infected psittacines. We also found that ABV-4 has a strong tropism towards 
the CNS and peripheral organs. This is in line with (Payne et al., 2011) where ABV-4 was not 
only detected in the cells of the central and autonomic nervous systems, but also within the 
mononuclear cells infiltrating the various organs such as adrenal gland, heart, spleen, liver, 
kidney, lungs, pancreas, testes and ovary in apparently healthy cockatiels (Nymphicus 
hollandicus). ABV antigen was found primarily in the nuclei and cytoplasm of neurons 
including Purkinje cells and in glial cells through out the brain as described in naturally ABV-
infected psittacines suffering from PDD by (Gancz et al., 2009; Weissenböck et al., 2009; 
Wünschmann et al., 2011). We detected ABV antigen in neurons of the brain, glial cells of the 
spinal cord, liver cells, neurons of adjacent ganglia in the heart, epithelial cells around feather 
follicles in the skin, and epithelial cells in the renal tubules of the kidney, neurons of the enteric 
ganglia in the lamina muscularis of gizzard, proventriculus and intestine, nerve fibers, 
epithelial cells in the crop, gizzard and proventriculus, and smooth muscle fibers in the lamina 
muscularis of all GIT organs after ABV-2 and ABV-4 infection. This indicates that the virus 
was disseminated in neural and non neural cells as previously described in naturally ABV-
infected birds (Weissenböck et al., 2009; Kistler et al., 2010; Payne et al., 2011; Wünschmann 
et al., 2011).  
 
5.5.1. Distribution pattern of ABV antigen after ABV-2 infection 
In the CNS, viral antigen detection was detected in the as score 1, score 2 and score 3 in the 
CNS after ABV-2 infection. We found viral antigen in neurons and glial cells in the cerebrum 
and brain stem after ABV-2 infection. Our results are in line with (Kistler et al., 2008; 
Staeheli et al., 2010) where ABV P was detected in the nucleus and cytoplasm of neurons in 
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the brain in natural cases of PDD. ABV antigen was also found in Purkinje neurons 
suggesting that ABV could play a role in the control of motor activity. Viral antigen in the 
brain was detected as score 1 and score 2 during the whole investigation period. These data 
indicate viral persistence in the CNS as known for the mammalian borna viruses. 
In the GIT, viral antigen was detected in all GIT organs over the entire investigation period. 
ABV antigen was mainly localized in the GIT organs after ABV-2 infection. These findings 
are in line with Rinder et al., 2009; Weissenböck et al., 2009 where ABV antigen was found 
in the nucleus and the cytoplasm not only of neural tissues but also in other cell types 
including GI epithelium, and cells in the lamina propria of the intestine psittacine birds with 
PDD (Rinder et al., 2009; Weissenböck et al., 2009). Viral antigen in the GIT was detected as 
score 1 and score 2 in all GIT organs during the whole investigation period of 231 dpi. This 
indicates a viral persistence in the GIT after ABV-2 infection. However, some variability in 
viral antigen detection was also found in the GIT after ABV-2 infection. Viral antigen was not 
found in the crop in 1/18 birds but it was detected as score 3 in the gizzard in 1/18 bird and in 
the proventriculus in 2/18 birds. It might indicate that so far unknown host factors played a 
role in such variability. 
In the peripheral organs, viral antigen was mainly detected in the heart, liver, kidney, 
pancreas, and skin. Thus, the virus has tropism to these peripheral organs. In previous studies, 
ABV-P was not only found in the cells of the central and autonomic nervous systems, but was 
also present in the other organs such as heart, liver, spleen and pancreas after natural ABV-2 
and ABV-4 infection in cockatiels (Rinder et al., 2009; Payne et al., 2011a; Kistler et al. 2010; 
Wünschmann et al., 2011). Our results are in line with Rinder et al., 2009; Payne et al., 2011a; 
Kistler et al. 2010; Wünschmann et al., 2011. Viral antigen was detected in liver cells, 
neurons of adjacent ganglia in the heart, epithelium of renal tubules, around ducts in the 
pancreas, around feather follicles in the skin. Thus, viral antigen was found in neural and non 
neural cells. This is in agreement with previous studies (Weissenböck et al., 2009; Rinder et 
al., 2009; Payne et al., 2011a; Kistler et al. 2010; Wünschmann et al., 2011). Viral antigen in 
the peripheral organs revealed variability among the peripheral organs. It increased in the 
liver and kidney at 231 dpi but it was consistent as score 1 and score 2 in the heart and 
pancreas during the whole investigation period. We do not know why such variability occurs. 
This requires further investigations. Our findings showed that viral antigen increased in the 
peripheral organs at late time point at 231 after ABV-2 infection, indicating a broad 
distribution of ABV-2 in the late stages of the infection. This is in line with Lierz et al., 2009. 
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In birds that lacked signs of PDD, viral antigen and ABV-2 RNA could also show a broad 
distribution pattern. This is in line with Wünschmann et al., 2011. 
 
5.5.2. Distribution pattern of ABV antigen after ABV-4 infection 
In the CNS, viral antigen was detected in the brain as score 1, score 2 and score 3 in 18/18, in 
the spinal cord as score 1 and score 2 in 11/18 and in the eye as score 1, score 2 and score 3 in 
9/18 experimentally ABV-4 infected birds. This showed that ABV-4 has strong tropism to the 
CNS. Our results are consistent with findings of Ouyang et al., 2009. The kinetic of viral 
antigen detection in the CNS showed consistency as score 1 and score 2 during the whole 
investigation period in experimentally ABV-4 infected birds. This indicates a persistence 
infection of the CNS during the entire investigation period of 230 dpi. The kinetic of viral 
antigen detection in the eye decreased at late time point. It might be possible that viral antigen 
in at least certain cells in the eye was not found at early time points 60 and 66 dpi or could be 
cleared from the eye at late time points 230 dpi. 
In the GIT, we detected viral antigen in all GIT mainly in intestine and proventriculus. Our 
results are in line with Weissenböck  et al., 2009 where ABV antigen was detected in the 
gastrointestinal tract in 31 psittacine birds suffering with PDD in Europe. Our results are also 
in accordance with Kistler et al, 2010 where ABV-P was detected in tissues of the 
gastrointestinal tract in naturally ABV-infected psittacine birds suffering from PDD. We 
detected viral antigen in neurons of the enteric ganglia in the lamina muscularis of gizzard and 
proventriculus and intestine, epithelium and smooth muscle fibers of the GIT, and blood 
vessels. These findings are in line with Rinder et al., 2009; Weissenböck et al., 2009; Last et 
al., 2012 in naturally ABV-infected psittacines. The kinetic of viral antigen in the GIT 
decreased in all GIT organs and was negative at late time point in experimentally ABV-4 
infected birds. This might indicate clearance of the virus from the GIT by the immune 
response at late time points. However, this needs to be confirmed in further studies. 
In the peripheral organs, viral antigen detection was mainly detected in the heart, liver, 
kidney and spleen. Thus, ABV-4 has tropism to these peripheral organs. It was described that 
ABV antigen was distributed broadly in the peripheral organs in naturally ABV-infected 
psittacines which suffered from PDD (Rinder et al., 2009; Kistler et al., 2010; Wünschmann 
et al., 2011).  This is in agreement with Rinder et al., 2009; Kistler et al., 2010; Wünschmann 
et al., 2011. Viral antigen in the peripheral organs was detected in the liver, kidney, pancreas 
and spleen as score 1, score 2, and score 3 during the whole investigation period of 230 dpi. 
This indicates viral persistence in the peripheral organs after ABV-4 infection. 
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5.5.3. Comparison of ABV antigen distribution after ABV-2 and ABV-4 infection 
In the CNS, viral antigen was not detected in the brain in 4/18 birds after ABV-2 infection 
but it was detected as score 1, score 2 and score 3 in 17/18 birds after ABV-4 infection. This 
indicates that ABV-4 has a strong tropism toward the CNS than ABV-2. Viral antigen was not 
detected in the brain in 2/18 birds at early time points 46-86 dpi, in 1/18 birds at mid time 
points at 88-137 dpi, and in 1/18 birds at late time points at 231 dpi after ABV-2 infection. 
However, viral antigen was detected in all GIT organs and in all the peripheral organs of these 
birds. It might be possible that the virus was cleared from the CNS in these birds, 
substantiating the role of host factors such as variation in the individual immune status among 
birds. Viral antigen in the CNS revealed that viral antigen was detected as score 1 and score 2 
during the whole investigation period after ABV-2 and after ABV-4 infection. This indicates 
that ABV-2 and ABV-4 exhibited viral persistence in the CNS. 
In the GIT, viral antigen was detected in all GIT organs mainly in gizzard and proventriculus 
in all birds after ABV-2 infection. It was also detected all GIT organs mainly in intestine and 
proventriculus but not in all birds after ABV-4 infection. This means that there is individual 
variation in distribution of viral antigen in the GIT among birds according to the genotype. 
This also means that ABV-2 has a strong tropism to the GIT than ABV-4. Viral antigen was 
detected as score 1 and score 2 in all GIT organs during the whole investigation period after 
ABV-2 infection, indicating viral persistence in the GIT after ABV-2 infection. Viral antigen 
decreased in all GIT organs at late time point 230 dpi after ABV-4 infection, probably 
indicating that the virus could be eliminated from the GIT by the immune response at late 
time points. This also might support that ABV-4 has less tropism to the GIT in comparison to 
ABV-2. 
In the peripheral organs, viral antigen was predominantly detected in the heart, liver, 
kidney, pancreas, spleen and skin after ABV-2 infection while viral antigen was mainly 
detected in the heart, liver, kidney and spleen after ABV-4 infection. This indicates that ABV-
2 and ABV-4 have broad tissue tropism in the peripheral organs as reported for naturally 
ABV-infected captive psittacines which suffer from PDD (Rinder et al., 2009; Wünschmann 
et al., 2011). However we also found some variability in detection of viral antigen in the liver 
and heart after ABV-2 infection and after ABV-4 infection. In the liver, viral antigen was not 
found at early time points but it was detected as score 1 in most of experimentally ABV-2 
infected birds and also as score 2 in one bird at mid time points and late time points after 
ABV-2 infection. In contrast, viral antigen was detected in the liver as score 1, score 2 and 
score 3 during the whole investigation period after ABV-4 infection. In the heart, viral antigen 
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was detected in neurons of the adjacent ganglia but not in the heart itself after ABV-2 
infection. In comparison, it was not only found in neurons of the pericardial ganglia but also 
in muscle fibers of the heart, smooth muscle layer, myocardial fibers and Purkinje fibers after 
ABV-4 infection. We do not know why such variability in detection of viral antigen in the 
liver and heart occurs. It might indicate that ABV-4 has a stronge tropism to the liver and 
heart than ABV-2. The kinetic of viral antigen detection in the peripheral organs decreased in 
all the peripheral organs at late time point 231 dpi after ABV-2 infection but it increased in all 
the peripheral organs at mid time points until late time points after ABV-4 infection. This 
might indicate that ABV-2 could be cleared from the peripheral organs at late time points 
while ABV-4 exhibited viral persistence in the peripheral organs during the whole 
investigation period. This also indicate that induction of immune response differ according to 
the genotype. 
The statistical analysis showed significant differences (P<0.05) in the mean scores of viral 
antigen detection in the CNS, GIT and in the peripheral organs according to the ABV 
genotype (Fig.23 and Fig.24). This means that viral antigen detection in the CNS, GIT and 
peripheral organs after ABV-2 infection was not the same after ABV-4 infection. Our results 
showed no significant differences (P<0.05) in the mean scores of viral antigen detection in the 
CNS, GIT and peripheral organs according to the route of inoculation. This means that ABV-
2 and ABV-4 initiated ABV infection in cockatiels regardless to the route of inoculation. 
 
5.6. Demonstration of ABV RNA 
Distribution pattern of ABV-2 and ABV-4 genomic RNA as well as viral mRNA of these 
genotypes were described in naturally ABV-infected psittacines suffering from PDD by in situ 
hybridization (Weissenböck et al., 2010). However, this is the first report describing the 
detection of ABV-2 and ABV-4 RNA as well as viral mRNA of these genotypes in 
experimentally ABV-2 and ABV-4 infected cockatiels by in situ hybridization. We found that 
ISH could be used as a tool for localizing ABV RNA in tissues of birds with PDD to detect 
viral replication and transcription in affected tissues. Our results showed that ABV-2 genome 
and ABV-2 mRNA were mainly distributed in the GIT and in the peripheral organs. However, 
ABV-2 genome and ABV-2 mRNA were also detected in the CNS but with low scores. This 
indicates that ABV-2 has higher tropism to the GIT and peripheral organs. Our results showed 
that ABV-4 genome and ABV-4 mRNA were mainly distributed in the CNS and in the 
peripheral organs. However, ABV-4 genome and ABV-4 mRNA were also detected in the GIT 
but with low scores and not in all birds. This indicates that ABV-4 has tropism for CNS and 
peripheral organs. We found that ABV-2 and ABV-4 RNA were detected in the same cells 
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type in the CNS, in the GIT, and in the peripheral organs. ABV-2 genome or ABV-4 genome 
were only detected intranuclearly within affected cells. In the proventriculus, ABV-4 genome 
and ABV-4 mRNA were detected mostly in the nucleus of epithelial cells. ABV-2 mRNA or 
ABV-4 mRNA were detected intranuclearly and intracytoplasmically within the affected cells. 
These data are also in line with Weissenböck et al., 2010.  
 
5.6.1. Distribution pattern of ABV-2 RNA after ABV-2 infection 
In the CNS, ABV-2 genome and/or ABV-2 mRNA were detected in the CNS in 
experimentally ABV-2 infected birds. This indicates an active replication and transcription of 
ABV-2 in the CNS. That is in consistency with findings of (Piepenbring et al., in revision) 
where total viral RNA was detected in the brain in all experimentally ABV-2 infected birds. 
Now, a question presents itself, why we detected either ABV-2 genome or ABV-2 mRNA or 
both in the brain after ABV-2 infection. An interpretation for this finding is that ABV-2 RNA 
might not be evenly distributed in the brain, and we had investigated the viral RNA in an area 
where ABV-2 genome or ABV-2 mRNA was not present as in BoDV infected horses. This 
means that ABV-2 genome or ABV-2 mRNA were below of ISH detection in some birds. 
BoDV RNA could be restricted to a certain regions in the brain. ABV-2 genome and ABV-2 
mRNA were detected in the cerebrum only. ABV-2 genome was not detected in the brain in 
6/18 birds. Moreover, ABV-2 mRNA was not detected in the brain in 8/18 birds. This 
indicates that ABV-2 has a weaker tropism in the CNS. The kinetic of ABV-2 RNA detection 
in the brain revealed that ABV-2 genome and ABV-2 mRNA were detected as score 1 during 
the whole investigation period. This could be explained that there is viral persistence but with 
low amounts of infected animals in the CNS. ABV-2 genome was detected in the brain as 
score 2 only in 1/18 bird at early time points 46-86 dpi and also in 1/18 bird at late time point 
231 dpi. It might be that these two birds were more susceptible. 
In the GIT, ABV-2 genome and ABV-2 mRNA were detected in all GIT organs during the 
whole investigation period of 230 dpi in 18/18 birds. This indicates that ABV-2 can 
successfully replicate and transcribe in the GIT organs during the whole period investigated 
and can persist in these organs. Presence of ABV-2 RNA in all the GIT organs during the 
whole investigation period indicated viral persistence in the GIT organs and the higher 
amount of the positive cells indicate a high tropism to the GIT organs. ABV-2 genome was 
detected in the GIT as score 1 and score 2 while ABV-2 mRNA was detected in the GIT as 
score 1, score 2 and score 3 during the whole investigation period 231 dpi. This means that 
there was abundance of ABV-2 mRNA in the GIT and ABV-2 transcription is efficient in the 
GIT. Weissenböck and colleagues (2010) also detected ABV-2 genome and ABV-2 mRNA 
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mainly in the GIT organs in naturally ABV-infected psittacine suffering from PDD. These 
results are also in accordance with findings of Kistler et al., 2010 who found that ABV-2 is 
broadly distributed in the GIT organs in the naturally occurring PDD psittacine birds. 
In the peripheral organs, ABV-2 genome and viral mRNA were detected in all the 
peripheral organs in 18/18 experimentally ABV-2 infected birds over the entire investigation 
period. Weissenböck and colleagues (2010) detected ABV-2 RNA in the central and 
peripheral nervous system in naturally ABV-infected psittacines suffering from PDD. Our 
results are in agreement with Weissenböck et al., 2010. Thus, ABV-2 can replicate and 
transcribe in the peripheral organs. ABV-2 genome was detected as score 1, score 2, and score 
3 in all the peripheral organs while ABV-2 mRNA was detected as score 1, score 2 and score 
3 in the heart and liver but not in the kidney and skin during the whole investigation period 
231 dpi. That means that there was abundance in the genomic RNA of ABV-2 in the 
peripheral organs. The kinetic of ABV-2 genome neither decreased nor increased in the heart, 
liver, kidney and was detected as score 1, score 2 and score 3 during the whole investigation 
period 231 dpi. This indicates viral persistence in the peripheral organs. The kinetic of ABV-2 
mRNA in the liver, pancreas, and skin decreased at late time points 231 dpi. This could be 
explained that ABV-2 transcription decreased in these organs at late time points and is not 
needed in huge amount to maintain viral persistence. 
 
5.6.2. Distribution pattern of the ABV-4 RNA after ABV-4 infection 
In the CNS, ABV-4 genome and viral mRNA were detected in the CNS in 18/18 
experimentally ABV-4 infected birds. Thus, ABV-4 replication and transcription was 
effective in the CNS. ABV-4 genome and ABV-4 mRNA were detected in the cerebrum and 
cerebellum, indicating to a broad distribution pattern of ABV-4 RNA in the CNS. This also 
indicates that ABV-4 has strong tropism to the CNS. Weissenböck and colleagues (2010) 
detected ABV-4 genome and ABV-4 mRNA in brain in naturally ABV-infected psittacines 
suffering from PDD (Weissenböck et al., 2010). Our data are in line with (Weissenböck et al, 
2010). The kinetic of ABV-4 genome neither increased nor decreased in the brain and was 
detected as score 1 and score 2 during the whole investigation period of 230 dpi. Moreover, 
ABV-4 mRNA neither increased nor decreased in the brain and was detected as score 2 and 
score 3 during the whole investigation period of 230 dpi and was therefore of higher scores. 
This might indicate active transcription until the end of the investigation period. This also 
indicates viral persistence in the CNS. These findings are in discrepancy with Weissenböck et 
al., 2010 in which ABV-4 genome was detected much more than ABV-4 mRNA in the CNS 
in naturally ABV-infected birds. The authors explained that ABV-4 transcription was not well 
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developed in naturally ABV-infected birds and this might be due to a more efficient host 
defense mechanism which also could explain the generally chronic course of the disease. We 
used semiquantitaive scores to evaluate and discriminate between ABV-2 and ABV-4 genome 
and their mRNA in experimentally ABV-2 and ABV-4 infected birds but we do not know 
how Weissenböck et al., 2010 evaluated the ABV-4 genome and ABV-4 mRNA in the 
various tissues of psittacine birds suffering from PDD. Moreover, the time point of detection 
of ABV-2 RNA or ABV-4 RNA was known in all experimentally ABV-2 and ABV-4 
infected birds but it was unknown to Weissenböck et al., 2010. The preferential transcription 
of ABV-4 in the CNS during the whole period of 231 dpi provides a strong tropism of ABV-4 
to the CNS and an ideal mechanism for ABV persistence. Our findings are in accordance with 
observations from natural or experimental BoDV infections in mammals, where viral mRNAs 
are usually more abundant than genomic RNAs (Ikuta et al., 2002; Werner-Keiss et al., 2008). 
In the GIT, ABV-4 genome and viral mRNA were detected in all GIT organs in 
experimentally ABV-4 infected birds, indicating an active replication and transcription of the 
virus in the GIT. Weissenböck and colleagues (2009) mentioned that ABV-4 also replicated in 
the CNS and in the visceral organs in naturally ABV-infected birds suffering from PDD. Our 
results are therefore in line with Weissenböck et al., 2009. ABV-4 genome was detected in all 
GIT organs as score 1, score 2 and score 3 while ABV-4 mRNA was detected in the GIT 
organs as only score 1 and score 2 during the whole investigation period. This indicates that 
there was more ABV-4 genome in the GIT in comparison with ABV-4 mRNA. Thus, 
transcription of ABV-4 in the GIT seems to be less active and more replication might take 
place than in the CNS and ABV-4 might have a weak tropism in the GIT. Weissenböck and 
colleagues (2010) detected an abundance of ABV-4 genome in the GIT in comparison with 
viral mRNA in naturally ABV-infected psittacine suffering from PDD. Our results for the GIT 
are therefore in line with Weissenböck et al., 2010 but not for the CNS. Many experimentally 
ABV-4 infected birds did not expressed ABV-4 mRNA in the GIT. We can not rule out that 
there was no ABV-4 mRNA in the GIT organs in these birds after ABV-4 infection. It might 
be possible that there are small amount of the viral mRNA in the GIT organs after ABV-4 
infection which were under the detection level of the ISH and therefore could not be detected.  
The kinetic of ABV-4 genome and ABV-4 mRNA decreased in all GIT organs at late time 
points 230 dpi. It might be possible that ABV-4 was diminished from the GIT at late time 
points and also means that ABV-4 has less tropism to the GIT. 
In the peripheral organs, ABV-4 genome was detected in all the peripheral organs in 
experimentally ABV-4 infected birds. ABV-4 mRNA was found but not in all the peripheral 
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organs. This indicates that ABV-4 replicates effectively in the peripheral organs but ABV-4 
transcription seems to be less effective. Our results for the peripheral organs are in 
discrepancy with Weissenböck et al., 2010 where ABV-4 mRNA was much more than ABV-
4 genome in naturally ABV-infected psittacines suffering from PDD. Thus, the time point was 
not known for the naturally ABV-infected psittacines suffering from PDD which were 
investigated by Weissenböck. It might also be possible that there was indeed ABV-4 mRNA 
in all peripheral organs of all experimentally ABV-4 infected birds but it was below our 
detection by ISH. The kinetic of ABV-4 genome increased in the heart, liver, pancreas and 
skin at mid time points 115,116,120 dpi until late time points at 230 dpi, indicating the active 
viral replication in the peripheral organs at mid time points and late time points. The kinetic of 
ABV-4 mRNA neither decreased nor increased in all peripheral organs, indicates viral 
persistence.  
 
5.6.3. Comparison of ABV RNA distribution after ABV-2 and ABV-4 infection 
In the CNS, we detected ABV-2 genome and/or ABV-2 mRNA in the CNS after ABV-2 
infection. ABV-4 genome and ABV-4 mRNA were detected in the CNS in 18/18 
experimentally ABV-4 infected birds. This indicates that ABV-4 replicates and transcribes 
more actively in the CNS in comparison with ABV-2. The kinetic of ABV-2 genome was 
detected as score 1 and score 2 while the kinetic of ABV-2 mRNA was detected as score 1 
during the whole investigation period. We detected the ABV-4 genome in the CNS as score 1 
and score 2 during the whole investigation period 230 dpi while we detected ABV-4 mRNA 
as score 2 and score 3 during the whole investigation period of 230 dpi. Thus, ABV-4 mRNA 
was more abundant than ABV-2 mRNA indicating more transcription of ABV-4 in the CNS 
than ABV-2. This also indicates viral persistence and also means that ABV-4 transcription 
was efficient in the CNS.  
In the GIT, we found that ABV-2 genome and ABV-2 mRNA in all GIT organs and in all 
experimentally ABV-2 infected birds, indicating active ABV-2 replication and transcription in 
the GIT. Moreover, the ABV-2 transcription was efficient in the GIT. In only 1/18 birds, ABV-
2 mRNA was not found in the gizzard. It might be possible that there was ABV-2 transcript in 
this bird but it was below of our detection by ISH. After ABV-4 infection, we detected ABV-4 
genome and ABV-4 mRNA in the GIT but not in all birds.  Moreover, we found more positive 
cells harbouring ABV-4 genome in the GIT in comparison with ABV-4 mRNA. This means 
that ABV-4 transcription was less active in the GIT than for ABV-2. We found that kinetic of 
ABV-4 genome and ABV-4 mRNA decreased in all GIT organs at late time points 230 dpi 
which might indicate that ABV-4 diminished from the GIT at late time points and also means 
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that ABV-4 has less tropism to the GIT. The kinetic of ABV-2 RNA was variable. ABV-2 
genome increased in the proventriculus, and decreased in the intestine at late time points at 231 
dpi.  
In the peripheral organs, ABV-2 genome and ABV-2 mRNA were detected as score 1, 
score 2, and score 3 in all the peripheral organs during the whole investigation period of 231 
dpi, indicating active replication and transcription in the peripheral organs. ABV-4 genome 
and ABV-4 mRNA were detected in most but not all of the peripheral organs after ABV-4 
infection. ABV-4 genome was detected as score 1, score 2 and score 3 in the peripheral 
organs while ABV-4 mRNA was detected as score 1 in the peripheral organs.  This means 
that abundant ABV-4 genome was found in the peripheral organs. In some birds, we detected 
ABV-4 genome but we did not detect ABV-4 mRNA in some of the peripheral organs after 
ABV-4 infection. We can not rule out that ABV-4 mRNA was not found in the peripheral 
organs after ABV-4 infection. There are at least two possible explanations for this 
observation. (1) Degradation of ABV-4 mRNA might have occurred during methodology. (2) 
It might also be possible that there were small amounts of viral mRNA in the peripheral 
organs but these amounts were bellow of detection in the peripheral organs after ABV-4 
infection by ISH. Nevertheless, this also means that ABV-4 transcription was not as effective 
as ABV-2 transcription in the peripheral organs.  
The kinetic of ABV-2 RNA neither decreased nor increased in the peripheral organs, 
indicating viral persistence. ABV-2 mRNA decreased in the liver, pancreas, and skin at late 
time point 231 dpi, which might be diminished in these organs at late time points. However, 
we still do not know why there was a variation in the kinetic of ABV-2 genome and ABV-2 
mRNA in the peripheral organs. 
The kinetic of ABV-4 genome increased in the heart, liver, pancreas and skin at mid time 
points 115,116,120 dpi until late time point at 230 dpi, indicating active replication of the 
virus at mid time points and late time points 230 dpi. The kinetic of ABV-4 mRNA neither 
decreased nor increased in the peripheral organs. However, we also still do not know why 
there was a variation in the kinetic of ABV-4 genome and ABV-4 mRNA in the peripheral 
organs. 
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5.7. Comparison of histological findings, detection of ABV antigen and ABV RNA and 
clinical observation 
Our results showed a moderate correlation (r= 0.60) between inflammatory lesions and viral 
antigen detection in the CNS after ABV-2 and after ABV-4 infection. That means, any change 
in inflammatory lesions in the CNS after ABV-2 or ABV-4 infection leads to change in viral 
antigen detection in the CNS after ABV-2 or ABV-4 infection. Our results also showed a mild 
correlation (r = 0.38) between inflammatory lesions and viral antigen detection in the 
peripheral organs after ABV-2 and after ABV-4 infection. That means, any change in 
inflammatory lesions in the peripheral organs after ABV-2 or ABV-4 infection leads to 
change in viral antigen detection in the peripheral organs after ABV-2 or ABV-4 infection. 
After ABV-2 infection, we detected variability in the course of ABV-2 infection in 
experimentally ABV-2 infected birds as previously described (acute, intermittent, abortive, 
and inapparent infection) in naturally ABV infected psittacines (Heffels-Redmann et al., 
2011). We found that birds which exhibited gastrointestinal and/or neurological signs, had 
dilatation of proventriculus, they had also viral antigen and ABV-2 RNA in the CNS, GIT and 
in the peripheral organs. These findings might represent an acute form of the infection but not 
when this occur at mid time points or late time points. However, some variability was found 
i.e bird 25 exhibited gastrointestinal signs, had dilatation of proventriculus, mild 
inflammatory lesions in the brain, viral antigen detection, ABV-2 mRNA were detected but 
ABV-2 genome was not detected in the brain of this bird. By RT-PCR, Piepenbring detected 
low total ABV-2 RNA load (Ct value=28) in the brain in bird 25. It might be possible that 
such small amount of ABV-2 genome in the brain of this bird was below of detection by ISH. 
Moreover, Piepenbring detected ABV-2 RNA as total RNA in the brain of bird 25 by RT-
PCR. By ISH, we discriminated between ABV-2 genome and ABV-2 mRNA and we detected 
ABV-2 mRNA in the brain of bird 25. Another example for variability, bird 34 exhibited 
gastrointestinal signs, had dilatation of proventriculus, mild inflammatory lesions in the brain, 
and ABV-2 mRNA were detected. However, we could not be able to detect viral antigen and 
ABV-2 genome in the brain of bird 34. By RT-PCR, Piepenbring detected low total ABV-2 
RNA load (Ct value=29) in the brain in bird 34. It might be possible that such small amount 
of ABV-2 genome in the brain of this bird was below of detection by ISH. Moreover, birds 
could not exhibit gastrointestinal or neurological signs, did not displayed dilatation of 
proventriculus but they could also have viral antigen and ABV-2 RNA in the CNS, GIT and 
in the peripheral organs. This indicates to asymptomatic ABV infection. That is in line with 
(Lierz et al., 2009; Payne et al., 2011; Encinas-Nagel et al., 2014) where the ABV RNA and 
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viral antigen were detected in healthy birds which exposed to ABV infection. The reasons for 
the differences in the clinical outcome have to be further investigated. 
After ABV-4 infection, we detected variability in the course of ABV-4 infection in 
experimentally ABV-4 infected birds as previously described (acute, intermittent, abortive, 
and inapparent infection) in naturally ABV infected psittacines (Heffels-Redmann et al., 
2011). Birds exhibited gastrointestinal and/or neurological signs, had dilatation of 
proventriculus and they had also viral antigen and ABV-4 RNA in the CNS, GIT and in the 
peripheral organs. These findings might represent an acute form of the infection but not when 
this occur at mid time points or late time points. However, some variability was found i.e bird 
15 exhibited gastrointestinal and neurological signs, had dilatation of proventriculus, 
inflammatory lesions in all organs, viral antigen detection in all organs except in skin, ABV-4 
genome was detected in all organs especially in the peripheral organs but ABV-4 mRNA was 
not detected in all peripheral organs of this bird. By RT-PCR, Piepenbring detected low total 
ABV-4 RNA load in all the peripheral organs of bird 15. Birds did not exhibit gastrointestinal 
or neurological signs, did not display dilatation of proventriculus, they could also have viral 
antigen and ABV-4 RNA in the CNS, GIT and in the peripheral organs. This indicates to 
asymptomatic ABV infection. That is in line with (Lierz et al., 2009; Payne et al., 2011; 
Encinas-Nagel et al., 2014) where the ABV RNA and viral antigen were detected in healthy 
birds which exposed to ABV infection. 
 
5.8. Isolation of cockatiels blood cells 
Piepenbring and colleagues (2012) demonstrated successful experimental infection via 
intracereberal and intravenous route of infection with ABV-2 and ABV-4 in cockatiels. 
However, the potential infection of blood cells was still unclear. In the current study, we 
investigated the potential role of blood cells for dissemination of ABV infection. Boyum 
(1968) was the first researcher who isolated peripheral blood mononuclear cells from human 
blood. Carlson and Kaneko (1973) isolated leukocytes from bovine peripheral blood. Boyum 
(1976) also isolated macrophages from human blood. Lee and colleagues (1996) described 
isolation of blood cells in a wide range of species of animals. Lavoie and Grasman (2005) 
described the optimal conditions for isolation, cryopreservation, and mitogenesis of peripheral 
blood lymphocytes from chickens (Gallus domesticus) and wild herring gulls (Larus 
argentatus). In this study, we provided for the first time an optimized protocol for isolation of 
cockatiel BC cells from small amount of blood volume. After successful isolation of BC cells, 
we determined the life span of BC cells in culture (15 days).  
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5.9. Characterization of the immune cells in cockatiel BC cells by IIF 
Characterization of BC cells is very important to know which cells were exactly in culture. 
However, by morphological analysis it is difficult to differentiate between BC cells. It is 
difficult to differentiate thrombocytes from erythrocytes in chicken (Lavoie and Grasman, 
2005). Likewise, scanning electron microscopy (SEM) is not an appropriate approach and 
helpful technique to distinguish peripheral blood mononuclear cells of chickens according to 
their morphology (Burkhardt, 1979). IIF is a useful approach to identify blood cells and cell 
surface markers using different cross reactive antibodies. Due to the lack of specific cell 
surface markers that identify immune cells of cockatiel blood, we tested the cross reactivity of 
antibodies directed against other species blood cells. Many previous studies have already 
demonstrated the homology between cell surface markers of chicken and other species of 
mammals. For instance, there is homology between chicken and mammalian B cell (Batten et 
al., 2000; Rolink and Melchers, 2002, Schneider et al., 2004). Findings of previous studies 
(Chen et al., 1996; Cooper et al., 1991) described a highly similarity between chicken T cell 
from Gallus gallus domesticus and mammalian T cells. The same was true with duck CD4 
cells and CD25 cells when compared to mammalian T cells (Revathi et al., 2012). Another 
study (Luhtala, 1998) substantiated the homology between CD4 cells, CD8 cells and T cell 
receptor (TCR) in chicken to CD4 cells, CD8 cells and TCR in mammals. Tregaskes and 
colleagues (1995) described an appropriate conservation between chicken and mammalian 
CD8 genes. Avian TCR1 and TCR2 have recently been shown large proportion of homology to 
mammalian TCR receptors (Chen et al., 1986; Bucy et al., 1988; Josef et al., 1988). Michael 
and colleagues (2012) mentioned that chicken thrombocytes have great homology to 
mammalian thrombocytes. Mast and colleagues (1997) described conservation between 
chicken mononuclear phagocytes and mammalian mononuclear phagocytes. Characterization 
of blood cells has been described in many different species of mammals, birds and man but not 
in cockatiels. We provided the first detailed report for characterization of the immune cells in 
cockatiel blood by using reliable cross reactive cell surface markers by IIF. The normal 
percentage of CD3 cells in avian blood is 76% (Kushima et al., 2004). Our findings also show 
a high percentage of CD3 positive cells (estimated 71%) in cockatiel BC by IIF (not by FC). 
Bounus and Stedman (2000) also mentioned that T lymphocytes are the most circulatory 
leukocytes in avian blood. Heterophils are regarded as the most predominant leukocytes 
population in the blood of most avian species (Fudge, 2000; Latimer and Bienzle, 2000). The 
normal percentage of CD4 cells in avian blood is 41% (Kushima et al., 2004). Our findings 
show a comparable percentage of CD4 positive cells (estimated 36%) in cockatiel BC. The 
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normal percentage of CD8 cells (alpha and beta) in avian blood are not exceeding 20% 
(Kushima et al 2004). Our findings also show a low percentage of CD8a positive cells 
(estimated 11% by IIF) in cockatiel BC. We detected 71% CD3-positive cells in the BC cells 
population. Moreover, we detected 36% CD4-positive cells, and 11% CD8a-positive cells. 
CD3 is a pan-T cell marker and it bounds to the membranes of all mature T cells. The 
estimated percentages of CD4-positive cells, and CD8a-positive cells (47%) did not match to 
the 71% of CD3-positive cells in the BC cells population. It means that 24% positive cells that 
were detected in the 71% CD3-positive cells of the BC cells population were lacking. It might 
be possible that these cells were other peripheral blood T-lymphocytes such as suppressor T 
cells, natural killer T cells, or even other subtypes of CD8 or CD4 cells (beta or gamma but not 
alpha). The normal percentage of B cells in avian blood ranged between 10-14% (Domingo et 
al., 1986). Our results show a low percentage of peripheral blood B positive cells (estimated 
9% by IIF) in cockatiel BC and are therefore in agreement with Domingo et al., 1986. The 
normal percentage of monocytes in blood range between 0-5%. We found few countable 
monocytes (1-10 positive cells) in the whole smear. We found low percentage of thrombocytes 
in cockatiels buffy coat cells (estimated 20% by IIF) and that is in agreement with a previous 
study (Lavoie and Grasman, 2005) who demonstrated that percentage of thrombocytes in buffy 
coat cells from herring gulls is 20% whereas proportion of thrombocytes in the isolated 
mononuclear cells are ranged 40-77 %. 
 
5.10. Characterization of the immune cells in cockatiel BC cells by FC 
Mack Fulwyler was the inventor of the flow cytometer particularly the cell sorter in 1965 
(Fulwyler, 1965). Characteristics that can be measured by flow cytometry include cell size, 
cytoplasmic complexity, nucleic acid content, membrane-bound and intracellular proteins 
(Recktenwald, 1993; Keren et al., 1994; Shaprio, 1995; Watson, 1999). Characterization of 
the immune cells in birds has been described in many of previous studies in different species 
of birds by flow cytometry. In chicken, it was used to characterize chicken monocytes (Mast 
et al., 1997), chicken thrombocytes (Lacoste et al., 1994) and chicken bone marrow-derived 
professional antigen-presenting cells (Zhiguang et al., 2010). In turkey, it was used to identify 
turkey CD4 and CD8 cells (Li, et al., 1999). In owls, it was used to identify the CD3 cells in 
great horned owl (Bubo virginianus) (Malka et al., 2008). In duck, it was used to recognize B 
lymphocytes proportion, T lymphocytes, T helper and T cytotoxic (Kothlow et al., 2005). 
Flow cytometric findings of other studies showed a homology between human and chicken 
immune cells. Marko and colleagues (1993) found the functional and biochemical 
conservation of chicken and human CD4 molecule by flow cytometry. Revathi and 
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colleagues, (2012) described the suppressive properties of chicken CD4 and CD25 positive 
cells similar to that of mammalian regulatory T cells by flow cytometry. Rodenberg and 
colleagues (2012) analyzed lymphocytes obtained from the blood, spleen, and bursa of normal 
chickens and of chickens infected with infectious bursal disease virus (IBDV) for phenotypic 
expression of CD4, CD8, and immunoglobulin cell surface markers by IIF and flow 
cytometry. Many recent studies have also investigated the expression of the chicken CD8 and 
CD4-positive cells after infection with Marek's disease virus (MDV) (Toshifumi et al., 1995) 
or after adenovirus infection (Chun et al., 2012) in chicken spleen, thymus, and blood by FC. 
We tested the cross reactivity of chicken cells surface markers to recognize cockatiel immune 
cells in FC. However, despite a broad range of methological approaches, it was not possible to 
reproduce and obtain results of IIF in the FC. We obtained low percentages of CD4-positive 
cells, CD8a-positive cells, monocytes, thrombocytes and B cells in cockatiel BC cells in the 
FC. We did not obtain positive results with CD3 marker in the FC. The results obtained by 
flow cytometry were in discrepancy with the data by IIF. Therefore, we believe the obtained 
results in the IIF that fit with the literature data but we do not believe the results which were 
obtained in the FC for characterization the immune cells in the BC. It is still unknown why we 
did not obtain similar positive results in the FC as in the IIF. It might be possible that cell 
surface markers that we used them in the IIF were not cross reactive in the FC or antigen were 
shed from the cells during the procedure. It might also possible that the FC protocol needs a 
further optimization. Another possibility that there are major differences in the sensitivity and 
quantification between flow cytometry and IIF (Uehlinger et al., 2008). That means, 
differences in the duration of laser excitation and detector sensitivity, the way the data is 
displayed, and what constitutes a signal between IIF and FC would make a difference to limit 
the detection of signals.  
 
5.11. ABV-4 infection of cockatiel BC cells 
5.11.1. ABV antigen and ABV-4 RNA in cockatiel BC cells 
IIF and PCR findings showed that neither ABV antigen nor ABV-4 RNA was detected in 
stimulated or non stimulated BC cells after experimental infection with ABV-4. Thus, blood 
cells could not be infected with ABV-4 by using the approaches of this study. By IHC, we 
found slight positive reactions of ABV antigen in endothelium of blood vessels of the heart, 
liver, and kidney in experimentally ABV-2 and ABV-4 infected birds. We still do not know 
whether such positive immunostaining in the endothelium was unspecific reaction when using 
polyclonal antibodies (anti-p24 antibodies) or indeed associated with ABV infection. This 
should be therefore tested in the future. It might be possible that vascular or lymphatic 
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endothelium of blood vessels contribute to disseminate ABV within peripheral organs after 
experimental infection with ABV-2 and after ABV-4 in cockatiels. This needs to be further 
investigated. By IHC, we have also found positive reactions of ABV antigen in some cells that 
located in the center of the follicular shape-like aggregations of the cellular infiltrates in the 
skin, pancreas, kidney, and liver. We do not know whether these are macrophage or dendritic 
cells presenting viral antigen. This requires more investigations. If so, this could be explained 
by the fact that these antigen presenting cells (APCs) have processed the ABV antigen, 
engulfed it and eventually present it on the cell surface to the T cells of the immune system in 
order to induce a primary immune response (Kaspers and Kaiser, 2014). Our data suggest that 
blood cells can not be infected with ABV-4 by using the applied techniques. 
 
5.12. ABV-4 infection of stimulated BC cells 
5.12.1. Stimulation of BC cells with PHA-M mitogen 
PHA-M mitogen is a T cell mitogen (Mills et al., 1985), however, other studies suggesting that 
PHA also has some effect on B lymphocytes (Chess et al., 1974, Knuutila and Kovanen, 1987, 
Weksler and Kuntz, 1976). PHA-M mitogen was used to activate B and T lymphocytes in 
human as well as in different species of animals in vitro in many previous studies, in mice 
(Doenhoff et al., 1976), chicken (Tapani et al., 1978) and for human peripheral blood 
lymphocytes (Mire-Sluis et al., 1978). IIF results showed that BC cells started to proliferate in 
culture 2 hours after incubation with PHA-M mitogen until day 14 post stimulation with PHA-
M mitogen. For the first time, we investigated the stimulation of cockatiel BC cells after 2 
hours post stimulation with PHA-M mitogen. Our results also showed that stimulated BC cells 
reached the maximal rate of cells proliferation at day 3 post stimulation with PHA-M mitogen. 
We detected high percentage (86%) of stimulated BC positive cells at day 3 post stimulation. 
These results are in line with findings of a previous study (Thiel and Burkhardt, 1984) who 
suggested that chicken peripheral blood lymphocytes have high mitogenic response to PHA-M 
at day 2 and day 3 post stimulation with PHA-M mitogen. In the current study, best stimulation 
results were obtained when PHA-M mitogen in a dilution of 1:15. These results are in 
accordance with that reported by (Thiel and Burkhardt, 1984). With this work, we also 
provided for the first time how to stimulate cockatiel BC cells.  
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5.12.2 Assessment of the proliferative state in cockatiel BC cells 
Detection of bromodeoxyuridine incorporation was used as an indicator for proliferation of 
cells in many previous studies by using different methods, i.e., immunohishtochemistry 
(Green et al., 1992; Wesley et al., 1998), flow cytometry (Harry and John, 1992), and 
immunofluorescence (Gratzner et al., 1975; Petersen et al., 2012). With this work, we 
provided for the first time an optimized protocol for detection of the proliferating cells in 
cockatiels after stimulation with PHA-M mitogen by investigation of BrdU incorporation. 
 
5.12.3. ABV antigen and ABV-4 RNA in stimulated BC cells 
We investigated whether stimulated BC cells could be infected with ABV-4 at a certain stage 
of differentiation. By IIF and PCR, we did not find ABV antigen and ABV-RNA in stimulated 
BC cells by IIF and by PCR respectively. Burkhardt and Müller (1987) found that lymphocytes 
could be infected with IBD virus at a certain stage of cells differentiation after stimulation with 
PHA-M mitogen. Burkhardt and Müller, (1987) demonstrated that the proliferating lymphoid 
cells isolated from chicken are the target cells for infectious bursal disease (IBD) virus 
indicating that IBD needs a rather immature target cells than mature cells for viral replication 
and infection. The study was suggested that IBD virus can replicate in lymphoblasts but not in 
lymphocytes obtained from phytohaemagglutinin (PHA-M) stimulated cultures and not in 
unstimulated lymphoid cells. Another study already (Müller, 1986) suggested that infectious 
bursal disease virus prefers to replicate in the in a population of proliferating cells 
characterized by increased thymidine uptake and by blast cell formation. Our results did not 
show viral antigen and ABV-4 RNA in stimulated or unstimulated BC cells after ABV-4 
infection. The stimulated BC cells could also not be infected with ABV-4.  
In the end, we still asking ourselves many open questions, we found slight positive reactions 
of ABV antigen in endothelium of blood vessels of the heart, liver, and kidney in 
experimentally ABV-2 and ABV-4 infected birds by IHC. We still do not know whether such 
positive immunostaining in the endothelium was unspecific reaction when using polyclonal 
antibodies (anti-p24 antibodies) or indeed associated with ABV infection. By IHC, we also 
found positive reactions of ABV antigen in some cells that located in the center of the 
follicular shape-like aggregations of the cellular infiltrates in the skin, pancreas, kidney, and 
liver. We do not know whether these are macrophage or dendritic cells presenting viral 
antigen. This requires more investigations. A question is presents itself, why the kinetic of 
inflammatory lesions, viral antigen, and viral RNA was variable among organs according to 
the genotype after ABV-2 and ABV-4 infection. Further investigations are needed to 
understand the pathogenesis of ABV and the different ABV genotypes. Another question 
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remains unclear how ABV-2 and ABV-4 reached to the GIT and peripheral organs when both 
genotypes were inoculated intravenously. Mode of transmission by which ABV spread within 
central and peripheral nervous systems and organs after ABV-2 and ABV-4 infection remains 
unclear. It might be possible that ABV infection was generalized within organs via infected 
macrophages or endothelial cells or may be transmitted via transient viremia. Further research 
into details of ABV widespread within organs will be essential to understand the pathogenesis 
of ABV after infection. 
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6. Summary 
  
Avian Borna viruses (ABV) are the etiological agents for proventricular dilatation disease 
(PDD). Distribution patterns of ABV-2 and ABV-4 in experimentally ABV-2 and ABV-4 
infected cockatiels were similar to distribution patterns of ABV in naturally PDD affected 
psittacines. ABV-2 and ABV-4 exhibited broad tissue distribution patterns in all organs in 
experimentally ABV-2 and ABV-4 infected cockatiels. Inflammatory lesions, ABV antigen, 
ABV-2 genome and ABV-2 mRNA were mainly detected in the gastrointestinal tract (GIT) 
and peripheral organs after ABV-2 infection. Inflammatory lesions, ABV antigen, ABV-4 
genome and ABV-4 mRNA were predominantly detected in the central nervous system (CNS) 
and peripheral organs after ABV-4 infection. ABV-2 transcription was effective in the GIT 
organs after ABV-2 infection. ABV-4 transcription was operative in the CNS after ABV-4 
infection. These findings indicate distinct differences in biological behaviour between the used 
ABV-2 and ABV-4 isolates. By immunohistochemistry, CD3-positive cells were detected in 
cellular infiltrations in all organs after ABV-2 and ABV-4 infection. Isolation of buffy coat 
(BC) cells of cockatiels and stimulation with phytohaemagglutinin (PHA-M) were successfully 
established. Characterization of CD3-positive cells, CD4-positive cells, CD8a-positive cells, 
monocytes, B cells, and thrombocytes was successful in cockatiel BC by indirect 
immunofluorescence. Characterization of CD4-positive cells, CD8-positive cells, monocytes, 
B cells, thrombocytes cells but not CD3-positive cells was possible in cockatiel BC by flow 
cytometry. ABV antigen and ABV-4 RNA were not found in BC cells of cockatiels from day 0 
until day 15 post infection with ABV-4. Moreover, ABV antigen and ABV-4 RNA were not 
found in stimulated BC cells from day 0 until day 15 after stimulation and ABV-4 infection. 
These results providing first evidence that cockatiel blood cells could not directly be infected 
with ABV-4. 
Further investigations on the role of macrophages or endothelial cells for the dissemination of 
ABV infection within an infection are therefore required. 
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6. Zusammenfassung 
 
Aviäre Bornaviren (ABV) sind Auslöser der neuropathischen Drüsenmagendilatation 
(proventricular dilatation disease, PDD). Die Verteilungsmuster von ABV-2 und ABV-4 in 
experimentell ABV-2 und ABV-4 infizierten Nymphensittichen stimmten mit dem 
Verteilungsmuster des Virus in natürlich an PDD erkrankten Psittaziden überein. Die beiden 
Genotypen ABV-2 und ABV-4 nach experimenteller Infektion von Nymphensittichen ein 
breites Verteilungsmuster in allen Organen auf. Entzündliche Läsionen, ABV-Antigen, ABV-
2-Genom und ABV-2-mRNA wurde hauptsächlich im Gastrointestinaltrakt (GIT) und in 
peripheren Organen nach ABV-2-Infektion festgestellt. Im Vergleich dazu wurden nach 
Infektion mit ABV-4 entzündliche Läsionen, ABV-Antigen, ABV-4-Genom und ABV-4-
mRNA vorherrschend im zentralen Nervensystem (ZNS) und in peripheren Organen 
festgestellt. Nach ABV-2-Infektion läuft eine effektive Transkription des Virus vor allem im 
GIT ab, während es nach ABV-4-Infektion zu einer deutliche Transkription  im ZNS kommt. 
Diese Ergebnisse zeigen, dass es deutliche unterschiede im biologische Verhalten zwischen 
den  verwendung ABV-2 und ABV-4 Isolaten gibt. Mittels Immunhistochemie konnten nach 
ABV-2- und ABV-4-Infektion CD3-positive Zellen in den zellulären Infiltrationen in allen 
Organen festgestellt werden. Die Isolierung von Buffy-Coat (BC) Zellen von 
Nymphensittichen und ihre Stimulation mit Phytohämagglutinin (PHA-M) wurden in dieser 
Arbeit erfolgreich. Mit Hilfe von indirekter Immunfluoreszenz konnten CD3-positive Zellen, 
CD4-positive Zellen, CD8-positive Zellen, Monozyten, B-Zellen und Thrombozyten in BC 
Zellen Charakterisierung von Nymphensittichen werden.  
In der Durchflusszytometrie war die Charakterisierung von CD4-positive Zellen, CD8-
positive Zellen, Monozyten, B-Zellen, und Thrombozyten, aber nicht von CD3-positive 
Zellen aus Nymphensittich BC möglich. Unsere Untersuchung zeigt weiterhin, dass kein 
ABV-Antigen und keine ABV-4-RNA in Buffy-Coat (BC) Zellen von Nymphensittichen im 
Zeitraum von 0 Tagen bis zu 15 Tagen nach einer Infektion mit ABV-4 gefunden wurden. 
Außerdem waren kein ABV-Antigen und keine ABV-4 RNA in stimulierten BC-Zellen von 
Tag 0 bis Tag 15 nach der Stimulation und ABV-4-Infektion nachweisbar.  
Diese Ergebnisse zeigt dass Nymphensittichblutzellen nicht direkt mit ABV-4 infiziert 
werden. 
Weitere Untersuchungen über die Rolle von Makrophagen oder Endothelzellen in der 
Verbreitung der ABV-Infektion innerhalb des infection wird erforderlich.  
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9. Annexes 
  
9.1. Dyes  
 
4' 6-diamidino-2-phenylindole (DAPI) (Thermo scientific, Germany) 
1 mg (DAPI) 4', 6-diamidino-2-phenylindole (MW 350.2 g/mol) 
1 ml sterile water  
 
3 3'-diaminobenzidine tetrahydrochloride dihydrate (DAB) (Fluka, Germany) 
To prepare a staining solution of the DAB, add: 
100 mg DAB (final concentration 0.05%) 
200 ml 0.1M imidazol, adjusted with HCl to pH 7.08 (final concentration 0.1M) 
70 µl hydrogen peroxidase (H2O2) (final concentration 0.01%) 
 
Papanicolaou 
Diluted 1:10 in bi-distilled water, mixed and then infiltrated. 
 
Midori-green dye (Nippon Genetics Europe GmbH, Germany) 
Diluted 1:10 in sterile water, mixed and then stored in the refrigerator until use. 
 
6X orange DNA loading dye (Thermo Scientific, Germany) 
Ready to use 
 
 
9.2. Sera  
 
5 % goat serum in sterile 1xPBS 
5 ml goat serum (Sigma Aldrich, Germany) 
95 ml sterile 1x PBS 
 
20% pigs serum / TBS 
20 ml pig serum (PAA, Austria) 
80 ml TBS 
 
10 % rat serum / TBS 
10 ml Rat serum (PAA, Austria) 
90 ml TBS 
 
Horse serum (Dako, Germany) 
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9.3. Kits 
 
Avidin biotin complex Vectastain kit® (Vector laboratories Inc, USA) 
Elite ABC complex (Vector laboratories Inc, USA) 
Digoxigenin (DIG) RNA labeling (SP6/T7) kit (Roche, Germany) 
TOPO TA cloning kit (Life technologies, Germany) 
QIAGEN Multiplex PCR Kit (Qiagen, Germany) 
RNasey Mini kit (Qiagen, Germany) 
Qiamp viral RNA mini kit (Qiagen, Germany) 
QuantiTect Reverse Transcription kit (Qiagen, Germany) 
 
9.4. Primary antibodies 
Polyclonal rabbit anti Borna disease virus (BoDV) antibody 
Mouse anti-duck IgY (Biorad, Germany) 
Mouse anti-human CD20 (DCS ImmunoLine, Germany) 
Rat anti-feline CD45, clone B220 (Cedarlane, USA) 
Mouse anti-dog IgG (Dianova, USA) 
Mouse anti-human MUM1 protein (Dako, Germany) 
Mouse anti CD79 cy, clone JBC117 (Dako, Germany) 
Mouse anti CD79 cy, clone HM 57 (Acris, Germany) 
Rabbit anti-human CD3 (Dako, Germany) 
Myeloid histiocyte antigen, clone MAC 378 (Dako, Germany) 
Rabbit anti-human lysosome (Dako, Germany) 
Mouse anti-chicken monocytes, KUL01 (Biorad, Germany) 
Alkaline phosphatase (AP) conjugated anti-digoxigenin antibody (Roche, Germany) 
Rabbit anti-human CD3 (Dako, Germany) 
Mouse anti-human CD3, clone PC3 (Dako, Germany) 
Mouse anti-human CD3, clone F7.2.38 (Dako, Germany) 
Rat anti-human CD45R, clone B220 (Dako, Germany) 
Rabbit anti-dog IgG2a (Dako, Germany) 
Mouse anti-human CD79αcy, clone HM 57 (Dako, Germany) 
Mouse anti-human CD79αcy, clone JBB117 (Dako, Germany) 
Mouse anti-chicken CD4, clone2-35 (Biorad, Germany) 
Rat anti-human CD3, clone CD3-12 (Biorad, Germany) 
Mouse anti-chicken CD8a, clone 11-39 (Biorad, Germany) 
Mouse anti-duck IgY, clone14A3 (Biorad, Germany) 
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Mouse anti-chicken thrombocytes, clone 11C3 (Biorad, Germany) 
Mouse anti-chicken monocytes, clone KUL01 (Biorad, Germany) 
 
9.5. Secondary antibodies 
Biotinylated pig anti-rabbit IgG antibody (Vector laboratories Inc, USA) 
Biotinlynated goat anti-mouse IgG (Vector lab, USA) 
Biotinlynated horse anti-mouse IgG (Vector lab, USA) 
Biotinlynated rabbit anti-rat IgG (H+L) (Vector, USA) 
Pig anti rabbit IgG1 (Dako, Germany) 
Rat anti-mouse IgG (Dianova, USA) 
Pig anti-rabbit IgG (Dako, Germany) 
Cy3 conjugate goat anti-rabbit IgG (H+L) (Dianaova, USA) 
Cy3 conjugate goat anti-rat IgG (H+L) (Dianaova, USA) 
Cy3 conjugate goat anti-mouse IgG (H+L) (Dianaova, USA) 
Allophycocyanin (APC) conjugated goat anti-rat IgG1 (BD Bioscience, Germany) 
Phycoerythrin (PE) conjugated goat anti-mouse (BD Bioscience, Germany) 
Mouse anti-BrdU antibody (Santa Cruz Biotechnology, Germany) 
 
9.6. Solutions and Buffers 
Washing buffer, to prepare 15 ml washing buffer (WP): add 
14, 910 µl  1 % BSA / 1x PBS  
15 µl  10 % NaN3 
75 µl  5% goat serum 
 
0.1M imidazol /HCL buffer (pH 7.1) 
Dissolve:  
6.81 g imidazol in 500 ml distilled water  
Adjust with 1N HCl to pH 7.1, then fill it to 1 liter. 
 
Endogenous hydrogen peroxidase (H2O2) solution, add: 
177 ml of pure methanol 
3 ml hydrogen peroxidase (H2O2) (final concentration 0.05%) 
 
Tris-buffered Saline (TBS), pH 7.6  
60.57 g Tris (MW 121.14) (Carlroth, Germany) 
 600 ml bi-distilled H2O  
 400 ml 1 M HCl,   Adjust pH with 1 M HCl   
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5 x TBE electrophoresis Buffer 
54 g Tris (MW 121.14)  
27.5 g Boric acid (MW 61.83)  
20 ml 0.5M EDTA (MW 372.24) 
1 l bi-distilled H2O, Autoclave at 121 ºC, 80 minutes, stored at 4- 8 ºC  
 
0.5 x TBE electrophoresis Buffer 
 100 ml 5 x TBE  
  900 ml bi-distilled H2O 
 
2% agarose gel 
 0.6 g agarose 
 30 ml 0.5x TBE buffer 
 
Citrate Buffer (pH 6.5) 
9 ml    0.1M citric acid  
41 ml   0.1M  Na2- Citrate  
500 ml bi-distilled H2O 
 
5M NaOH 
20 g NaOH (MW 40 g/mol) 
100 ml bi-distilled H2O 
 
0.2M Disodium Ethylenediaminetetraacetate (EDTA) 
7.44 g EDTA-Na2  
100 ml bi-distilled H2O, Adjust volume with 5N NaOH pH to 8  
 
4M Lithium chloride 
 25.4 g LiCl (MW 49.39 g/mol) 
 250 ml bi-distilled H2O 
 
1x phosphate buffered saline (PBS)  
8 g NaCl (MW 58.44)  
 0.2 g KCl (MW 74.56)  
 1.44 g Na2-HPO4 2 H2O (MW 177.99)  
 0.24 g KH2PO4 (MW 136.09)  
 700 ml bi-distilled H2O, adjust pH with 1 M NaOH to 7.4 and then, adjust volume to 1 liter 
with distilled H2O. Autoclave it at 121 ºC, 80 minutes 
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10 x PBS, pH 7.4  
80 g NaCl (MW 58.44)  
2 g KCl (MW 74.56)  
14.4 g Na2-HPO4 2 H2O (MW 177.99 g/mol)  
 2.4 g KH2PO4 (MW 136.09)  
 700 ml bi-distilled H2O, adjust pH with 1 M NaOH to pH7.4, then, adjust volume to 1 l with 
distilled H2O, Autoclave it at 121 ºC, 80 minutes 
 
DEPC-H2O RNAse free water  
1 ml of Diethylpyrocarbonat (DEPC)  
1 l of bi-distilled H2O   
Mix overnight, autoclave at 120 ºC, one hour and 15 minutes   
 
0.5 M EDTA-Na2    pH 8 
18.6 g Di-Nitrium-EDTA-di-hydrate (MW 372.13 g/mol)  
60 ml of bi-distilled H2O with DEPC 
 Adjust solution with 5N NaOH to pH 8 
 
20 x SSC (standard saline citrate) pH7 
175.3 g NaCl (MW 58.44)  
88.2 g Tri-Na-Citrate x 2 H2O (MW 294.1)  
800 ml bi-distilled H2O  
 Adjust pH to 7.0 with 1 M HCl  
Adjust volume to 1 l with bi-distilled H2O, Autoclave at 121 ºC, 80 minutes 
 
2 x SSC (standard saline citrate)  
50 ml 20 x SSC 
500 ml bi-distilled H2O 
 
0.2 x SSC (standard saline citrate)  
1.2 ml 20 x SSC 
120 ml bi-distilled H2O 
 
2 x SSC + 5 mM EDTA-Na2  
50 ml 20 x SSC pH 7.0  
 5 ml 0.5 M EDTA-Na2   
 Adjust volume to 500 ml with bi-distilled H2O, autoclave it at 121 ºC, 80 minutes  
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0.2M HCl 
50 ml 2N HCL 
450 of bi-distilled H2O  
 
1 M Tris pH 8.0  
12.11 g Tris (MW 121.14)  
 50 ml bi-distilled H2O  
 Adjust pH with 1 M HCl to 8.0, Adjust volume with bi-distilled H2O to 100 ml. Autoclave it 
at 121 ºC, 80 minutes 
 
Proteinase K 
 16.2 mg Proteinase K (Boehringer Mannheim, Germany) 
 1 ml 10 mM Tris-HCL  pH7.5 
 
0.1M   CaCl2 
 1.47 g CaCl2 (MW 147.02 g/mol) 
100 ml of bi-distilled H2O   
 
Proteinase K solution  
1 ml 1 M Tris pH 8.0  
1 ml 0.1 CaCl2  
Adjust volume to 60 ml with DEPC-H2O, mix   
 
1M   MgCl2 
20.33 g MgCl2 (Hexanhydrate MW 203.3 g/mol) 
100 ml of bi-distilled H2O 
 
5M NaCl 
29.22 g NaCl (MW 58.44 g/mol) 
100 ml of bi-distilled H2O 
 
3M NaCl 
87.66 g NaCl (MW 121.14 g/mol) 
 500 ml of bi-distilled H2O  
 
0.2 % Glycine-PBS  
1 g Glycine (MW 75.07)  
 450 ml PBS pH 7.4, Adjust pH with 1M HCl to 7.4 
  Adjust volume to 500 ml with PBS pH 7.4, Autoclave at 121 ºC, 80 minutes  
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4 % Paraformaldehyde, pH 7.4  
 40 g Paraformaldehyde  
  900 ml PBS pH 7.4  
   Dissolve at 60 °C on a magnetic stirrer  
   Adjust pH with 1M NaOH to 7.4  
 
0.25 % Acetanhydride in 0.1 M Triethanolamine-DEPC-H2O    (pH 7.5)  
 894 mg    Triethanolamine (Merck, Germany)  
 50 ml DEPC-H2O  
  Adjust pH with 1 M HCl to 7.5  
  Add 150 µ l Acetanhydride (Fluka, Germany) 
 Adjust volume to 60 ml with DEPC-H2O 
 
PBS + 5 mM MgCl2  
10 ml 10 x PBS  
5 µl 1 M MgCl2  
Adjust volume up to 100 ml with bi-distilled H2O 
 
Prehybridization mix (PHB-Mix) 
450 ml 20 x SSC  
 675 ml 100 % Formamid  
 150 ml 50 x Denhardts  
210 ml bi-distilled H2O, Mix and aliquot as 49 ml volume in tubes, store at - 20 °C. 
 
50 x Denhardts  
5 g Ficoll 
5 g polyvinylpyrrolidone 
5g bovine serum albumin 
 Fill up to 500 ml with bi-distilled H2O, autoclave at 121 ºC, 80 minutes. 
 
Sodium salt Deoxyribonucleic acid (ssDNA)  
 10 mg ssDNA (Sigma Aldrich, Germany) 
 1 ml buffer 4, final concentration (10 mg/ml) 
 
RNA stocks solution (Ribonucleic acid from calf liver type IV) 
 10 mg RNA (Sigma Aldrich, Germany) 
 1 ml   bi-distilled H2O treated with DEPC  
 Final concentration 250µg/ml 
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0.5M Piprazin   (Pipes) 
8.65 g PIPES 
50 ml of bi-distilled H2O 
 
20x hybridization salts 
10 ml 0.5M EDTA (pH 8) 
10 ml 0.5M Pipes (pH 7) 
30 ml 5M NaCl 
Aliquot and store at - 20 °C  
  
Hybridization mixture (HM) 
16 ml 100 % Formamid, deionised 
8 ml 20x hybridization salts 
3.2 ml 50 x Denhardts 
320 µl Heparin (10 mg Heparin 16,000 IU in 1 ml 10% iges Triton X-100) 
320 µl 10% iges Triton X-100 
Mix and aliquot as 696 µl volume in eppendorfs , store at - 20 °C   
 
6 x SSC (standard saline citrate) with 45 % formamide 
36 ml 20 x SSC  
54 ml 100 %iges Formamid 
50 ml bi-distilled H2O 
 
RNAse solution 
10 ml 3M NaCl 
600 µl 1M Tris (pH 8) 
120 µl  0.5M EDTA (pH 8) 
49 ml bi-distilled H2O (prewarm it in the water bath at 37 ºC)  
 2.5 µl RNAse A (5000 U/ml)  
100 µl RNase T (100,000 U/ml) (Roche GmbH, Mannheim, Germany) 
 
Buffer 1, pH 7.5  
12.11 g Tris (MW 121.14)  
8.77 g NaCl (MW 58.44)  
500 ml bi-distilled H2O  
Adjust pH with 1 M HCl to 7.5  
Adjust volume to 1 l with bi-distilled H2O  
Autoclave at 121 ºC, 80 minutes 
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Buffer 2 (Blocking solution) 
1.2 ml Neutral sheep serum (Sigma Aldrich, Germany) 
1.8 ml 10 % Triton X-100  
Adjust volume to 60 ml with buffer 1  
 
Buffer 3 (pH 9.5) 
12.11 g Tris 
5.84 g  NaCl 
10.17 g MgCl2 X 6H2O (MW 203.3 g/mol) 
 Fill up to 1000 ml with bi-distilled H2O, adjust it with 1N HCL to pH 9.5. Autoclave at 121 
ºC, 80 minutes 
 
Buffer 4 (pH8) 
1.21 g Tris  
0.37 g EDTA (MW 372.3 g/mol) 
Fill up to 600 ml with bi-distilled H2O, adjust volume with 2N HCL to pH 8, fill up to liter, 
autoclave at 121 ºC, 80 minutes 
 
Anti- digoxigenin antibody solution,  
For each 3 ml with buffer 1, add 
15µl anti-DIG antibody (150 Unit), (Roche GmbH, Germany) , dilution 1:300 
31µl sterile Neutral sheep serum (NSS)  
94 µl 10% Triton X-100  
 
50 mg/ml 5-bromo-4-chloro-3-indolyl phosphate (BCIP) stock solution 
Dissolve: 
500 mg BCIP in 10 ml 100% dimethylformamide (DMF).  
BCIP stock solutions were stored at -20 °C. 
 
75mg/ml Nitroblueteterazolium (NBT) Stock Solution, dissolve: 
1g NBT in 13.3 ml of 70% dimethylformamide in water.  
The NBT stock solutions were stored at -20 °C. 
 
NBT/ BCIP staining solution  
250 µl   Nitroblueteterazolium (NBT) (75 mg / ml NBT Stock Solution) 
210 µl    X-Phosphate (BCIP) (50 mg / ml BCIP stock solution) 
15 mg    Levamisol (Sigma Aldrich, Germany) 
60 ml      Buffer 3 
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0.1M sodium borate Buffer (Na2B4O7) (pH 8.5) 
380 mg Sodium teteraborate (Carlroth, Germany) 
10 ml bi-distilled H2O  
Use 0.2 micron filter membrane to filter.  
Adjust volume with 1N HCL to pH 8.5 
  
0.3% Triton X-100 
 300 µl Triton X-100 (Serva, Germany) 
 100 ml sterile bi-distilled H2O 
 
2M HCL  
167 ml concentrated HCl (MW 36 g / mol) 
 1 Liter bi-distilled H2O 
 
1% BSA / TBS 
1 g   Bovine serum albumin 
100 ml TBS 
 
9.7. Equipments 
1. Automatic Tissue Tek VIP® machine (Sakura, Germany) 
2. Automatic Tissue-Tek® TEC TM (Sakura, Germany) 
3. Fully automated Leica RM2255 rotary microtome (Leica, Germany) 
4. Automatic HMS740 Microm robot-stainer (Microm GmbH, Germany) 
5. Automated Tissue Tek® coverslipper machine (Sakura, Germany) 
6. PTC-200 Peltier thermal cycler (Biorad, Germany) 
7. UV light with a transilluminator (Bachhofer Laboratories, Germany) 
8. Scale (Ohaus, Germany) 
9. Mettler Balance Scale Model PN1210 (Mettler-Toledo GmbH, Germany) 
10. Mettler Toledo PM4600 DeltaRange Balance (Mettler-Toledo GmbH, Germany) 
11. Heating Magnetic Stirrer  (Heidolph instruments GmbH, Germany) 
12. Vortex mixerer (Heidolph instruments GmbH, Germany) 
13. Vortex mixerer (MAGV instruments GmbH, Germany) 
14. Centrifuge 5415C (Eppendorf, Germany) 
15. Universal 32 centrifuge (Hettich, Germany) for FC 
16. Rotina 48RC Centrifuge (Hettich, Germany) 
17. Microcentrifuge Rotor (Thermo Scientific, Germany) 
18. Laboratory water bath (Labortechnik, Germany) 
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19. Laboratory water bath (Memmert, Germany) 
20. Water bath at the cell culture lab (Kottermann laboratories GmbH, Germany) 
21. Incubator (Memmert, Germany) 
22. Heraeus® BBD6220 CO2-Incubator (Thermo Scientific, Germany) 
23. IX70 S8F inverted microscope (Olympus, USA) 
24. Eclipse E200 microscope (Nikon, Germany) 
25. Nikon fluorescence microscope (Nikon, Germany) 
26. Accu BlockTM Mini heat block (Labnet International Inc, Germany). 
27. BD flow cytometer machine (BD Bioscience, Germany). 
28. Sterilizer (Memmert, Germany) 
29. Medizintechnik  sterilisator (Melag, Germany) 
30. Vertical floor-standing autoclave (Systec, Germany) 
31. pH meter (Blue line, Germany) 
32. Heraues laminiair instrument (Thermo scientific, Germany) 
33. Laminar flow hood (Weiss GWE GmbH, Germany) 
34. Laminar flow (Captair, Germany) 
35. Airflow control DIN EN 14175 (Vinitex GmbH, Germany) 
36. UVC/TM-AR DNA/RNA UV-cleaner box (LTF Labortechnik GmbH, Germany) 
37. BMP51 Label maker (Brady, Germany) 
38. Nanodrop®2000 spectrophotometer (Thermo scientific GmbH, Germany). 
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